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Chapter 1: Introduction 
 
1.1. The death of a child 
 
[Klaas suffers from cystic fibrosis and is eleven years old when the illness 
reaches the terminal stage] “I am dying, am I?” “Yes Klaas, I’m afraid you are… 
It’s not yet completely hopeless, but I’m afraid you are.” “Okay.” He was quiet 
for a while when he tried to cope with this fact. With dry eyes. Clarity. That’s 
where children thrive. Even if that clarity is horrible. They can deal with that, 
better than grown-ups. “I don’t want to die… with a suffocating… shortness of 
breath.” I laid my hand on his arm. “No, I don’t want that either.” He looked at 
his parents. “Dad and mom… when I die… I want you… to be there… with me.” I 
won’t ever forget the sorrow I saw that moment. Something broke in those two 
big strong people, so intense, and I saw it happen before my own eyes. Tears 
rushed from their eyes. […] “Are you scared?” [the father asked] […] “No… no, 
there’s nothing more… that I wait for.” […] He gave it some thought and then 
shook his head. “It takes too long… but I am… not afraid… to leave… I think 
it’s… pretty good over there.” He was quiet for a while. “Are you guys scared?” 
Whatever was left of his dad now evaporated in his son’s arms. “Yes,” he said, 
“yes… I’m so scared… scared of losing you.” 
Quoted and translated from Brand P, “De Stoel van God”, 2009, p. 278-
279, Nieuw Amsterdam Uitgevers.  
 
The death of a child is the most devastating and traumatic experience parents can face. 
Through advances in medicine and hygiene, a significant decrease in child mortality 
has occurred in the course of the 20th century. Worldwide, under five-year-old 
mortality has dropped from 93 in a thousand live births in 1990 to 68 in a thousand live 
births in 2007. Large differences however exist across the world. In 2007, under-five 
mortality was six in a thousand live births in industrialized countries, while it was still 
169 in Western and Central Africa.(1) Although the incidence of cancer in European 
children and adolescents has increased significantly since the 1970s, overall five year 
survival rates have increased substantially from 44% in the 1970s to 64% in the 1980s 
and 74% in the 1990s.(2) The death of a child is consequently becoming a rare event in 
Western developed countries. In Flanders, the Dutch-speaking part of Belgium, with 
approximately six million inhabitants, between 400 and 500 live-born children die 
before the age of 18 every year, of which more than half die before the age of one. The 
absolute number of child deaths has steadily decreased between 2000 and 2005 in 
Flanders, mainly because of a decrease in traffic casualties amongst children.(3) 
The small and decreasing number of child deaths should, however, not obscure the 
impact of the issue on families. The rarity of child death could even be one of the 
reasons why it has such an awesome impact on families, as it is no longer a part of 
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everyday life for most people in Western developed societies. Parents who lose a child 
risk being socially isolated because many friends and acquaintances will feel insecure 
about how to cope with the situation. Moreover, birth rates are currently at their 
lowest level in Western developed societies and parents who lose a child are often left 
childless, which increases the impact of the event even more.(4;5) Most parents 
experience feelings of guilt after the death of their child.(6) The impact of a child’s 
death has been shown to be highest four to six years after bereavement, when bereaved 
parents have higher risks of depression and anxiety, and to decrease afterwards. Losing 
a child at age nine or older appears to be related to an increased risk of psychological 
distress.(7) 
The mortality rate is highest for neonates and adolescents, and lowest for children in 
between. The causes of death vary strongly with age: neonates and infants die mainly 
from congenital abnormalities, older children from external causes, including suicide 
and traffic accidents.(3) In general, external factors are the leading cause of death for 
children in Western developed societies.(8) This implies that children often die 
suddenly and unexpectedly, which precludes any palliative or end-of-life care. 
 
1.2. Pediatric end-of-life care 
 
1.2.1.Specific challenges 
 
Pediatric end-of-life care faces several critical challenges which make it different from 
end-of-life care in adults, and justify the need for specific approaches and research. 
 
a)  Developing decision-making capacities in children 
 
Childhood is characterized by constant and extensive physical and psychological 
changes. Different levels of development will require different approaches by health 
professionals. Very young children will for instance lack skills to verbalize their 
symptom burden. Caregivers will then have to tailor symptom assessment to the 
developmental level of the child and use alternative ways to come to a good 
understanding of the child’s symptoms, by for example using body charts or face 
scales.(9-11) Particularly relevant for our discussion, is the development of the required 
level of psychological competence in order for the child to be involved in medical 
decision-making. 
The psychological competence of minor patients is evidently a crucial factor in 
determining whether they should be allowed to make decisions autonomously. The 
concept of psychological competence poses several challenges to health care 
professionals. Below, we will focus on two pivotal challenges: first, defining the 
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standards for competence, and second, establishing how these standards should be 
assessed. Both challenges are inherently related to each other, as an assessment of 
competence can only take place when it is sufficiently clear which standards it should 
be compared to. 
An especially relevant aspect of competence, where decisions in pediatric end-of-life 
care are concerned, is the development by the child of a clear concept of death. Three 
components constitute a full concept of death: irreversibility (the understanding that 
once a living thing dies, its physical body can not be made alive again), non-
functionality (understanding that all life-defining functions cease at death) and 
universality (the understanding that all living things die). Based on their 1984 review, 
Speece and Brent conclude that in general, healthy children achieve an understanding 
of all three components at age five to seven.(12) Other authors regard the age of ten as 
the age at which most children acquire a mature concept of death.(13) This is only a 
rough indication, as wide variations exist between children. Chronological age 
correlates significantly with understanding of death, as does death experience.(14) The 
different components of death are differentially affected by several factors: the 
acquisition of the more abstract component of universality is affected by cognitive 
development, verbal ability and cultural and religious experience, while direct 
experience affects the more physical components of non-functionality and 
irreversibility.(13) The acquisition of a mature concept of death has been shown to be 
an important part of end-of-life care, and reduces fear of death in young children.(15) 
The acquisition of a clear concept of death is of course not in itself a sufficient standard 
of competence for a child to be involved in end-of-life decision-making. Other 
capacities are required in order to be able to fully participate in decision-making, such 
as understanding the diagnosis, the remaining treatment options and chances for 
survival, being able to weigh alternatives and being able to communicate 
preferences.(16) Some authors have tried to establish a comprehensive set of standards 
and thresholds for competence. In their MacArthur studies of competence, Appelbaum 
and Grisso have for instance identified four legal standards which constitute 
competence: the ability to communicate a choice, the ability to understand relevant 
information, the ability to appreciate the situation and its likely consequences and the 
ability to manipulate information rationally.(17-20) Until now, there is however no 
clear consensus on this set.(21;22) 
Determining whether children are psychologically competent requires an assessment. 
This assessment creates additional challenges for health professionals. First, as outlined 
above, it is not clear which standards should be assessed. Second, the conditions for 
competence to be involved in decision-making vary with the risks of the decisions at 
hand, and will be more rigorous if far-reaching decisions, such as life and death 
matters, are concerned.(21) Third, psychological competence is a continuous concept: 
children can be more or less competent. An assessment thus faces the challenge of 
establishing the thresholds for sufficient competence to be involved in a particular 
decision, which is a normative judgment. The assessment of competence is thus 
necessarily a dynamic process. Finally, it is not clear who should make this assessment. 
In practice, it is often the treating physician who makes the assessment, and this 
judgment is seldom questioned in courts.(21) However, others argue that it may be 
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feasible to leave this assessment to specialized professionals, such as child 
psychologists.(23;24) 
Some experts have attempted to provide a framework for assessment of 
competence.(23) Besides providing the child with all the relevant information to 
enhance competence, health care professionals are recommended to take several 
specific factors into account when assessing the competence of minor patients.(23) 
These recommendations include providing a developmentally appropriate assessment 
(with tailored communication), exploring systemic external influences and pressures, 
testing cognitive development in a specific rather than standardized manner, and 
assessing the child’s ability to balance risks and benefits.(23) In the United Kingdom, 
the concept of “Gillick competence” is used to test whether children younger than 
sixteen years can consent to medical treatment independent of their parents. Children 
are deemed “Gillick competent” when they have reached sufficient understanding and 
intelligence to understand fully what is proposed.(25) 
Most authors agree that most adolescents, at an approximate age of 14 and older, are 
competent decision-makers, and no less competent than adults.(26) Already in the 
1970s, Grisso and Vierling concluded from their review that there are no psychological 
grounds to assume that children can not provide competent consent at age 15 and 
older.(20) They also concluded that children aged younger than 11 demonstrate 
developmental psychological evidence of diminished psychological capacities. The 
group of children between the ages of 11 and 14 appears to be in a transition period in 
the development of important cognitive abilities and perceptions of social 
expectations. In this group, it is possible that competence will be demonstrated in 
individual cases.(20) Again, age is only a rough indicator and competence has been 
shown to be influenced by experience with chronic illness, which can make 
experienced children more competent to decide on end-of-life matters than their 
inexperienced peers.(12;13;26-28) Some studies have reported differences in 
competence between adults and adolescents.(29) 
The outcome of the assessment of a minor patient’s psychological competence is of 
course a crucial factor determining whether a child should be allowed to be involved in 
medical decision-making, or even to make autonomous decisions. As a rationale, 
medical and ethical consensus exists to give minor patients decisional authority, and if 
full decisional authority is not appropriate, to have them express their treatment 
preferences.(30) But even if a minor patient is found competent, it does not necessarily 
follow that he or she should be able to make decisions autonomously.(31;32) Different 
arguments have been formulated that may impede involvement of minor patients in 
medical decision-making. Some authors have stated that allowing children to 
participate in medical decision-making is an undue burden on them, certainly if they 
are dying. Even when they are psychologically competent, it is suggested that they 
need a “protected period”, in which they can learn from adults, who make decisions on 
their behalf, how to make competent decisions. (31;32) Furthermore, it has been noted 
that providing full decisional authority to minor patients undermines parental 
rights.(31;32) Additionally, warnings have been formulated that minor patients are 
highly suggestible to interventions from authority figures, which holds the risk that 
only fake consent or assent will be obtained from the minor patients and that their 
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autonomy will thus not be improved.(31;32) These arguments are however not widely 
accepted, and most guidelines suggest that there is a consensus that competent minor 
patients should be allowed to make autonomous decisions.(33-35) 
Just as these arguments indicate that it does not necessarily follow from a positive 
competence assessment that minor patients should always participate in end-of-life 
decision-making, health care professionals should not simply disregard an incompetent 
minor patient’s opinions.(36;37) It is generally recommended that incompetent minor 
patients should be involved in decision-making as much as possible, by informing them 
about treatment options, albeit without granting them full decisional authority.(38) 
Parents will decide as surrogates on behalf of their children, but professional caregivers 
face the challenge of involving the incompetent minor patient in an ethical way, 
without placing an undue burden on them.(33;38) It is recommended that incompetent 
children’s assent with a decision should be sought, and that any strong and sustained 
dissent with the decision should be taken seriously by health professionals. (38) 
 
 
b)  Involvement of parents and models of decision-making 
 
“Eleven-year-old Samantha is a bright, loving child who was treated for 
osteosarcoma in her left arm. The arm had to be amputated, and 
Samantha was given a course of chemotherapy. She has been cancerfree 
for 18 months and is doing well in school. She is self-conscious about her 
prosthesis and sad because she had to give away her cat, Snowy, to 
decrease her risk of infection. Recent tests indicate that the cancer has 
recurred and metastasized to her lungs. Her family is devastated by this 
news but do not want to give up hope. However, even with aggressive 
treatment Samantha’s chances for recovery are less than 20%. Samantha 
adamantly refuses further treatment. On earlier occasions she had 
acquiesced to treatment only to struggle violently when it was 
administered. She distrusts her health care providers and is angry with 
them and her parents. She protests, “You already made me give up Snowy 
and my arm. What more do you want?” Her parents insist that treatment 
must continue. At the request of her physician, a psychologist and 
psychiatrist conduct a capacity assessment. They agree that Samantha is 
probably incapable of making treatment decisions; her understanding of 
death is immature and her anxiety level very high. Nursing staff are 
reluctant to impose treatment; in the past Samantha’s struggling and the 
need to restrain her upset them a great deal.” 
(Quoted from Harrison C, Kenny N, Sidarous M, Rowell M. Bioethics 
for clinicians: 9. Involving children in medical decisions. CMAJ 
1997;156(6):825) 
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Professional caregivers face the difficult challenge of choosing an adequate model of 
decision-making. Different models are possible: paternalistic, patient-centered and 
shared decision-making. In paternalistic models, decisions are predominantly made by 
the physician, in the patient’s best interest. This has been the dominant decision-
making model for a long time, based on assumptions that each disease has one single 
best treatment, that physicians know which treatments are best, and are best placed to 
weigh different alternatives and to make the decision.(39) Since the 1980s, these 
assumptions have been questioned and the model has been largely abandoned.(39) It 
has since been acknowledged that choices between different treatment alternatives 
require a careful comparison of risks and benefits, which are often weighed very 
differently by different individual patients, who each have their own preferences and 
values. With the rise of the concept of informed consent, the predominant decision-
making model has shifted to a patient-centered paradigm of information-exchange. In 
this model, the physician’s main responsibility is to provide the patient with all the 
necessary information regarding diagnosis, prognosis and treatment options. The 
patient can then deliberate options and make his or her own decisions autonomously, 
based on this information. This model however also has some flaws in that the patient’s 
deliberation and choices will be influenced by their preferences, beliefs and fears, 
which may lead to suboptimal decisions that may ultimately even go against the 
patient’s best interest. Therefore, the most widely accepted model is one of shared 
decision-making between patient and physician.(36;39;40;40-45) Characteristic for this 
model is the two-way information-exchange, where physicians will provide patients 
with all necessary information, but patients will also communicate their preferences, 
values, beliefs and fears to the physician. This two-way information enables patients 
and physicians to deliberate the available treatment options together, and will 
ultimately help patients to make an informed and well-deliberated decision, together 
with their physician, in their own best interest.(39;40) It has been argued that different 
partners can assume different decisional priority depending on the situation.(46) When 
cure is more likely, physicians can assume more decisional priority, as cure is usually 
the ultimate goal and represents the patient’s best interest. When more than one 
reasonable treatment alternative exists, parents and patients can assume more 
decisional priority, because they are better placed to choose between reasonable 
alternatives in line with their preferences.(46) 
Decision-making is already complex when only a physician-patient dyad is considered, 
but will be even more complex when a physician-parents-patient triad exists. As a 
general rule, parents or representatives are necessarily involved in pediatric end-of-life 
decision-making and they are legally assumed to exercise the rights of their child as a 
patient, and to make decisions in their best interest.(47-52) The involvement of minor 
patients will largely depend on their psychological competence. In situations where 
children have not reached a sufficient level of competence, the situation is fairly clear 
for professional caregivers, and they will turn to parents or representatives to make 
choices and decisions on behalf of the minor patient, in their best interest. This 
paternalistic approach is justifiable, as incompetent minors lack the skills to make their 
own autonomous decision, yet it remains a challenge to inform them adequately.(38) 
However, situations can arise where treatment-limitation is considered at the end-of-
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life. In these cases, some studies recommend not leaving these decisions to the parents, 
as they may experience feelings of discomfort and grief when “signing a death warrant 
for their child”.(53;54) Some therefore suggest that members of the medical team can 
take on the responsibilities of healthcare surrogate for terminally ill patients.(54) The 
decision-making process will be complicated when parents and their children have 
different ideas about the treatments they (or do not) prefer, and conflict between 
patient, parents or physicians arises as to which plan should be followed.(55) This has 
led to conflict being resolved by judicial intervention, an option which is not to be 
recommended.(56;57) 
The situation is more challenging when children approach adolescence, and may have 
reached adequate decision-making capacities.(58) As outlined above, professional 
caregivers will then have to assess to what degree the competent minor patient should 
be involved in decision-making and to what degree decisions can be made 
autonomously by the patient. Existing guidelines clearly recommend that decision-
making should be shared with minor patients to the extent that they are 
competent.(44;47;48;59-61) This approach is substantiated in the Belgian law on patient 
rights, which also includes a cascaded model of decision-making, in function of the 
minor patient’s competence.(62) In Belgium, minors’ rights as patients are in principle 
exercised by their parents or legal representatives.(62) However, minors are to be 
involved in the exercise of their rights in function of their age and maturity. If they are 
deemed capable of making a rational assessment of their interests, they can exercise 
their rights as a patient independently. Additionally, the Belgian law on patient rights 
requires professional caregivers to involve minor patients as much as possible in 
exercising their rights as a patient, in function of their level of understanding. The 
result of the assessment of minor patients’ competence thus directly relates to the 
degree to which it is legally enforceable for minors to exercise their rights as a patient 
independently. The law does not, however, specify who should make the assessment of 
competence, and how this should be done. As minor patients are assumed to be 
incompetent, the risk exists of setting higher standards for minor patients’ competence 
than for adults. 
 
c)  Limited experience and expertise in professional caregivers 
 
As outlined above, professional caregivers can accumulate limited specific expertise in 
pediatric end-of-life care due to the small number of children who die, and the high 
proportion who die from external causes. Pediatric end-of-life care is thus often 
provided by professionals who have little specific experience or training, which has 
been identified as one of the main challenges in pediatric palliative care.(10;63-67) 
American pediatric oncologists reported a lack of training in pediatric palliative care, 
and relied on trial and error in learning to care for dying children – a less than optimal 
situation.(68) Most expertise is usually available in pediatric oncology settings, where 
relatively many dying children are cared for. For children suffering from life-limiting 
illnesses other than cancer, end-of-life care provisions are often more limited. The 
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small population of minor palliative patients impedes the development of specialized 
centers of expertise and children’s hospices in Belgium. Three initiatives currently 
provide liaison pediatric palliative home care in Flanders: the “Koester” project of 
Ghent University Hospital(69), the Palliative home care team of Leuven University 
Hospital and a team in Antwerp.(70) These projects are mostly operating from pediatric 
oncology settings, and try to use their expertise in palliative care to organize and 
coordinate palliative home care for children and their families. These projects have 
relied entirely on charitable fund-raising until 2009 when an act was accepted by the 
Chamber, providing a first structural financing for palliative home care for 
children.(71) 
 
1.2.2. Place of end-of-life care and death 
 
It is not surprising that pediatric palliative care provisions in Belgium focuses strongly 
on home care, as the provision of palliative home care for children is regarded as an 
important aspect of high quality pediatric end-of-life care.(72;73) It has been long 
recognized that palliative home care is a desirable option and that good symptom 
control is possible for children dying at home.(74-76) Parents caring for a dying child 
generally prefer home as the place of care and death, because they value the time 
remaining and perceive this to be the child’s wish.(77-84) However home care is not 
always the preferred option for parents.(85;86) 
For parents who care for a child who is dying from cancer, being aware of their child’s 
impending death and understanding the prognosis increased the chances that they 
prefer their child to be cared for, and for it to die, at home.(87;88) The child being able 
to die at home has been shown to be related to more positive psychological 
bereavement outcomes and less pathological grief in bereaved parents.(89;90) Being 
able to care for their terminally ill child at home meets one of the principal needs for 
parents in the palliative phase, that is to retain the responsibility of caring for their 
dying child.(91) Also for siblings, witnessing their brother or sister’s death at home is 
related to more positive outcomes as compared to death in hospital.(90;92) Some 
authors have nuanced the importance of place of care and death, and emphasize that 
the match between the planned and actual place of end-of-life care and death is also 
important, and associated with parents being better prepared for their child’s 
death.(93) Furthermore, one study showed that the establishment of a palliative care 
unit integrated in a Pediatric Hematology Oncology department actually decreased the 
proportion of home deaths among their patients.(94) This finding has led 
commentators to suggest that there may be better options than palliative home 
care(95), possibly because sending the child home to die can be considered as “giving 
up on us” by some families.(96) 
Most studies on the actual place of death of children have been conducted in specific 
care settings and patient groups. Often, only children dying from cancer are reported 
on. As can be expected, proportions of home deaths among children vary considerably 
across studies, ranging between 9.5% in French cancer patients and 78% in an American 
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study on advance directives in pediatric patients.(77-79;82;85-87;97-104) These 
differences are almost impossible to interpret, as settings and patients groups are not 
comparable. 
Unlike in adults, there are only a limited number of population studies on place of 
death in children. Important studies in this field were conducted by Feudtner and 
colleagues in the US.(105;106) In their study of death certificates, they found that 
among all deaths of people dying aged 19 or younger between 1989 and 2003 in the 
United States, the proportion of home deaths increased from 12.8% (1989-1993) over 
16.0% (1994-1998) to 17.7% (1999-2003). The chances of dying at home were higher for 
children dying from complex chronic conditions and for children dying from 
malignancies.(105) For Europe, no population-based studies on place of death in 
children are yet available. 
 
1.3.  End-of-life decisions and sedation 
 
Through advances in medicine, imperiled lives can now be sustained for ever longer 
periods. This evolution has brought new challenges for health professionals, and they 
now face difficult questions and ethical dilemmas, including how to weigh quality and 
quantity of life. When the actual and expected quality of life drop below an acceptable 
threshold, physicians sometimes make decisions which impact on patient longevity. A 
framework to classify these decisions was developed in the Netherlands, and has been 
used in all population-based studies since.(107-111) These decisions include: the 
withdrawing or withholding of life-sustaining treatments, the intensified alleviation of 
pain and symptoms and the deliberate hastening of death by means of provision or 
administration of lethal drugs. The last category is often termed physician-assisted 
death, and comprises different kinds of decisions, depending on who administers or 
provides the lethal drugs: physician-assisted suicide (if the drugs are administered by 
the patient him or herself), euthanasia (if the drugs are administered by someone else 
than the patient, but at the patient’s explicit request) and life-ending acts without 
explicit patient request. The fact that these decisions are often linked to an ever-ageing 
population should not obscure the fact that decisions to limit treatment and to shorten 
life are also considered in children. The specific challenges for pediatric health care 
workers, described above, become even more pronounced when end-of-life decisions 
are at hand. 
Non-treatment decisions and intensified alleviation of pain and symptoms are 
generally accepted as a part of common and sound medical practice, and different 
professional pediatric organizations include these practices in their 
guidelines.(47;48;59;112) The intensified alleviation of pain and symptoms with a life-
shortening effect is often excused by the principle of double effect: the act has two 
effects (pain relief and shorter longevity), the physician only intends the good effect, 
and accepts the negative effect as a necessary but unintended side-effect.(44) The 
practice of physician-assisted death on the other hand, where death is explicitly 
intended by the physician, is much more controversial.(113-124) The legal status varies 
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according to the different categories of physician-assisted death, and between 
countries. The administration of lethal drugs without an explicit patient request is 
illegal in all countries. Assisted suicide is legally allowed in the US states of Oregon, 
Washington and Montana(125-128), in Switzerland(129) and in the Netherlands.(130) 
Euthanasia, that is the administration of drugs with the explicit intention of ending the 
patient’s life at the latter’s explicit request, is legally allowed in Belgium, the 
Netherlands and Luxemburg.(131) All three laws on euthanasia list strict due care 
requirements, and require all cases of euthanasia to be reported to a commission. 
Minor patients can validly request euthanasia or assistance in suicide only in the 
Netherlands. A request for euthanasia or assisted suicide can be granted from the age of 
12 when the parents consent to it, and from the age of 16 when parents are informed. 
Additionally, a protocol was developed at the University Hospital of Groningen to 
provide practical guidelines for intentional life-ending in neonates. An agreement with 
the public prosecutor was reached, in that physicians will not be prosecuted if they 
meet all criteria of due care, including certainty about the diagnosis, presence and 
confirmation by an independent second physician of hopeless and unbearable suffering 
and informed consent by the parents. The practice is to be reported to the local medical 
examiner, who in turn reports it both to the district attorney and to a review 
committee for public control.(132;133) The protocol was welcomed with a lot of 
international criticism, many critics seeing evidence of a “slippery slope” in the 
protocol.(134-141) 
In Belgium, non-emancipated minors are explicitly excluded from the application of 
the euthanasia law. This seems to go against existing guidelines on minor patients’ 
involvement in medical decision-making, and the right for competent minor patients to 
exercise their patient rights independently.(44;47;48;59-62) That does not take away the 
fact that the issue of extending the application of the Belgian law on euthanasia to 
include minors is being debated, both in public and in politics. This has led to several 
proposed amendments to the euthanasia law in recent years, some of which are still 
under consideration by the commissions of the Senate.(142-148)  
Unlike in adult patients(109;111;149-154), end-of-life decisions have been infrequently 
studied in children, and studies are often limited in care settings and patient groups. 
Most studies have been conducted at pediatric and neonatal intensive-care units, and 
most have focused on decisions to withdraw or to withhold treatments. All these 
studies indicate that decisions to forgo life-sustaining treatment are frequently made in 
neonates and children, proportions often surpassing 50 percent of studied 
deaths.(96;155-168)  
Population-based studies, which include deaths across care settings and patient groups, 
remain rare in children. Studies in neonates have been conducted in Belgium and the 
Netherlands, and indicate that end-of-life decisions are frequently made in this group. 
In Flanders, 57% of all neonatal deaths were preceded by an end-of-life decision, and 7% 
by physician-assisted death.(169;170) In the Netherlands, the incidence of end-of-life 
decisions in newborns was similar: 62% to 68% of all deaths were preceded by an end-
of-life decision, and 9% to 10% by physician-assisted death.(170;171) In children dying 
after the age of one, only one population study has so far been conducted. In the 
Netherlands, 36% of all deaths of children dying between one and 17 years in 2001 were 
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preceded by an end-of-life decision. Intensified alleviation of pain and symptoms was 
the most frequent decision, with 21%, while physician-assisted death occurred in 2.7%. 
It was estimated that annually five cases of euthanasia of children occur in the 
Netherlands, and 15 cases where physician-assisted death occurred without a patient 
request, but at the explicit request of the family.(172) 
In recent years, the practice of terminal or palliative sedation, ie lowering the 
conscience of patients in order to alleviate refractory symptoms, is gaining interest and 
has been studied frequently in adults.(173-184) The incidence of continuous deep 
sedation has been studied population-wide in Belgium and the Netherlands, and is 
shown to have risen significantly since 2001 in both countries.(111;185) Until now, very 
little has been known about the incidence and practice of sedation in minors. However, 
the clinical and ethical challenges linked to sedation at the end-of-life are likely to be 
similar in minor patients, while the specific challenges of pediatric end-of-life care 
remain present. Challenges of palliative or terminal sedation include the choice of 
drugs to be used, the optimal duration of sedation, whether sedation is to be used 
continuously or intermittently, whether or not artificial food or fluids are to be 
administered and whether or not shortening of life may be intended by the 
physician.(179;181;186-188) Several guidelines have been proposed to help practitioners 
deal with these challenges. They generally state that benzodiazepines should be the 
first choice of drugs, that sedation at the end-of-life should not last longer than two 
weeks, sedation should only be used to relieve refractory symptoms, artificial food and 
fluids should not be administered and life-shortening should not be intended.(182;189-
191) One of the main problems with the practice of terminal or palliative sedation is 
that - contrary to the guidelines - it may sometimes be used as an alternative to 
physician–assisted death. A recent study in the Netherlands suggested that since 2001 
some substitution has taken place between both practices, whereby euthanasia has 
become less frequent and the incidence of sedation has risen significantly.(185) This 
substitution may indicate that sedation is indeed sometimes used as a covert form of 
euthanasia, with the same life-ending intention. While euthanasia is legally regulated 
by strict due care requirements and an obligation to openly report the practice, no such 
requirements exist for sedation. This suggests that sedation is sometimes used as an 
alternative to physician-assisted death, but without any reference to due care 
requirements or societal control. In children, there are only a few studies which have 
addressed the practice of sedation at the end-of-life.(192-195) These studies were 
limited in scope and care setting, but suggest that sedation may also be used as an 
option at the end-of-life of children. To our knowledge, no specific guidelines on 
sedation at the end-of-life of children have been formulated thus far. 
Attitudes towards end-of-life decisions have been studied frequently, revealing a large 
variance in attitudes between countries and between groups of subjects.(196-206) 
Studies are often difficult to compare, as different methodologies and groups of 
subjects are used. One study on public acceptance of euthanasia in 33 European 
countries however clearly demonstrated the substantial cross-national differences in 
attitudes, with the most positive attitudes towards euthanasia in the Netherlands, 
Denmark, France, Sweden and Belgium, and the most negative in Romania, Malta and 
Turkey.(197) In general, physicians are less inclined to accept euthanasia and 
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legalization of euthanasia as an option at the end of life than the general 
public.(201;204;207) Public acceptance of euthanasia has increased significantly 
between 1981 and 1999 in Europe.(208) A study in five European countries and Australia 
found a significant relation between religious stance and end-of-life attitudes and 
practices. Physicians with religious attitudes had significantly less accepting attitudes 
than non-religious physicians, and they engaged in physician-assisted death less 
frequently.(198) The link between attitudes and actual end-of-life practices was also 
demonstrated in other studies.(196) These studies indicate the importance of studying 
attitudes towards end-of-life decisions of all persons involved. 
Most studies on attitudes towards end-of-life decisions have focused on adults. Studies 
on attitudes related to end-of-life decisions in pediatric and neonatal practice display a 
similar pattern of variability between physicians and the public and between 
countries.(169;209-220) Pediatricians and physicians generally accept limitation of life-
support in certain instances, but in most countries explicit life-shortening in children is 
not acceptable for physicians, except in Belgium, the Netherlands and 
France.(169;212;218) Attitudes of children and adolescents towards end-of-life decisions 
in minors have largely remained unstudied until the present. 
 
1.4.  Research questions 
 
The introduction above has made it clear that important questions still remain 
unanswered in the literature on pediatric end-of-life care. These questions are situated 
in different domains. A first gap concerns systematic population-based information on 
where children die in Europe. It was demonstrated that place of death is an important 
part of quality end-of-life care in children. Understanding the factors that facilitate 
home death in children is necessary to improve the rate of home deaths among 
children. It would also be interesting to compare the preferred (by parents or patients) 
place of death with the actual place of death of children, but collecting this information 
on an individual level is hard to reconcile with our goal of collecting population-wide 
data. We will therefore mainly focus on where children die, and which factors are 
related.  
A second gap concerns data on end-of-life decisions in children dying between one and 
17 years. As we described above, end-of-life decisions not only pose difficult challenges 
for health professionals; a possible extension of the Belgian law on euthanasia is also 
being debated. There is therefore an urgent need to learn more about these decisions, 
how they are made, and how minors and physicians view these issues. Until now, little 
has been known about these practices in children, and debates are currently largely 
being conducted without an empirical foundation. Therefore, we will first try to 
understand how adolescents think about end-of-life decisions in minors and whether 
experience with chronic illness influences these attitudes. Subsequently, we will focus 
on physicians’ attitudes towards physician-assisted death in minors, and whether they 
think the Belgian law on euthanasia needs to be amended to include minors. As our 
methodology guarantees full anonymity of the patients (see below), it was not possible 
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to contact the parents to study their attitudes as well. Finally, for the first time in 
Flanders, we will try to estimate the incidence of end-of-life decisions in children dying 
at age one to 17. As decision-making is very challenging for health professionals, we 
also focused on how these decisions are made and which partners are involved in 
making them.   
A third and final gap concerns continuous deep sedation in minors. Our discussion 
above makes it sufficiently clear that this practice is related to several clinical and 
ethical challenges, but that there are virtually no data available on this practice in 
minors. Therefore, and as far as we know for the first time in the world, we aim to 
estimate the population-wide incidence of continuous deep sedation at the end-of-life 
in minors, and to describe the characteristics of the practice and how these decisions 
are made. These data are indispensable in understanding the role of sedation in 
children’s end-of-life care, and to finding out whether sedation is practiced with due 
care by physicians.    
In summary, we will focus on the following main research questions in this 
dissertation: 
 
1. Where do children die, and which factors are related to this? 
2. What do minors think of end-of-life decisions in children? 
3. Does experience with chronic illness influence the attitudes of adolescents towards 
end-of-life decisions? 
4. What do physicians think about physician-assisted death in minors and a possible 
amendment to the Belgian law on euthanasia to include minors? 
5. How often do end-of-life decisions, including continuous deep sedation, occur in 
children in Flanders, Belgium? 
6. What are the characteristics of these decisions, and how are they made? 
 
1.5.  Methodologies 
 
To answer these research questions, different data sources and methodologies were 
used. 
 
The first research question was approached by using a database containing information 
from death certificates for all children dying between the ages of one and 17 in 2002 or 
2003 in nine European countries. Within this database, countries were selected where 
the data allowed for discerning home from other places of death. Six countries were 
retained in the dataset: Belgium (Flanders and Brussels), the Netherlands, Italy (the 
regions of Tuscany and Emilia Romagna and the city of Milan), Norway, Wales and 
England. Standard descriptive statistics were used to describe the proportion of home 
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deaths. Chi-square statistics and multivariate binomial logistic regressions were used to 
investigate which factors influence the chances of home death for children dying from 
complex chronic conditions. 
For the second research question, data from a 2000-2001 study in 1.769 Flemish 
adolescents from second and fourth grades in 20 secondary schools were used. 
Hypothetical case descriptions were presented to these adolescents. All cases described 
a situation where a 14-year old was suffering from a terminal or non-terminal disease. 
Participants were asked whether the patient could ask the physician for different types 
of end-of-life decisions. Additionally, participants were surveyed on their opinion on 
the right of minor patients to be informed about a terminal prognosis, and whether 
they would want to be informed themselves when faced with a similar situation. 
Standard descriptive statistics were used to describe the participants’ attitudes and chi-
square statistics to test whether attitudes were related to participant characteristics. 
A similar approach was used to answer the third research question. To this end, data 
were used from a 2004 interview study in 83 adolescents, aged between 11 and 18 years, 
who had been treated for cancer a least two years prior to the study. During the 
interviews, they were presented with similar hypothetical case descriptions and similar 
questions as in the study above. Besides describing the adolescent cancer survivors’ 
attitudes, Chi-square tests were used to compare the answers of the cancer survivors 
with the answers of the students in the above mentioned study because questions were 
similar. 
The third, fourth and fifth main research questions were answered with a population-
based post-mortem physician survey, based on death certificates of all patients who 
died during an 18-month period in 2007 and 2008 in Flanders at age one to 17 years. The 
certifying physicians were sent an anonymous questionnaire asking about the end-of-
life decisions, including continuous and deep sedation, made in the death concerned, 
characteristics of the end-of-life decision and the decision-making process prior to the 
decision. Additionally, physicians were asked about their attitudes towards 13 
statements relating to euthanasia and physician-assisted death in minors. In order to 
guarantee strict anonymity of patients and physicians, a complex mailing procedure 
was used, with a lawyer as intermediary between the Flemish Ministry of Health who 
sent the questionnaires, and the researchers who received the questionnaires only 
after they were made fully anonymous by the lawyer. To enhance response, the Total 
Design Method was used, with three reminders.(221;222) Standard descriptive statistics 
were used to describe incidence, characteristics and decision-making process prior to 
end-of-life decisions. The attitudes of the physicians were described and clustered in a 
K-means cluster analysis. Cluster membership was used to investigate whether 
attitudes and actual end-of-life practices were related. 
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1.6.  Dissertation outline 
 
In Chapter 2, the data on place of death and factors related to home death in children 
dying from complex chronic conditions are presented. Chapter 2 will answer the first 
research question described above. 
Chapter 3 to 5 will focus on attitudes towards end-of-life decisions in minors, and starts 
with the data from a study in adolescents in order to get a picture of how healthy 
adolescents think about end-of-life decisions in minors. Subsequently, the study in 
adolescent cancer survivors will be described, with a focus on how their attitudes differ 
from the healthy adolescents in the first study. Finally, the attitudes towards 
euthanasia and physician-assisted death of physicians who were involved in the care of 
all dying children in Flanders will be described. Chapter 3 to 5 will try to answer 
research questions 2 to 4 described above. 
In Chapter 6 and 7, an answer to research questions 5 and 6 will be formulated. First, 
the prevalence of end-of-life decisions in children will be described, and descriptions of 
characteristics and decision-making process will be provided. Second, the focus will be 
on prevalence, characteristics and decision making prior to continuous deep sedation 
in minors. 
In Chapter 8, the results will be summarized, integrated and discussed, and general 
conclusions will be formulated. 
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Abstract: 
 
Objectives 
Until now there have been no population based European data available regarding 
place of death of children. This study aimed to compare proportions of home death for 
all children and for children dying from complex chronic conditions (CCC) in six 
European countries and to investigate related sociodemographic and clinical factors. 
 
Methods 
Data were collected from the death certificates of all deceased children aged 1-17 in 
Belgium, the Netherlands, Norway, England, Wales (2003) and Italy (2002). Gender, 
cause and place of death (home vs. outside home) and sociodemographic factors (socio-
economic status, degree of urbanization and number of hospital beds in the area) were 
included in the analyses. Data were analyzed using frequencies and multivariate logistic 
regression. 
 
Results 
In total 3,328 deaths were included in the analyses; 1,037 (31.2%) related to CCC. The 
proportion of home deaths varied between 19.6% in Italy and 28.6% in the Netherlands 
and was higher for children dying from CCC in all the countries studied, varying 
between 21.7% in Italy and 50% in the Netherlands. Among children dying from CCC, 
home death was more likely for cancer patients and those aged over 10. After 
controlling for potentially related clinical and sociodemographic factors, differences in 
the proportion of home deaths between countries remained significant, with higher 
proportions in Belgium and the Netherlands as compared to Italy. 
 
Conclusions 
Although home deaths comprise a substantial proportion of all deaths of children with 
CCCs, variation among disease categories and across countries suggest that 
considerable potential still exists for further improvements in facilitating end-of-life 
care in the home for those children and families who desire to be in this location. 
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2.1. Introduction 
 
Guidelines on pediatric palliative care, as published by the American Academy of 
Pediatrics and the European Association of Palliative Care, state that care at the end of 
life of chronically ill children should preferably be provided in the child’s home.(1;2) 
Although sometimes dying at home is either not desired by the patient or family, or not 
feasible due to limited possibilities of complex symptom control in the home setting, 
for the majority of parents home is still the preferred place of end-of-life care for 
children with life-limiting illnesses.(3-6)  
Studies of bereaved parents show that the child’s death taking place at home is related 
to more positive bereavement outcomes for parents and siblings.(7-10) This is not 
surprising as home care enables parents to sustain their relationship as caregivers for 
their children better than they can in hospital. This has been identified as a paramount 
need of parents at the end of their children’s life.(3) For children, dying in a familiar 
environment can help to make the final stage of their life less confusing and 
psychologically more comfortable.  
Studying place of death is particularly relevant for children suffering from chronic 
disease, as planning place of death and end-of-life care may be impossible for a 
significant proportion of children dying suddenly and unexpectedly. Population-based 
studies in the United States have shown that home is a frequent place of death for 
children suffering from chronic disease.(11-14) In the United Kingdom, a population-
based study in children and adolescents dying from cancer from 1995 to 1999 showed 
that with 52% home was the most frequent place of death.(15) 
Until now, studies on children’s place of death have often been limited in setting and 
patient groups. As population based studies are not restricted to specific settings or 
patient groups, they can be helpful to generate hypotheses on factors influencing place 
of death and to inform clinicians and policy makers. To our knowledge, cross-national 
comparisons of place of death in children have not until now been reported. Comparing 
place of death in different countries with different organization of care could be useful 
to help identify factors that facilitate home death. For all the participating countries 
(Belgium, Italy, the Netherlands, Norway, England and Wales), this study addressed the 
following research questions: (1) what proportion of deaths of patients aged 1 to 17 
occurs at home; (2) what proportion of patients aged 1 to 17 dying from complex 
chronic conditions (CCC) occurs at home; (3) which clinical and socio-demographic 
factors are related to home deaths for children dying from CCC; and (4) after 
controlling for related factors, are there differences between countries in the 
proportions of home deaths among children dying from CCC? 
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2.2. Method 
 
When studying characteristics of deaths on a population level, death certificates are a 
useful tool in providing valid and reliable information.(13;14;16;17) From a database 
containing data from death certificates in nine European countries, all deaths of 
children aged 1 to 17 were selected.(16) Six countries where data from death 
certificates made it possible to discriminate between home and other places as place of 
death were retained in the dataset: Belgium (year of death 2003, the regions Flanders 
and Brussels, approximately 65% of all deaths in Belgium), Italy (2002, the regions 
Tuscany, Milan, Emilia Romagna, approximately 17% of all deaths in Italy), the 
Netherlands (2003), Norway (2003), England (2003) and Wales (2003). Procedures to 
obtain the data differed between countries but all necessary approvals were obtained. 
These procedures are described elsewhere in full.(16) 
Variables included in the database were, on an individual level, retrieved from death 
certificates: gender, age, underlying cause of death (ICD-10 code) and place of death. 
For Norway, the variable age only allowed the identification of the group of 1 to 17 year 
olds from the population database but provided no further detail. Information on cause 
of death was only available as a recoded variable consisting of 38 categories for Italy 
(see Appendix). For computation of variables based on cause of death, estimations had 
to be made for Italy, based on these 38 categories. To identify the group of children 
dying from chronic condition, we used Feudtner’s operationalization of “complex 
chronic condition” (CCC) and recoded the included ICD-9 codes into ICD-10 codes (see 
Appendix) (11-14): “Complex chronic conditions (CCC) are defined as medical conditions that 
can be reasonably expected to last at least 12 months (unless death intervenes) and that involve 
either several different organ systems or 1 organ system severely enough to require specialty 
pediatric care and probably some period of hospitalization in a tertiary care center.”  
Besides individual information from death certificates, three variables were included 
based on community characteristics, providing information on an aggregated level 
using the municipality or province codes of the residence of the deceased child: 
number of hospital beds in the region, socio-economic status (SES) and degree of 
urbanization. For Italy, data on SES was not available. 
The first research question was answered using descriptive statistics. Age was recoded 
into two categories (1-10y and 11-17y). Using ICD-10 codes, the underlying cause of 
death was recoded into eight categories: external causes, cancer (haematological and 
non-haematological), diseases of the central nervous system, congenital causes of 
death, cardiovascular diseases, respiratory diseases and other causes of death. 
Additionally, the proportion of deaths caused by CCC was calculated per country (see 
Appendix). Place of death was recoded into two categories: home and outside home. 
The third and fourth research questions were answered using Chi-square statistics and 
multivariate logistic regression in the subgroup of children dying from CCC, with home 
death (vs. death outside the home) as dependent variable and gender, age (1-10y and 
11-17y), underlying cause of death (recoded into two categories: cancer and non-
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cancer), the number of hospital beds in the region (median split per country), socio-
economic status (SES, per country: high, average and low, derived from average income 
in the community where death occurred) and the level of urbanization per country 
(very high, high and average/low) as independent variables. To gain insight into how 
factors influence home death and how these factors can explain differences between 
countries, a stepwise multivariate binary logistic regression model was constructed. 
Model 1 contained country as independent variable, Model 2 added the individual 
variables age, gender and cause of death while Model 3 added number of hospital beds 
and degree of urbanization. SES was not included in the regression because detailed 
data on this variable were missing for Italy. Norway was excluded from multivariate 
logistic regression because detailed data on age were missing. The logistic models do 
not account for possible clustering of observations within countries. Adjusted odds 
ratios and 95% confidence intervals (CI) were calculated. Significance was set at p-
values <.05. SPSS 15.0 was used for all analyses. 
 
2.3. Results 
 
In all the countries studied, 3,328 (0.37%) deaths were of children between 1 and 17 
years of age (see Table 1). The proportion of deaths from external causes varied 
between countries, from 30.6% in England to 42.5% in Belgium. The proportion of 1-
17y-olds dying from cancer ranged between 13.5% in Belgium and 19.5% in Italy. Cancer 
was the second leading cause of death in all countries studied. A total of 1,037 children 
(31.2%) died of complex chronic conditions (CCC), ranging between 27.6% in Belgium 
and 35.0% in England. 
The proportion of all children dying at home was 19.6% in Italy, 20.5% in England, 20.6% 
in Wales, 21.0% in Norway, 23.8% in Belgium and 28.6% in the Netherlands. The 
proportion of home deaths for children dying from CCC was higher than the proportion 
of home deaths in the total population of 1-17y-olds in all countries studied, although 
differences were small in Italy and Norway. The proportion of home deaths for children 
dying from CCC varied significantly between countries and was highest in the 
Netherlands (50.0%) and lowest in Italy (21.7%) (see Table 2). 
Bivariate analyses showed that the proportion of deaths occurring at home was higher 
in cancer patients as compared to non-cancer patients in Belgium, the Netherlands, 
England and Wales. Age was significantly related to the proportion of home deaths in 
England, where children dying after the age of 10 were more likely to die at home. SES 
was only related to the proportion of home deaths in Belgium, where children living in 
regions with higher SES were more likely to die at home. 
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Table 1: Characteristics of the population (1-17y) by country of residence (N = 3,328). 
  Country of residence* 
  
Belgium 
2003 
Italy 
2002 
Netherlands 
2003 
Norway 
2003 
England 
2003 
Wales 
2003 
Total N of deaths N=67,264 N=99,849 N=141,936 N=42,550 N=505,341 N=33,810 
Total N of deaths 1-17y 
(%) 
N=214 
(0.32) 
N=185 
(0.19) 
N=650 
(0.46) 
N=146 
(0.34) 
N=1,890 
(0.41) 
N=102 
(0.30) 
Gender       
 Male 57.9 64.3 60.0 56.2 57.9 61.8 
  Female 42.1 35.7 40.0 43.8 42.1 38.2 
Age       
 1-10y 53.7 51.4 56.3 † 51.4 46.1 
  11-17y 46.3 48.6 43.7 † 48.6 53.9 
Cause of death‡       
 External 42.5 34.6 32.3 31.5 30.6 36.3 
 Cancer - Non-hemat. 11.2 10.3 11.4 10.3 14.0 9.8 
             - Hematological 2.3 9.2 5.1 6.8 4.7 3.9 
 Central nervous system 8.9 6.5 11.2 13.7 13.3 8.8 
 Congenital 6.1 13.0 7.8 13.0 7.9 10.8 
 Cardiovascular 4.2 3.2 4.9 4.1 6.3 5.9 
 Respiratory 4.2 2.2 4.5 3.4 5.9 6.9 
 Other 20.6 21.1 22.8 17.1 17.2 17.6 
      Total CCC§ 27.6 32.4 27.7 32.9 35.0 28.4 
Place of death       
 Home 23.8 19.6 28.6 21.0 20.5 20.6 
  Outside home 76.2 80.4 71.4 79.0 79.5 79.4 
Presented figures are percentages per country. 
* Belgium: Flanders and Brussels Capital Region; Italy: Tuscany, Milan and Emilia Romagna 
†  Datailed data on age were missing for Norway, because aggregated data were used 
‡ Because cause of death was available in 38 categories instead of ICD-10 codes for Italy, the 
categories of complex chronic conditions had to be estimated on the basis of these 38 categories 
§ The criteria proposed by Feudtner were used to operationalise deaths from complex chronic 
conditions (CCC) (11-14) 
   
 
 
 
 
 
 
 
46
Chapter 2 - Home deaths of children__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
Table 2:  Percentage of deaths occurring at home by country of residence and 
background variables for all deaths 1-17y caused by a complex chronic condition** (N = 
1,037). 
  Country of residence*  
  Belgium Italy Netherlands Norway UK Wales p-
value§ 
Total N of CCC-deaths N = 59 N = 60 N = 180 N = 48 N = 661 N = 29  
% of home deaths (N) 35.6 (59) 21.7 (60) 50.0 (180) 22.9 (48) 31.8 (661) 37.9 (29) <.001 
Gender         
 Female 23.1 (26) 30.4 (23) 45.0 (60) 12.5 (24) 31.6 (304) 35.7 (14) .077 
 Male 45.5 (33) 16.2 (37) 52.5 (120) 33.3 (24) 31.9 (357) 40.0 (15) <.001 
 p-value¶ .075 .215 .343 .086 .922 .812  
Age         
 1-10y 31.4 (35) 13.5 (37) 50.0 (108) † 27.6 (370) 30.0 (20) <.001 
 11-17y 41.7 (24) 34.8 (23) 50.0 (72) † 37.1 (291) 55.6 (9) .267 
 p-value¶ .420 .063 >.999 - .009 .237  
Cause of death‡         
 CCC-cancer 51.7 (29) 22.2 (36) 62.9 (105) 16.0 (25) 42.8 (353) 71.4 (14) <.001 
 CCC-non-cancer 20.0 (30) 20.8 (24) 32.0 (75) 30.4 (23) 19.2 (308) 6.7 (15) .109 
 p-value¶ .011 .898 <.001 .235 <.001 <.001  
N Hospital beds         
 Above median 33.3 (33) 23.3 (30) 44.9 (89) 16.7 (18) 32.2 (323) 30.8 (13) .101 
 Below median 38.5 (26) 20.0 (30) 54.9 (91) 26.7 (30) 33.3 (318) 43.8 (16) .001 
 p-value¶ .683 .754 .180 .499 .759 .702  
Urbanization         
 Very strong 20.0 (20) 24.4 (41) 38.7 (31) 25.0 (12) 34.1 (135) 50.0 (2) .564 
 Strong 45.5 (22) 15.8 (19) 51.2 (41) 30.8 (13) 37.5 (96) 27.3 (11) .137 
 Average/low 41.2 (17) 0.0 (0) 52.8 (108) 17.4 (23) 31.2 (410) 43.8 (16) <.001 
 p-value¶ .193 .522 .379 .644 .466 .643  
SES         
 High 64.3 (14) † 45.8 (59) 23.5 (34) 32.6 (193) 31.3 (16) .030 
 Average 36.4 (22) † 56.1 (57) 30.0 (10) 33.3 (234) 71.4 (7) .008 
 Low 17.4 (23) † 49.2 (61) 0.0 (4) 33.0 (185) 16.7 (6) .018 
 p-value¶ .015 - .524 .477 .989 .091  
Presented figures are percentage (number of cases per country per category of background variables) of 
home deaths per country. Numbers of denominators do not always add up to the total number of CCC-
deaths because of missing values. 
* Belgium: Flanders and Brussels Capital Region; Italy: Tuscany, Milan and Emilia Romagna 
†  Detailed data on age were missing for Norway because aggregated categories were used; data on SES 
were missing for Italy 
‡  Because cause of death was available in 38 categories instead of ICD-10 codes for Italy, the categories of 
complex chronic conditions had to be estimated on the basis of these 38 categories 
§ Pearson Chi-square test, testing differences between countries and within categories of background 
variables 
¶ Pearson Chi-square test, testing differences between categories of background variables and within 
countries. Fisher’s Exact test was used when expected cell counts were less than five. 
** The criteria proposed by Feudtner were used to operationalise deaths from complex chronic 
conditions (CCC) (11-14) 
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Table 3: Factors related to home death for all deaths caused by complex chronic 
condition§ (N = 989). Results from multivariate logistic regression analyses. 
  Model 1$ Model 2$ Model 3$ 
  OR 95% CI OR 95% CI OR 95% CI 
Country of residence*        
 Italy 1 [ref] 1.0-1.0 1 [ref] 1.0-1.0 1 [ref] 1.0-1.0 
 Belgium 1.2 0.9-4.5 2.4 1.0-5.6 2.4 1.0-5.6 
 England 1.7 0.9-3.2 1.9 1.0-3.6 1.9 1.0-3.9 
 Wales 2.2 0.8-5.8 2.8 1.0-7.7 2.7 1.0-7.6 
 Netherlands 3.6 1.8-7.1 4.1 2.0-8.2 4.0 1.9-8.3 
Gender        
 Female   1 [ref] 1.0-1.0 1 [ref] 1.0-1.0 
 Male   1.1 0.8-1.4 1.1 0.8-1.4 
Age        
 1-10y   1 [ref] 1.0-1.0 1 [ref] 1.0-1.0 
 11-17y   1.4 1.1-1.8 1.4 1.1-1.9 
Cause of death†        
 CCC-non cancer   1 [ref] 1.0-1.0 1 [ref] 1.0-1.0 
 CCC-cancer   3.3 2.5-4.4 3.3 2.5-4.5 
N Hospital beds        
 Above median     1 [ref] 1.0-1.0 
 Below median     1.1 0.9-1.5 
Urbanization        
 Very High     1 [ref] 1.0-1.0 
 High     1.1 0.7-1.7 
 Average/low     1.1 0.7-1.5 
Results from multivariate logistic regression analyses, with home death vs. death outside home as 
dependant variable. Independent variables were entered in block and were: country of residence in 
Model 1; country of residence, gender, age and cause of death in Model 2; and country of residence, 
gender, age, cause of death, number of hospital beds in the region and degree of urbanization in 
Model 3. Presented figures are odds ratios (OR) and 95% confidence intervals (95% CI).  Norway was 
excluded from the analysis because detailed data on age were missing. 
* Belgium: Flanders and Brussels Capital Region; Italy: Tuscany, Milan and Emilia Romagna 
† Because cause of death was available in 38 categories instead of ICD-10 codes for Italy, the 
categories of complex chronic conditions had to be estimated on the basis of these 38 categories 
§ The criteria proposed by Feudtner were used to operationalise deaths from complex chronic 
conditions (CCC) (11-14) 
$ Nagelkerke R² for Model 1: .035; Model 2: .138; Model 3: .142 
 
For children dying from CCC (excluding Norway), Model 1 of the multivariate binary 
logistic regression showed that home death was more likely for children dying from 
CCC in the Netherlands (OR 3.6; 95% C.I. 1.8-7.1) as compared to Italy (see Table 3). 
Controlling for gender, age and cause of death, in Model 2, differences between 
countries were more pronounced: children dying from CCC in Belgium, Wales and the 
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Netherlands had higher chances of dying at home than children dying from CCC in 
Italy. Model 2 fitted the data better than Model 1 (Likelihood Ratio Test: 78.8, 3 df, 
p<.001). The final Model 3 included the number of hospital beds and the degree of 
urbanization and differences between countries remained significant. Children dying 
from CCC in the Netherlands and Belgium still had higher chances of dying at home 
than those in Italy, while the chances of home death approached significance in Wales 
and England. The higher chances of home deaths for children dying after the age of 10 
(OR 1.4; 95% C.I. 1.1-1.9) and children dying from cancer (OR 3.3; 95% C.I. 2.5-4.5) 
remained significant, while both community-based variables were not significant 
factors in the final model. Children dying after the age of 10 and children dying from 
cancer had a higher chance of dying at home. Model 3 fitted the data better than Model 
2 (Likelihood Ratio Test: 18.8, 3 df, p<.001). 
 
2.4. Discussion 
 
The results of our study show that of all children dying at age 1 to 17 in the six 
European countries studied, about one in five died at home. Children dying from CCC 
were more likely to die at home than those not dying from CCC. The proportion of 
home deaths amongst children who died from CCC varied strongly between countries, 
from 21.7% in Italy to 50.0% in the Netherlands. The chances of dying at home for 
children dying from CCC were higher for those dying after the age of 10 and for those 
dying from cancer. After controlling for differences in age, gender, cause of death and 
community-based variables, differences in the chances of dying at home remained 
significant between countries. Children in Belgium and the Netherlands had 
significantly higher chances of dying at home than children in Italy. 
This study was the first, to our knowledge, to study systematically the place of death of 
children at a population level in different European countries. The use of death 
certificates allowed for studying different individual variables and making reliable 
estimates at a population level. The analyses made it possible to focus on cross-national 
comparisons across different care settings and patient groups. Moreover, the group of 
children dying from CCC could be identified by detailed information on cause of death 
on the death certificates, which allowed for more relevant analyses. 
This study has several limitations that should be kept in mind when interpreting the 
data. Place of death may be considered a robust indicator of how societies, from a broad 
perspective, approach death and dying, and how they have accordingly organized their 
end-of-life care. However, it does not give information on the palliative care before 
death, on the quality of care at that time in the disease trajectory, or on the (cultural) 
preferences which might account for part of the country differences, which makes 
interpretation of appropriateness of home death in specific instances difficult. SES was 
only available on an aggregated level and was estimated by average income in the 
region. It cannot be ruled out that this measurement was too imprecise to capture the 
49
Chapter 2 - Home deaths of children__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
SES of the actual households of individual children. Categories of cause of death had to 
be estimated on the basis of 38 categories instead of ICD-10 codes for Italy. It is possible 
that this caused some bias in the results as for Italy the subgroup of children dying 
from CCC was not as distinct.  
The finding that about one in five of all children dies at home was in line with findings 
from a population based study in the United States.(13;14) The percentage of deaths 
occurring at home for children dying from CCC in the six European countries studied, 
ranging between 21.7% and 50.0%, was only consistent with findings in the United 
States that about 30% of 1 to 19y-olds died at home following CCC in 2002 for some of 
the countries.(14) While research indicates that home is the preferred place of care for 
parents caring for terminally ill children, especially when they are emotionally and 
intellectually aware and well informed about their child’s impending death, a large 
majority of children do not die at home, even if they are suffering from a complex 
chronic condition.(18) As the present study did not measure parents’ or children’s 
preferences on place of death, or medical complications making hospitalization 
necessary, only cautious conclusions can be drawn.(19) 
The observed proportion of children dying at home was generally lower than the 
proportion of adults dying at home in the same countries.(17) This could be related to 
different patterns of illness and differences in availability of specialized homecare for 
children.(20) The proportion of home deaths was highest for children in the 
Netherlands which equally applies to the proportion of home deaths among adults.(17) 
This suggests that the general organization of health care in the different countries 
may influence place of death. General practice is well developed in the Netherlands, 
which can facilitate the organization of homecare.(21) Although every Norwegian 
citizen has a general practitioner since the country’s reform of general practice in 2000, 
the proportion of home deaths was low in Norway. Perhaps, a possible effect of this 
reform on place of death will need some more time to become evident in the admission 
practice at the end-of-life.    
We found cancer to be positively related to children’s chances of dying at home in four 
of six of the countries studied. This finding was in line with previous research (14;22), 
and could be related to the more predictable course of cancer which makes it easier to 
plan end-of-life care (23-26); home death is also more frequent in adults dying from 
cancer (23;27). Furthermore, pediatric palliative homecare, eg in Belgium, is often 
developed from oncology settings where professional caregivers are the most 
experienced in providing homecare for terminally ill children. It is important to notice 
that the biggest potential in improving the rates of home deaths exists in children not 
dying from cancer.   
An important finding was that after controlling for differences in age, gender, cause of 
death and community-based variables, children dying from CCC in Belgium and the 
Netherlands still had higher chances of dying at home than those dying from CCC in 
Italy. Different explanations can be suggested to account for these differences. First of 
all, differences in organization of care and homecare provision for chronically ill 
children may be influential. The finding that in Belgium, the Netherlands, England and 
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Wales, children dying from cancer were more likely to die at home as compared to 
children dying from other causes suggests that opportunities for homecare for child 
cancer patients are already better developed in these countries. In Italy and Norway, 
we found no significant differences between cancer and non-cancer patients, indicating 
that homecare provisions for child cancer patients may not be better developed than 
provisions for children suffering from other diseases in these countries. It should 
however be noted that recently an agreement on a national plan for pediatric palliative 
care was reached in Italy, including the promotion of homecare for children with life-
threatening illness.(28) 
Secondly, cultural differences may also be of influence. In Italy, while for older people 
home death is desirable, young patients are often treated intensively in hospital even 
when death is imminent, whereas in the Netherlands a greater openness exists in 
accepting death.(29;30) This is confirmed by studies showing that end-of-life decisions 
with a possible life-shortening effect are less frequently taken in Italy than in other 
European countries.(31;32) It was not possible to conclude from the data whether end-
of-life care had been aggressive, because no information was available on the specific 
hospital setting where death occurred (eg pediatric intensive care). However, our 
findings provided some support for the influence of a cultural factor, as the chances of 
dying at home for children under the age of 11 were especially low in Italy as compared 
with the other countries. This aggressiveness of care, rather than a palliative approach 
focusing on comfort and symptom management, may be specific to Italy. Research is 
needed to investigate whether the low proportion of children dying at home in some 
countries (eg Norway) also is related to specific cultural factors, such as attitudes of 
both physicians and the general public towards life-supporting treatment at the end-
of-life as well as towards home as an appropriate place of death. 
 
2.5. Conclusion 
 
Although parents of children with life-limiting complex chronic conditions mostly 
attest that home is their desired location of end-of-life care for their children, in most 
countries included in this study, less than half of the patients died at home, indicating 
that there are considerable opportunities to increase the proportion of these deaths 
occurring at home. The proportion of home deaths was largest for children with 
cancer. Furthermore, this proportion varied considerably across countries, suggesting 
that closer comparative investigation among countries may uncover important related 
factors to improve pediatric home-based end-of-life care. 
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Appendix: Complex Chronic Conditions (CCC) - list of ICD-10 codes 
 
CCC Category Subcategory ICD-10 
Brain and spinal cord 
malformations 
Q000, Q001, Q002, Q019, Q02, Q039, Q043, 
Q048, Q050, Q051, Q052, Q054, Q055, Q056, 
Q057, Q059, Q062, Q064, Q068, Q078, Q079 
Mental retardation  F719, F729, F739 
Central nervous system 
degeneration and disease 
E752, E754, G10, G111, G114, G118, G120, 
G121, G122, G128, G129, G20, G210, G211, 
G212, G213, G218, G219, G238, G241, G242, 
G243, G244, G245, G248, G250, G253, G255, 
G256, G258, G259, G309, G310, G311, G318, 
G319, G320, G328, G900, G908, G909, G910, 
G911, G937, G950, G951, G958, G959, G990, 
G992, M890 
Infantile cerebral palsy G801, G802, G808, G809 
Epilepsy  G403, G410, G411, G412 
Neuromuscular 
Muscular dystrophies and 
myopathies 
G710, G711, G712, G723 
Heart and great vessel 
malformations 
Q200, Q201, Q203, Q204, Q205, Q208, Q209, 
Q210, Q211, Q212, Q213, Q220, Q221, Q223, 
Q224, Q225, Q230, Q231, Q232, Q233, Q234, 
Q240, Q242, Q243, Q244, Q245, Q246, Q248, 
Q249, Q250, Q251, Q252, Q254, Q257, Q262, 
Q263, Q268, Q269 
Cardiomyopathies I421, I423, I424, I428, I515 
Cardiovascular  
Conduction disorders and 
dysrhythmias 
I440, I441, I442, I443, I446, I447, I451, I452, 
I453, I454, I455, I456, I458, I459, I471, I472, 
I479, I48, I490, I491, I494, I495, I498, I499 
Respiratory malformations Q300, Q308, Q310, Q324, Q330, Q334, Q336, 
Q338, Q339, Q348, Q349 
Chronic respiratory disease P279 
Respiratory  
Cystic fibrosis E840, E841, E848, E849 
Congenital anomalies Q600, Q610, Q611, Q612, Q613, Q614, Q615, 
Q618, Q619, Q623, Q628, Q638, Q641, Q643, 
Q644, Q647, Q649 
Renal  
Chronic renal failure N189 
Congenital anomalies Q391, Q419, Q429, Q431, Q441, Q442, Q445, 
Q446, Q453, Q458, Q459 
Chronic liver disease and 
cirrhosis 
K730, K738, K739, K745, K746, K760, K769 
Gastrointestinal  
Inflammatory bowel disease K500, K501, K508, K509, K510, K511, K512, 
K513, K514, K518, K519 
Sickle cell disease D570, D571, D572, D573 Hematology and 
immunodeficiency  Hereditary anemias D551, D558, D569, D580, D581 
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Hereditary immunodeficiency D71, D720, D800, D801, D802, D803, D804, 
D805, D808, D814, D819, D820, D821, D830, 
D831, D838, D849, D898, D899, M303, M359 
Human immunodeficiency virus 
disease 
B24 
Amino acid metabolism E700, E708, E710, E720, E721, E722, E728, 
E728, E729 
Carbohydrate metabolism E739, E740, E741, E742, E748, E749 
Lipid metabolism E756, E780, E781, E782, E783, E784, E786, 
E788, E789, E881 
Storage disorders E763, E806, E853, E858 
Metabolic  
Other metabolic disorders E798, E806, E830, E831, E833, E834, E880, 
E888, E889 
Chromosomal anomalies Q909, Q913, Q917, Q930, Q950, Q952, Q968, 
Q984, Q988, Q999 
Bone and joint anomalies E343, M410, M411, M412, M413, M965, 
Q750, Q751, Q752, Q753, Q758, Q759, Q760, 
Q761, Q762, Q764, Q765, Q766, Q773, Q776, 
Q780, Q781, Q782, Q788, Q789 
Diaphragm and abdominal wall K449, Q791, Q795 
Other congenital 
or genetic defect 
Other congenital anomalies Q870, Q871, Q872, Q874, Q878, Q897, Q898, 
Q899, Q992 
Malignancy   C000-D489, H350, N648, Q850 
 
For Italy, cause of death was available in following categories: 
 
1: Tuberculosis 
2: Viral hepatitis 
3: Human immunodeficiency virus (HIV) disease 
4: Malignant neoplasm of stomach 
5: Malignant neoplasms of colon, rectum and anus 
6: Malignant neoplasm of pancreas 
7: Malignant neoplasms of trachea, bronchus and lung 
8: Malignant neoplasm of breast 
9: Malignant neoplasms of cervix uteri, corpus uteri and ovary 
10: Malignant neoplasm of prostate 
11: Malignant neoplasms of urinary tract 
12: Non-Hodgkins lymphoma 
13: Leukemia 
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14: Other malignant neoplasms 
15: Diabetes mellitus 
16: Alzheimers disease 
17: Hypertensive heart disease with or without renal disease 
18: Ischemic heart diseases 
19: Other diseases of heart 
20: Essential (primary) hypertension and hypertensive renal disease 
21: Cerebrovascular diseases 
22: Atherosclerosis 
23: Other diseases of circulatory system 
24: Influenza and pneumonia 
25: Chronic lower respiratory diseases 
26: Peptic ulcer 
27: Chronic liver disease and cirrhosis 
28: Nephritis, nephrotic syndrome and nephrosis 
29: Pregnancy, childbirth and the puerperium 
30: Certain conditions originating in the perinatal period 
31: Congenital malformations, deformations and chromosomal abnormalities  
32: Sudden infant death syndrome 
33: Symptoms, signs and abnormal clinical and laboratory finding 
35: Transport accidents 
36: All other and unspecified accidents and adverse effects 
37: Intentional self-harm (suicide) 
38: Assault (homicide) 
 
To identify the group of children dying from CCC, these were recoded as follows: 
CCC-cancer: 4-14 
CCC-non-cancer: 15, 25, 27, 31 
No CCC: else 
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Abstract: 
 
Background 
The aim of the study was to investigate attitudes of secondary school students towards 
acceptability of requests by minors for end-of-life decisions (ELDs) with a possible life-
shortening effect: non-treatment decisions, potentially life-shortening alleviation of 
pain and symptoms (APS) and euthanasia. 
 
Methods 
A cross-sectional survey was conducted among second and fourth grades students in 20 
secondary schools in Flanders, Belgium. An anonymous structured questionnaire was 
administered to measure attitudes towards acceptability of requests for euthanasia and 
other ELDs, towards the right to be informed about terminal prognosis and their own 
desire to be informed. 
 
Results 
In total, 1769 students participated. In case of a terminal patient, 61% found a request 
for euthanasia acceptable, 60% a request for APS and 69% a request for non-treatment 
decision, compared with 18% (euthanasia) and 50% (APS) in case of a non-terminal 
patient. Acceptance was highest among: boys, participants older than 14 years and 
participants from general as opposed to technical and vocational education. Sixty-six 
per cent said the parents’ opinion not being asked was a circumstance that should hold 
back a physician from administering a lethal drug. Ninety per cent of participants 
thought a minor has the right to be informed about terminal prognosis of a disease 
while 78% would like to be informed themselves. 
 
Conclusions 
Attitudes towards ELD requests varied with case and participant characteristics and 
type of ELD. The studied adolescents have a clear wish to be informed about terminal 
prognosis. Physicians and caregivers should adequately involve adolescents in decision 
making and tailor prognosis-related information to their needs and level of 
competence. 
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3.1. Introduction 
 
In the final phase of a patient’s life, physicians often balance quality of life against 
prolongation.   Medical end-of-life decisions (ELDs) which possibly or certainly hasten 
death are frequently taken (1-6). ELDs comprise several kinds of decisions:  
(1) withholding or withdrawing life-sustaining treatments (non-treatment decisions, 
NTDs); 
(2) alleviation of pain and other symptoms with a possible life-shortening effect (APSs);  
(3) the administration of drugs, by a physician, with the explicit intention of ending the 
patient’s life at the explicit request of the patient: euthanasia. 
 
The high prevalence of ELDs is usually associated with an ageing society but ELDs are 
also frequently taken in relation to minors, defined as not having reached the age of 
adulthood (in Belgium < 18 yrs.), and infants (7-10).  For minors aged 1-17 yrs, a 
nationwide Dutch study reports that ELDs precede 36% of all deaths in this age category 
(11). 
 
The involvement of minors in decision-making at the end of life raises questions about 
the patient’s competence to make such decisions.  This competence is continually 
evolving in developing children, and influenced by different factors such as illness 
experience, the development of a clear concept of death and the extent to which the 
child is adequately informed about his/her illness and prognosis (12-14).  The evolving 
nature and context-dependency of the minor’s competence makes it difficult to assess.  
In addition according to the Belgian law on patients’ rights, unless minors are judged to 
be competent, their rights as a patient are exercised by their parents or legal 
representatives.  Striking a balance between the patient’s interests and the legitimate 
interests of the parents and achieving multi-party consent are crucial.  These factors, 
among others, complicate the decision-making process in minors. This complexity is 
present in all ELDs, but while APS and NTD are more accepted as part of normal medical 
practice, the complexity is heightened by the controversial nature of physician-assisted 
death. 
 
In the Netherlands minors (< 18) may request euthanasia from the age of 12 years (15).  
Their legal representatives must be informed and their assent to euthanasia is required 
when the child is between 12 and 16. In Belgium, minors are excluded from the 
application of the euthanasia act altogether (with the exception of emancipated 
minors, who are removed from guardianship by a juvenile court) and extending the  
application of the law to those under 18 has become the objective of proposals 
submitted to the Senate and widely discussed in the national media (16-18). Whereas 
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the actual legal position of minors regarding euthanasia currently does not differ from 
other countries where euthanasia is not legal, the open debates on this issue in society 
and politics may be specific for Belgium.   
 
While the results of end-of-life attitude research are available for many adult groups 
(19-25) at present no representative data have been published on how minors 
themselves think about euthanasia or other ELDs.  
In this study we examine the following research questions: 
 whether and under which conditions adolescents (≥ 12 yrs. and < 18yrs.) find 
requests from their peers for euthanasia and other end-of-life decisions (NTD, 
APS) acceptable; 
 which circumstances should hold a physician back from administering a lethal 
drug?   
 whether adolescents think a minor has the right to be informed about a 
terminal prognosis and whether they would want to be informed about a 
terminal prognosis themselves. 
We also study some characteristics (age, gender, type of education and educational 
network) in relation to the opinions of the adolescents studied. 
 
3.2. Method 
 
An anonymous questionnaire consisting of pre-structured questions concerning 
requests for ELDs by minors undergoing intense suffering was presented to students by 
means of touch-screen units. The study population consists of students from the second 
and fourth grades of Flemish secondary schools in the school year 2000-2001 (before 
the legalisation of euthanasia in Belgium). These students were reached via a sample of 
twenty secondary schools. 
The school sample was drawn from the registry of schools of the Flemish Department of 
Education, containing 891 secondary schools and 133.053 students in second and fourth 
grades (Statistics of the Flemish Department of Education 2000-2001). The school 
sample was stratified according to province (Flanders has five provinces) and to school 
network.  In Flanders, schools belong to the “free network” (private, most of which are 
Catholic, schools; 76% of all students in ordinary secondary education) or to the 
“official school network” (schools run by state, province or town; 24% of students) 
Four schools were sampled from each province, of which three were from the “free 
network” (75%) and one from the “official network” (25%), thus assuring 
representativity for the network variable. If a school refused to participate in the study 
another school from the same network and province was chosen at random. 
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In each school the principal was asked to propose which classes would participate to 
make up a total of 100 students of which 50 were from the second grade and 50 from 
the fourth grade. If the populations proposed consisted of fewer than 50 then all 
students were included.  
In order to avoid a priori class consensus, the students were only informed of the 
content of the questionnaire beforehand in general terms. 
 
Box 1:  Description of hypothetical cases  
 
  
Attitudes towards euthanasia and other kinds of ELDs were measured by two 
hypothetical cases, both describing situations in which a minor clearly expresses the 
wish to die and asks the physician for an ELD (Cases 1 and 2, Box 1). After discussion 
with an expert panel, the case descriptions were constructed to distinct a terminal and 
a non-terminal sitution and to reflect realistic situations, which were based on 
unstructured interviews with severely ill children. The first hypothetical case describes 
a terminally ill girl suffering from cancer (Case 1). The second describes a non-
terminally ill girl suffering intensely from burns (Case 2). The respondents were asked 
their opinion of the acceptability of requests by these minors (“Yes”, “No” or “I don’t 
know”) regarding the following decisions: (1) the administration of a lethal drug with 
the explicit intention of ending the patient’s life (“Can the patient ask the physician for 
1. Acceptability of requests for euthanasia and other ELDs by minors  
Case 1:  
Femke is a 14 year old girl with bone cancer.  She experiences a lot of pain. The 
treatment she receives is very painful and burdensome. Everyone, including Femke 
herself, knows that she has only a limited time to live. Femke cannot tolerate the 
pain any longer and wants to die.  
Case 2: 
Nathalie, a 14 year old girl, is severely burnt over the whole of her face and body. 
She has a lot of pain and because of the burns she cannot move very well. Nathalie 
does not want to continue living like that, although she has a normal life 
expectation. 
 
2. Information about terminal prognosis 
Case 3: 
Katrien is a 14 year old girl. She has a disease that will not allow her to live much 
longer. Everyone around her knows that she will die soon. Katrien has asked 
repeatedly whether she will die, but nobody will tell her. 
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a lethal injection which will end the patient’s life?”); (2) the  alleviation of pain and 
symptoms with a possible life-shortening side-effect (APS)  (“Can the patient ask to 
increase pain medication? This might shorten the patient’s life”), and (3) the 
withdrawing or withholding of life-sustaining treatment with a possible life-shortening 
effect (NTD) (“Can the patient ask to stop the treatments? This will shorten the 
patient’s life”) (this question was not asked in Case 2).  The questions were formulated 
in this way to learn about participants’ opinions on feeling free to discuss these end-of-
life decisions with a physician. Instead of using value-laden words like “euthanasia”, 
descriptions of what the physician would do were used.  
The case descriptions and questionnaire were tested in four students from secondary 
school. The descriptions were found to be easy to understand and clearly formulated. 
No subsequent changes to the questionnaire were necessary.  
The next question aimed to identify in which circumstances should hold back the 
physician from a lethal drug. Participants could indicate one or more from following 
circumstances: refusal by the patient of a lethal drug, the patient being badly informed 
about his/her condition, the patient expressing the wish to die because of fear of 
becoming a burden to his/her parents, the parents disagreeing with wish of the 
adolescent, the physician not having asked the parents’ opinion and the request being 
considered to be due to illness-induced depression. 
Two questions were designed to chart the attitudes of the participants towards being 
informed about a terminal prognosis (Case 3, Box 1). The first question asked whether 
the girl in Case 3 should have the right to be informed about her terminal prognosis, 
the second whether participants would like to be informed themselves if faced with a 
similar situation.   
Further questions concerned general background variables (age and gender). 
Information on other background variables (type of education, educational network 
and province) was provided per participating class by the school principal.  In Belgium 
students in normal secondary education select one of three types of education.  
Students in “general education” are offered only theoretical courses: “general 
education” is intended to prepare students to continue their education at university or 
college.  Students in “technical education” participate in a mixture of theoretical and 
practical courses and may then choose to enter the labour market or to continue their 
education at university or college.  “Vocational education” is intended to teach the 
students the skills for a trade, by offering practical courses and internships. 
All descriptive research questions were answered using standardised descriptive 
methods (frequency tables). Confidence intervals were calculated to examine the 
differences between the two hypothetical case descriptions (terminal vs. non-terminal) 
and between different types of ELDs.  The relations between background variables (age 
(two groups:  14 and > 14 years), gender, network and type of education) and the 
opinions of the adolescents were analysed exploratory using multiple logistic 
regression.  Answers on the questions related to the case descriptions were 
dichotomised (1 = yes, 0 = no and I don’t know).   
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The consent to participate was secured at all levels i.e. students and parents by the 
school principals. Data were collected by a trusted third party, an independent 
company specialised in quantitative data collection, using touch screen units.  The data 
file was also prepared by this trusted third party and given to the researchers when all 
data were collected and anonymised.  The students participating in the study were 
offered the opportunity to attend a debriefing session with the main researcher.  At the 
time of the study, review by an ethical review board was nor required, nor usual, for 
studies of this kind in Belgium. 
 
3.3. Results 
 
All students from the classes selected by the school principals participated in the study 
(N = 1769, Table 1).  Characteristics of the response population were compared to the 
population (data registry of all students of the Flemish Department of Education).  The 
response population differed significantly from the research population for age, gender 
and school network. 
 
Table 1:  Characteristics of participants (N = 1.769) and population (N = 133.053) 
Variable  Sample % 
(N = 1.769) 
Population % 
(N = 133.053) 
Gender Male 52.5 51.3 
 Female 47.5 48.7 
Age  13 years 30.6 39.1 
 14 years 15.0 10.7 
 15 years 31.7 34.5 
 16 years 15.4 11.9 
 17 years 7.4 3.8 
School network Free/Catholic 78.3 75.8 
 Official/State 21.7 24.2 
Type of education* General 33.4 - 
 Technical 33.3 - 
 Vocational 33.3 - 
* Population data on type of education are not available for second grade of secondary 
education. 
 
 
In Case 1 (cancer patient, terminal situation), 61% of participants would find a request 
for euthanasia acceptable, 60% a request for APS and 69% a request for NTD (Table 2).  
In Case 2 (serious burns, non-terminal situation), 18% would find a euthanasia-request 
acceptable while 50% would find a request for APS acceptable. 
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Table 2: Percentage of respondents finding requests for euthanasia and other end-of-
life decisions acceptable, unacceptable or undecided (N = 1.769) 
Requests of minors for: 
Case 1 
(terminal cancer 
patient) 
Case 2 
(non-terminal burns 
patient) 
Yes 60.7 (58.4-63.0) 17.6 (15.8-19.4) 
No 24.4 (22.4-26.4) 72.5 (70.4-74.6) 
Injection of a lethal drug, 
in order to end her life 
(EUTH) Don’t know 14.9 (13.2-16.5) 9.9 (8.6-11.3) 
Yes 60.0 (57.7-62.3) 49.7 (47.4-52.0) 
No 26.7 (24.6-28.7) 39.2 (36.9-41.5) 
Increased pain 
medication so that her life 
may be shortened (APS) Don’t know 13.3 (11.8-14.9) 11.1 (9.7-12.6) 
Yes 69.5 (67.3-71.6) - 
No 20.9 (19.0-22.8) - 
Stopping treatment, so 
that her life will be 
shortened (NTD) Don’t know 9.7 (8.3-11.0) - 
Percentage of ‘yes, ‘no’ and ‘don’t know’-answers and 95% confidence intervals. 
 
In the terminal situation (Case 1, Table 3), acceptability of a request for euthanasia is 
higher for male students than for female, for students in the older age-group than for 
the younger and for students from general education than for students from technical 
and vocational education.  The acceptability of a request for APS and NTD in a terminal 
situation is related to age and type of education: older participants and students from 
general education show more acceptability than younger participants and students 
from technical and vocational education.  
In the non-terminal situation (Case 2, Table 3) more male participants found a request 
for euthanasia acceptable than did their female counterparts.  In the same case, male 
participants, students from the older age-group and students from general education 
showed the highest rate of acceptability regarding a request for APS. 
The most frequently cited circumstances that should hold back a physician from 
administering a lethal drug were: the child not agreeing (76%), the child being badly 
informed about his/her condition (68%) and the opinion of the parents has not been 
sought (66%).  Agreement of the parents was indicated by 40% of participants, while 
34% find that the administration of lethal drugs is not acceptable when the child 
doesn’t want to live any longer because of the burden he/she causes to the parents. For 
42% of participants it was not acceptable that the physician should be allowed to 
administer a lethal drug when the adolescent longs to die because of a depressed state 
of mind induced by their illness (data not shown in table) 
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Table 3: Acceptability of minor’s requests for euthanasia and other ELDs according to 
the minor’s characteristics. 
  
Case 1 
(terminal cancer patient) 
Case 2 
(non-terminal burns patient) 
  EUTH APS NTD EUTH APS 
Variables  %* 
OR 
(95% CI)$ 
%* 
OR 
(95% CI)$ 
%* 
OR 
(95% CI)$ 
%* 
OR 
(95% CI)$ 
%* 
OR 
(95% CI)$ 
Gender Male 63.4 1 (Ref.) 59.9 1 (Ref.) 68.6 1 (Ref.) 21.0 1 (Ref.) 53.3 1 (Ref.) 
 Female 58.3 
0.7 
(0.6-0.9) 
60.0 
0.9 
(0.8-1.2) 
70.3 
1.0 
(0.8-1.2) 
14.4 
0.6 
(0.5-0.8) 
46.4 
0.7 
(0.6-0.9) 
Age  14 56.5 1 (Ref.) 52.6 1 (Ref.) 63.8 1 (Ref.) 18.1 1 (Ref.) 46.2 1 (Ref.) 
 > 14 64.3 
1.6 
(1.3-1.9) 
66.1 
2.0 
(1.6-2.4) 
74.2 
1.8 
(1.5-2.2) 
17.1 
0.9 
(0.7-1.2) 
52.6 
1.4 
(1.2-1.7) 
Network 
Free/ 
Catholic 
60.2 1 (Ref.) 61.2 1 (Ref.) 69.5 1 (Ref.) 17.9 1 (Ref.) 50.5 1 (Ref.) 
 
Official/ 
State 
62.5 
1.0 
(0.8-1.3) 
55.7 
0.7 
(0.6-0.9) 
69.3 
0.9 
(0.7-1.2) 
16.4 
0.9 
(0.7-1.3) 
46.9 
0.8 
(0.6-1.0) 
Type General 71.4 1 (Ref.) 68.0 1 (Ref.) 76.4 1 (Ref.) 18.3 1 (Ref.) 57.5 1 (Ref.) 
 Technical 60.6 
0.6 
(0.5-0.8) 
61.3 
0.6 
(0.5-0.8) 
72.0 
0.7 
(0.5-0.9) 
18.0 
1.0 
(0.8-1.4) 
49.6 
0.7 
(0.5-0.9) 
 Vocational 50.2 
0.4 
(0.3-0.5) 
50.7 
0.4 
(0.3-0.5) 
60.0 
0.4 
(0.3-0.5) 
16.4 
0.8 
(0.6-1.1) 
42.0 
0.5 
(0.4-0.6) 
Abbreviations: EUTH: administering a lethal drug to the patient, knowing that this will shorten the 
patient’s life; APS: increasing pain medication, which might shorten the patient’s life; NTD: stopping or 
withholding life-sustaining treatment, which might shorten the patient’s life. 
* Percentage of acceptance 
$ Odds Ratios and 95% confidence intervals.  Results of multiple logistic regression.  Gender, age, network 
and type of education were entered in block as independent variables, with acceptance of euthanasia and 
other ELDs (1 = yes, 0 = no or don’t know) as dependent variables. 
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Table 4: Characteristics of respondents in relation to attitudes towards the right and 
willingness to be informed about terminal prognosis. 
 Has Katrien the right to be 
informed that she will die? 
Would you want to be 
informed? 
Total % (95% C.I.) 89.7 (88.3-91.1) 78.4 (76.3-80.3) 
Variables %* OR (95% 
C.I.)$ 
%* OR (95% 
C.I.)$ 
Gender     
Male 86.3 1 (Ref.) 75.3 1 (Ref.) 
Female 92.8 1.9 (1.3-2.6) 81.1 1.4 (1.1-1.7) 
Age     
≤ 14 88.5 1 (Ref.) 74.6 1 (Ref.) 
> 14 90.8 1.4 (1.0-1.9) 81.5 1.5 (1.2-1.9) 
Network     
Free/Catholic 89.5 1 (Ref.) 78.5 1 (Ref.) 
Official/State 90.4 1.0 (0.7-1.5) 77.9 1.0 (0.7-1.3) 
Type     
General 92.0 1 (Ref.) 78.1 1 (Ref.) 
Technical 92.0 0.9 (0.6-1.4) 81.5 1.1 (0.8-1.5) 
Vocational 85.1 0.5 (0.3-0.7) 75.4 0.8 (0.6-1.1) 
* Percentage of acceptance 
$ Odds Ratios and 95% confidence intervals.  Results of multiple logistic 
regression.  Gender, age, network and type of education were entered in block as 
independent variables, with answers on questions concerning information about 
terminal prognosis (1 = yes, 0 = no or don’t know) as dependent variables. 
 
Ninety percent of the respondents find that the terminally ill patient described in Case 
3 (see Box 1) has the right to be informed about her terminal prognosis (Table 4). 
Seventy-eight percent of the participants would like to be informed themselves if in the 
same situation.  Agreement with the right to be informed about a terminal prognosis 
and the willingness to be informed themselves is highest among female participants 
and students from the older age-group.  Agreement with the right to be informed about 
terminal prognosis is lowest for students from vocational education. 
 
3.4. Discussion 
 
The present study found that the acceptability of ELD requests varied with case 
characteristics (terminal vs. non-terminal), type of ELD (euthanasia, potentially life-
shortening pain and symptom alleviation or non-treatment decisions) and participant 
characteristics, with higher acceptance in male participants, participants aged 14 and 
older and students who are in general education as opposed to students from technical 
68
Chapter 3 - Attitudes of secondary school students__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
and vocational education.   A large majority of participants agreed with the right of 
minors to be informed of a terminal prognosis and demonstrated willingness to be 
informed themselves.  The rate of agreement was higher for female participants, 
participants aged 14 or older and students from general and technical education as 
opposed to vocational education.  Participants cited the parents not being asked their 
opinion as an important condition that should hold the physician back from 
administering a lethal drug.  Fewer participants thought the lack of parental consent 
was a reason for not administering a lethal drug. 
This study is the first, to our knowledge, to study systematically the attitudes of minors 
towards end-of-life decision-making. The study design, using clear and brief vignettes 
and descriptions of the medical decisions concerned, rather than specialised terms, 
assumed no prior knowledge of the study-topic, making it well-suited to capturing the 
perspective of minors from different age-groups and different cognitive levels.  The 
computerised touch-screen units were intended to appeal to the adolescents’ sphere of 
interest, motivating them to participate.  The study design further prevented missing 
values on the questionnaires, no non-response at the level of participation of students, 
while a priori class consensus on the study topic was avoided.  The study also has some 
shortcomings. Because the vignettes presented were very brief, some complexity and 
differentiation could not be covered.  The answer categories “yes”, “no” and “don’t 
know” possibly didn’t give enough opportunity for participants to nuance their 
opinions.  Participating classes were proposed by the school principals, which could 
have caused some selection bias. It is however unlikely that this has systematically 
distorted the data, as principals may propose classes for different reasons (e.g. most 
motivated classes or classes who had already addressed end-of-life issues during their 
courses), which could bias the attitudes of students in the study sample in different 
directions (both more and less permissive towards end-of-life decisions).     
The first important finding, that attitudes vary strongly with case characteristics and 
type of ELDs, clearly demonstrates that adolescents are capable of nuancing their 
opinions according to the characteristics of the actual situation.  The high rate of those 
wanting to be informed about terminal prognosis further indicates that adolescents 
would want to be actively involved in end-of-life decision-making relating to 
themselves.  Although the importance they ascribe to the involvement of parents 
suggests that they would prefer not to be left alone with the difficult decisions at the 
end of life, their opinion that parental consent was not necessary points to their 
willingness to be regarded as capable of taking responsibility for themselves.  These 
findings are in line with previous studies which found that cancer patients who are 
minors want to be informed about a terminal prognosis, and adapt their willingness to 
be involved to the type of decisions concerned (26-28). 
The higher acceptability of ELD-requests and the higher rate of agreement with the 
right to be informed about terminal prognosis and the wish to be informed themselves 
found in older participants was perhaps not surprising and is in line with a previous 
study of cancer patients who are minors (26).  As adolescents mature they become 
increasingly capable of making autonomous decisions, while they find individuality and 
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independence increasingly important.  These developments may lead adolescents to 
prefer a more active role in the decision-making process, by wanting prognosis-related 
information and agreeing more with the acceptability of requests by minors for ELDs.  
Maturity in thinking about end-of-life issues is not only linked to age-related cognitive 
development however but also to experience with chronic disease (29-31). 
Unfortunately, as illness experience was not measured in the present study, its possible 
effect on opinions concerning end-of-life issues could not be investigated. 
We found very little relation between the adolescents’ attitudes and the school 
network, which roughly coincides with the distinction between Catholic and non-
Catholic schools; other studies have demonstrated the important influence of life-
stance on attitudes towards end-of-life decisions (23;32).  We presume that, although 
the school network variable coincides well with the school’s religious stance it does not 
relate as well to the participants’ individual life-stance, as choice of school is probably 
more determined by other factors e.g. closeness to the place of residence and the 
perceived quality of education than by the underlying ethos of the school.   
The clear effect of the type of education on the opinions of adolescents in this study 
was in accordance with a previous study on values in Flemish adolescents (33).  We 
hypothesise that the type of education influences adolescents’ opinions in that students 
in general education are more often required to think about ethical issues in class, 
which makes thinking about these issues more familiar for these students.  This might 
lead them to adopt a more nuanced attitude towards requests for ELDs, and to find 
being informed about these topics more important. 
 
3.5. Conclusion 
 
The findings of the present study show that adolescents want to be involved in medical 
decision making at the end-of-life even though their attitudes varied strongly 
according to case characteristics, type of ELD and they believe that parents should be 
involved in the process. Attitudes were also related to participant characteristics, 
although the observed differences in attitudes were smaller than these in relation to 
case characteristics and type of ELD. Physicians and caregivers should take these 
variations into account when faced with adolescents at the end of their lives.  As not all 
adolescents find requests for ELDs equally acceptable and not all adolescents want to be 
informed about terminal prognosis, the results suggest that a differentiated approach 
taking into account the different views of adolescents is needed for the optimal 
involvement of adolescents in the decision-making process.  Careful assessment by 
paediatricians or other caregivers of the adolescent’s needs and competence and the 
subsequent tailoring of prognosis-related information to the level of competence and 
needs of the adolescent will be necessary to create the conditions for high quality care 
at the end of life for adolescent patients. 
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Abstract: 
Objectives 
The present study aimed to investigate the attitudes of adolescent cancer survivors 
towards end-of-life decisions (ELDs) with a life-shortening effect: non-treatment 
decisions (NTDs); intensified alleviation of pain and symptoms (APS), and euthanasia, 
and the influence of illness experience on these attitudes. 
 
Methods 
Adolescent cancer survivors were interviewed with a structured questionnaire using 
hypothetical case descriptions to assess their attitudes towards: requests for ELDs by 
minor patients, the circumstances in which physicians should hold back from 
administering a lethal drug to a minor, their right to be informed about a terminal 
prognosis and their willingness to be informed. The results were compared with a study 
of 1.769 adolescents without experience of chronic illness. 
 
Results 
Eighty-three adolescents, 11-18 years old, were interviewed. In a terminal situation, 
70% to 90% found a request for NTD acceptable, 84% a request for APS and 57% to 64% 
requests for euthanasia. Requests for ELDs were less acceptable in a non-terminal 
situation, where 28% found a request for NTD acceptable, 39% to 47% requests for APS, 
and 11% to 21% requests for euthanasia. Frequently-cited reasons for holding back 
physicians from administering a lethal drug to a child were: the child not being well-
informed about his/her condition (92%) and the parents’ opinion not being asked 
(92%). Compared to adolescents without experience with chronic illness, cancer 
survivors were more acceptant toward requests for NTD and APS in a terminal 
situation. 
 
Discussion 
Adolescent cancer survivors, like other adolescents, want to be involved in medical 
decision-making at the end of life. They value autonomous decision-making, without 
excluding parents from the process. The experience of living through life-threatening 
illness can alter adolescents’ attitudes towards requests for NTD and APS. When trying 
to involve adolescents and their parents adequately in medical decision-making, the 
adolescent’s illness-experience should be taken into account. 
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4.1. Introduction 
 
Medical end-of-life decisions with a possible life-shortening effect (ELDs) precede about 
40% of deaths, not only in adults but also – and this is less clearly recognized - in minors 
(<18y) (1-5). The legal status of these ELDs generally depends on the category they 
belong to: (1) the withholding or withdrawing of life-sustaining treatments (non-
treatment decisions, NTDs); (2) intensified alleviation of pain and other symptoms 
(APSs); (3) the provision, prescription or administration of lethal drugs by the physician 
with the explicit intention of ending the patient’s life, subdivided into: (1) euthanasia: if 
the physician administers lethal drugs at the patient’s explicit request; (2) physician-
assisted suicide: if the physician prescribes or provides lethal drugs administered by 
the patient him or herself; (3) the administration of lethal drugs by the physician 
without explicit patient request. 
In minors several factors complicate an ethically and legally justifiable decision-making 
process. According to the Belgian Law on Patient’s rights (2002), a minor’s legal rights 
as a patient are exercised by the parents or guardian unless the minor is regarded as 
competent. Thus, a minor may refuse treatment, even without parental consent, if he 
or she is judged sufficiently competent to make the medical decision. On the other 
hand, even if the minor is fully competent according to the Law on Patient’s Rights, he 
or she may not choose euthanasia, as the Belgian Law on Euthanasia (2002) explicitly 
excludes persons under the age of 18 (6). Because of this perceived inconsistency, the 
possibility of the inclusion of minors in the application of the euthanasia act is being 
heavily debated, both in politics and in wider society. This has resulted in several 
proposals for amendments to the law, some of which are under consideration. (7-9) 
Other challenges in the decision-making process preceding ELDs in minors are 
specifically related to minor patients’ decision-making competencies. The concept of 
competence, however, is difficult to establish for several reasons. First of all, it is not 
clear who should assess the competence of a minor patient and how this might be done. 
Secondly, as children are developing physically and mentally, their level of competence 
is continually evolving, making it more difficult to assess unequivocally. Finally, several 
factors may influence a child’s normal competence, one of which is experience with 
severe and chronic illness. (10-13). 
Despite the frequent occurrence of ELDs in minors, the current debates on non-
treatment decisions and euthanasia, and the complexity of the decision-making process 
preceding ELDs, little is known about how minors themselves think about ELDs and 
how experience of illness influences their attitudes. Although attitudes towards ELDs 
have been extensively studied in adults (14-20), they have received less attention in 
minors. One study among students in Flemish secondary schools showed that 
adolescents find requests for ELDs, including euthanasia, acceptable in hypothetical 
cases under certain circumstances (21). This study will address the following research 
questions in adolescents who survived cancer: 
77
Chapter 4 - Attitudes of cancer survivors__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
 whether and under which conditions they find requests from their peers for 
end-of-life decisions - non-treatment decisions (NTD), intensified alleviation of 
pain and symptoms (APS) and euthanasia - acceptable; 
 in which circumstances they consider a physician should hold back from 
administering a lethal drug to a minor patient;  
 whether they think a minor has the right to be informed about terminal 
prognosis and whether they would want to be informed about a terminal 
prognosis themselves; 
 and, by comparing the attitudes of adolescent cancer survivors with the 
attitudes of adolescents never diagnosed with cancer: does illness experience 
change an adolescent’s attitudes towards ELDs. 
 
4.2. Method 
 
Adolescent cancer survivors were contacted via the Department of Pediatric Hemato-
Oncology of Ghent University Hospital in 2004. Participants were included in the study 
if they were between 11 and 18 years of age and clear from treatment for at least 2 
years. The adolescent’s parents were sent a letter explaining the research objectives 
and details, and were asked to give informed consent for their child to participate in 
the study. One week after the informed consent form was sent, the parents were 
contacted by psychologists from the department. Adolescents for whom parents 
provided informed consent were subsequently asked to consent to participation in the 
study and, if they agreed, interviewed at their home or at another place of their choice. 
Parents or adolescents who did not want to take part in the study were asked about the 
reasons they preferred not to participate. 
Interviews were administered by three trained interviewers and structured by a 
questionnaire with closed questions, based on a previous study in secondary schools 
(21). The questionnaire consisted of three parts, measuring acceptability of requests for 
ELDs, circumstances in which a physician should not administer a lethal drug to a child, 
and attitudes towards information about terminal prognosis. 
In the first part, hypothetical case descriptions concerning adolescents with an explicit 
wish to die (see Box 1) were presented to the participants. Case T1 and Case T2 
concerned terminal situations, while Case NT1 and Case NT2 concerned non-terminal 
situations. Questions were asked about acceptability of requests for different types of 
ELDs: the withdrawing or withholding of life-sustaining treatment with a possible life-
shortening effect (NTD) (“Can the patient ask to stop the treatments? This will shorten 
the patient’s life”); the alleviation of pain and symptoms with a possible life-shortening 
side-effect (APS) (“Can the patient ask to increase pain medication? This might shorten 
the patient’s life”); and the administration of a lethal drug with the explicit intention of 
ending the patient’s life (euthanasia) (“Can the patient ask the physician for a lethal 
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injection which will end the patient’s life?”). To prevent misconceptions about value-
laden words like “euthanasia”, descriptions of what the physician would do were used. 
 
 
In the second part of the questionnaire, also using hypothetical examples, participants 
were asked to indicate whether a physician can administer a lethal drug in following 
situations: the minor patient doesn’t want a lethal injection; the patient isn’t well 
informed about his/her illness; the patient wants to die because of the burden he/she 
causes to parents; the patient’s parents don’t agree with the child’s death wish; the 
parents’ opinion is not asked and the patient wants to die because of illness-induced 
sadness. 
In the third part, two questions were asked in order to identify attitudes towards being 
informed of a terminal prognosis (Case 3, Box 1). The first question asked whether the 
girl in Case 3 should have the right to be informed about her terminal prognosis, the 
second asked whether participants would like to be informed themselves if faced with a 
similar situation. During the interviews, further information was obtained on the 
personal and clinical characteristics of the participants: current age, age at diagnosis, 
gender, diagnosis, type and duration of treatment. The study protocol was reviewed 
and approved by the ethical review board of Ghent University Hospital. 
For questions where formulation and answer categories were comparable, data from 
the present study were merged with data from a previous study in adolescents without 
previous experience with cancer, which is described in full detail elsewhere (21). 
Comparable questions were related to the hypothetical case descriptions Case T1 and 
Case NT1 and to the questions on the right and willingness to be informed about 
terminal prognosis. 
 
 
 
 
 
 
 
The first three research questions were answered using standard descriptive statistics 
with 95% confidence intervals. Data from both studies were compared with Chi square 
statistics, with answers on attitude-items dichotomized into two categories (yes vs. 
no/don’t know). Level of significance was set at p < .05. All analyses were performed 
with SPSS 15.0. 
 
Box 1:  Description of hypothetical cases  
 
1. Acceptability of requests for ELDs by minors  
Case T1:  
F is 14 years old and has bone cancer.  F experiences a lot of pain. The treatment is very 
painful and burdensome. Everyone, including F, knows that F has only a limited time to 
live. F cannot tolerate the pain any longer and wants to die. 
Case T2: 
D, 14 years old, has cancer and has become dependent on other people. D has to undergo 
different treatments and is has no privacy. D can for instance no longer go to the toilet 
alone. This causes a lot of fuss, with changing diapers, using bedpans,.... D knows that he 
doesn’t have long to live, and can no longer stand that he is deprived of all feeling of 
honor. D wants to die. 
Case NT1: 
N, 14 years old, is severely burnt over the whole of her face and body. She has a lot of 
pain and because of the burns she cannot move very well. N does not want to continue 
living like that, although she has a normal life expectation. 
Case NT2: 
A, 14 years old, has had a severe bicycle accident. A has to undergo difficult and painful 
surgery to stay alive. A does not want to continue this way. 
 
2. Information about terminal prognosis 
Case 3: 
K is 14 years old. She has a disease that will not allow her to live much longer. Everyone 
around her knows that she will die soon. K has asked repeatedly whether she will die, 
but nobody will tell her. 
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4.3. Results 
 
Table 1: Description of participant characteristics (N=83) 
  N(%) 
Gender Male 43 (51.8) 
 Female 40 (48.2) 
   
Age 11 years 2 (2.4) 
 12 years 13 (15.7) 
 13 years 15 (18.1) 
 14 years 12 (14.5) 
 15 years 7 (8.4) 
 16 years 10 (12.0) 
 17 years 11 (13.3) 
 18 years 13 (15.7) 
   
Age at diagnosis 0-1 years 18 (21.7) 
 2-3 years 22 (26.5) 
 4-5 years 14 (16.9) 
 6-7 years 11 (13.3) 
 8-9 years 6 (7.2) 
 10 years or older 12 (14.5) 
   
Cancer type leukemia 32 (38.6) 
 central nervous system 13 (15.7) 
 lymphoma 10 (12.0) 
 sympathetic nervous system 9 (10.8) 
 renal tumors 7 (8.4) 
 bone tumors 4 (4.8) 
 other 8 (9.6) 
   
Treatment chemotherapy 65 (78.3) 
 surgery 35 (42.2) 
 radiotherapy 7 (8.4) 
 bone marrow 
transplantation 
3 (3.6) 
   
Duration of treatment less than 2 years 8 (9.6) 
 2 years or more 75 (90.3) 
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Parents of 198 adolescents were approached for their consent to the participation of 
their child in the study. Parents of one adolescent could not be reached because they 
were abroad during the study period. Parents of 179 adolescents gave their informed 
consent. Of these 179, 83 consented to participate in the study (total response rate of 
83/197, 42%) and were interviewed. The main reasons indicated by the adolescents for 
not participating in the study were: the subject of the study was too confrontational 
(indicated by 56) and lack of interest (indicated by 12). 
Of the 83 participating adolescents, 52% were male and 51% were 14 years or younger 
(see Table 1). Leukemia was the most frequent diagnosis (39%), followed by 
malignancies of the central nervous system (16%). Participants had been in treatment 
for two years or longer in a large majority of cases (90%). Treatment was often a 
combination of treatment modalities and comprised chemotherapy for 78% of 
participants and surgery for 42%. Radiotherapy and bone marrow transplantation were 
less frequent.  
 
Table 2: Acceptability of different types of end-of-life decisions (ELDs) in different case 
descriptions 
  Terminal Non-terminal 
  Case T1 Case T2* Case NT1* Case NT2 
      
NTD yes 90.4 (83.9-96.8) 69.9 (59.8-80.0) - 27.7 (17.9-37.5) 
 no 8.4 (2.3-14.5) 26.5 (16.8-36.2) - 72.2 (52.5-82.1) 
 don’t know 1.2 (0.0-3.6) 3.6 (0.0-7.7) - 0.0 (0.0-0.0) 
      
APS yes 84.3 (76.4-92.3) - 47.0 (36.0-58.0) 38.6 (27.9-49.2) 
 no 8.4 (2.3-14.5) - 44.6 (33.7-55.5) 57.8 (47.0-68.7) 
 don’t know 7.2 (1.5-12.9) - 8.4 (2.3-14.5) 3.6 (0.0-7.7) 
      
Euthanasia yes 63.9 (53.3-74.4) 56.6 (45.7-67.5) 20.5 (11.6-29.3) 10.8 (4.0-17.7) 
 no 34.9 (24.5-45.6) 37.3 (26.7-48.0) 75.9 (66.5-85.3) 88.0 (80.8-95.1) 
 don’t know 1.2 (0-3.6) 6.0 (0.8-11.3) 3.6 (0.0-7.7) 1.2 (0.0-18.8) 
      
Percentages of participants answering ‘yes’, ‘no’ and ‘don’t know’, per ELD and per hypothetical case 
description (95% confidence intervals). 
Abbreviations: APS: increasing pain medication, which might shorten the patient’s life; NTD: 
withdrawing or withholding life-sustaining treatment, which might shorten the patient’s life. 
* For case T2 attitudes towards APS were not asked, for Case NT1 attitudes towards NTD were not asked.  
 
In response to the two hypothetical cases describing terminal situations, 90% (Case T1) 
and 70% (Case T2) of participants found a request for NTD acceptable (see Table 2). The 
level of acceptance of a request for NTD was substantially higher in the terminal than 
in the non-terminal case descriptions: 28% (Case NT2). A request for APS was found 
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acceptable by 84% of participants when a terminal situation was concerned, which was 
significantly higher than acceptance of APS-requests in the non-terminal examples 
(47% in Case NT1 and 39% in Case NT2). Requests for euthanasia were found acceptable 
in terminal situations by 64% (Case T1) and 57% (Case NT2) of participants, which was 
significantly higher than in the non-terminal situations: 21% (Case NT1) and 11% (Case 
NT2). In Case T1 a requests for euthanasia was significantly more acceptable for 
participants aged 15 or older (78%) than for younger participants (50%) (data not shown 
in table).  
 
Table 3: Conditions under which administration of a lethal drug is not acceptable and 
attitudes towards right and willingness to be informed about terminal prognosis 
 yes no don’t know 
    
Can a physician administer a lethal drug to a child 
when: 
   
- Child doesn’t want a lethal injection - 100.0 - 
- Child isn’t well informed about its illness 3.6 (0.0-7.7) 91.6 (85.5-97.7) 4.8 (0.0-9.5) 
- Child wants to die because of burden to parents 8.4 (2.3-14.5) 91.6 (85.5-97.7) - 
- Parents don’t agree with the child’s death wish 39.8 (29.5-50.5) 49.4 (38.4-60.4) 10.8 (4.0-17.7) 
- Parents opinion is not asked 6.0 (0.8-11.3) 91.6 (85.5-97.7) 2.4 (0.0-5.8) 
- Child wants to die because of illness-induced sadness 8.4 (2.3-14.5) 89.2 (82.3-96.0) 2.4 (0.0-5.8) 
    
If a child is suffering from terminal illness:    
- Has he/she the right to know that he/she will die 
soon? 
96.4 (92.3-100) 2.4 (1.0-5.8) 1.0 (0.0-3.6) 
- Would you be willing to know yourself? 85.5 (77.8-93.2) 12.0 (4.9-19.2) 2.4 (1.0-5.8) 
    
Percentages of participants answering ‘yes’, ‘no’ and ‘don’t know’ (95% confidence intervals) 
 
Participants identified different circumstances that should hold a physician back from 
administering a lethal drug to a child (see Table 3). None of the participants thought a 
physician can administer a lethal drug to a child when the child doesn’t want it, while 
92% thought it should not be allowed when the child isn’t well informed about his/her 
condition, when the child wants to die because of the burden he/she causes to the 
parents and when the parents’ opinion is not asked by the physician. Eighty-nine 
percent of participants found a physician should not administer a lethal drug to a child 
when he/she wants to die because of illness-induces sadness. Participants significantly 
less frequently thought a physician should not administer a lethal drug to a child when 
the parents do not agree with their child’s wish to die (49%). 
All but two participants (96%) agreed that a terminally ill minor should have the right 
to be informed about the terminality of his/her condition, 86% also indicated that they 
would want to be informed themselves, if ever faced with a similar situation. 
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When comparing the results of the present study with a previous study in secondary 
schools, distribution of age and gender did not differ significantly between the two 
studies (data not shown in table) (21). Where a terminal situation was concerned, 
acceptance of requests for NTD and APS was significantly higher in the cancer survivors 
than in participants without cancer diagnoses (see Table 4). Percentage of acceptance 
of requests for APS did not differ significantly between the two studies when a non-
terminal situation was concerned. Participants from both studies did not differ in their 
level of acceptance of euthanasia requests, both in terminal and in non-terminal 
situations. Adolescent cancer survivors agreed more than participants from the study 
in secondary schools with the right of minor patients to be informed about a terminal 
prognosis. 
 
Table 4: Acceptability of different types of end-of-life decisions in adolescents with 
(N=83) and without (N=1.769) cancer diagnosis. 
  Cancer 
Survivors 
Adolescents without 
cancer diagnose* 
p-value§ 
  N=83 N=1769  
     
Case T1 (terminal cancer patient): NTD 90.4 69.5 <.001 
 APS 84.3 60.0 <.001 
 Euthanasia 63.9 60.7 .566 
     
Case NT1 (heavily burnt patient): APS 47.0 49.7 .630 
 Euthanasia 20.5 17.6 .499 
     
Right to be informed about terminal prognosis 96.4 89.7 .048 
Willingness to be informed about terminal 
prognosis 
85.5 78.3 .118 
Percentage of participants answering ‘yes’. 
Abbreviations: APS: increasing pain medication, which might shorten the patient’s life; NTD: 
stopping or withholding life-sustaining treatment, which might shorten the patient’s life. 
* Pousset G, Bilsen J, De Wilde J, Deliens L, Mortier F. Attitudes of Flemish secondary school 
students towards euthanasia and other end-of-life decisions in minors. Child: Care, Health and 
Development 2009;35(3):349-356. 
§ p-value for Chi-square statistic testing for differences between both studies. 
 
4.4. Discussion 
 
We investigated adolescent cancer survivors’ attitudes towards end-of-life decisions 
(ELDs). A large majority of participants thought minor patients should be allowed to 
request a non-treatment decision (NTD) or intensified alleviation of pain and symptoms 
(APS) when they are in a terminal situation. Participants were less inclined to find 
requests for NTD and APS acceptable when a non-terminal situation was concerned. 
83
Chapter 4 - Attitudes of cancer survivors__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
While a request for euthanasia by a minor patient was generally less acceptable than 
requests for NTD or APS, more than half of participants found a euthanasia request 
acceptable in a terminal situation. Almost all participants identified different 
safeguarding circumstances where the administration of a lethal drug is concerned: the 
adolescent should agree with the administration of a lethal drug, should be well 
informed about his/her condition, and the parents’ opinion should be asked. The 
burden caused to parents and illness-induced sadness were found not to be sufficient 
reasons to permit the administration of a lethal drug, while parental agreement with 
the adolescent’s wish for euthanasia was not a necessity for all participants. Compared 
with adolescents without a cancer diagnosis, adolescent cancer survivors were more 
acceptant towards requests for NTD and APS where a terminal situation was concerned. 
Patient-reported outcomes are relatively few in number in pediatric oncology (22). By 
focusing on attitudes of minors with a cancer diagnosis, the present study can help to 
fill this gap. This study is the first to our knowledge to investigate attitudes towards 
ELDs in adolescents who recovered from cancer and had thus had experience of a life-
threatening illness. Because the questionnaire was similar to a previous study in 
secondary schools, it was possible to compare the present results with the attitudes of 
adolescents without a cancer diagnosis. The study also has some shortcomings. Firstly, 
the response rate was fairly low. Non-response was partly at parent-level, and partly 
caused by adolescents not wanting to be confronted with their period of illness. It is 
possible that this caused some bias in the results. However, as it is vital to obtain 
informed consent, both at parent and adolescent level, when conducting studies on 
these sensitive topics, potential bias could not be prevented. Secondly, when 
comparing with the previous study in secondary schools, it cannot be entirely ruled out 
that some of the participants from the first study had also had a cancer diagnosis in the 
past. However, as this is probably a very small proportion it is highly unlikely that it 
has substantially influenced the results of the comparative analyses. Finally, some 
participants were very young at the time of diagnosis and treatment, whilst others 
were already nearing adulthood, causing heterogeneity in the degree of illness 
experience. 
The first major finding, that attitudes towards ELDs vary strongly with case 
characteristics (terminal vs. non-terminal), was in accordance with the previous study 
(21). Apparently, adolescent cancer survivors also find ELDs more acceptable in 
situations where treatment is no longer possible and death is imminent than in non-
terminal situations. This is not surprising, as adolescents have been shown to be very 
resilient and perseverant, even in life-threatening situations, making them less likely to 
accept life-shortening options when death is not imminent (23;24). 
The second important finding was that adolescent cancer survivors were more 
acceptant of requests for NTD and APS in terminal situations than adolescents without 
cancer a diagnosis. This finding suggests some effect of illness experience on attitudes 
towards ELDs. We hypothesize that cancer survivors, having lived through the pain and 
symptoms caused by cancer, are better able to empathize with the cancer patients in 
the terminal case descriptions, leading to less resistance to a request for an end-of-life 
84
Chapter 4 - Attitudes of cancer survivors__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
decision that may shorten life. It may have been more difficult for them to identify and 
empathize with the severely burnt patient in the non-terminal case description. A 
second hypothesis is possible, based on the specific developmental issues related to 
adolescence. Psychological literature has identified individuation (identity formation 
and the development of autonomy) as one of the most important developmental tasks 
adolescents face, and this is often challenged by the feelings of invincibility which are 
prominent in adolescence (25;26). As research shows, living or having lived with cancer 
can influence these developmental processes and outcomes (27;28). It could be 
hypothesized that adolescent cancer survivors detach more easily from these feelings 
of invincibility than do adolescents who have not lived through a cancer episode, which 
causes them to accept life-limiting options, under certain circumstances, more easily. 
More specific research is needed to explore further the psycho-developmental 
processes of children who have survived cancer. 
Illness experience did not significantly affect attitudes towards requests for euthanasia. 
This finding suggests that attitudes towards euthanasia, as opposed to other ELDs, are  
influenced more by stable personal attitudes on eg religion (14), autonomy and self-
determination, than they are by experience with chronic illness. 
A third striking finding was that almost all adolescent cancer survivors participating in 
the study identified one or more circumstances in which a physician should hold back 
from administering a lethal drug to a patient. Involvement of parents in the decision-
making process was found to be very important to the participants, although for 40% of 
cases parental agreement with the child’s wish for euthanasia was not required. Also, 
nearly all cancer survivors agreed that children should have a right to be informed 
about a terminal prognosis. These results were all in line with the previous study, and 
show that although they value a certain amount of autonomous decision-making, 
adolescents do not take these end-of-life issues lightly, and want their parents to be 
involved (21). The results also accord with a study of American adolescent cancer 
patients who stressed the relational aspect of the end-of-life decision-making process 
and valued parental involvement (13). 
 
4.5. Conclusion 
 
The results of the present study show that adolescent cancer survivors, like other 
adolescents, want to be involved in medical decision-making at the end of life. Not only 
are they acceptant towards requests for certain ELDs, especially when terminal 
situations are concerned, but they also value a certain degree of autonomous decision-
making, albeit without excluding the parents from the process. The findings further 
suggest that the experience of living through a life-threatening illness can lead 
adolescents to become more acceptant towards requests for NTD and APS where a 
terminal situation is concerned. When trying to involve adolescents and their parents 
adequately in medical decision-making, age, sex and type of education are factors that 
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should be taken into account by physicians and caregivers (21). As the present study 
shows, the adolescent’s own illness experience should also be taken into consideration. 
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Abstract: 
 
Objective 
Investigating attitudes towards physician-assisted death in minors of all physicians 
involved in the treatment of children dying in Flanders, Belgium over an 18-month 
period, and how these are related to actual medical end-of-life practices. 
 
Method 
Anonymous population-based post-mortem survey among physicians signing death 
certificates of all patients aged 1 to 17 years who died between June 2007 and November 
2008 in Flanders, Belgium. Attitudes towards physician-assisted death in minors and 
actual end-of-life practices in the deaths concerned were surveyed. 
 
Results 
Response was obtained from 124 physicians for 70.5% of eligible cases (N=149). Sixty-
nine percent favor an extension of the Belgian law on euthanasia to include minors, 
26.6% think this should be done by establishing clear age-limits. Sixty-one percent 
think parental consent is required before taking life-shortening decisions. Cluster-
analysis yielded a cluster (67.7% of physicians) acceptant of, and a cluster (32.2% of 
physicians) reluctant about physician-assisted death in minors. Controlling for 
physician specialty and patient characteristics, acceptant physicians were more likely 
to engage in practices with the intention of shortening the patient’s life than were 
reluctant physicians.  
 
Conclusion 
A majority of surveyed Flemish physicians appear to accept physician-assisted dying in 
children under certain circumstances and favor an amendment to the euthanasia law to 
include minors. The approach favored is one of assessing decision-making capacity 
rather than setting arbitrary age-limits. These stances, and their connection with 
actual end-of-life practices, may encourage policy-makers to develop guidelines for 
medical end-of-life practices in minors that address specific challenges arising in this 
patient group. 
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5.1. Introduction 
 
It is increasingly recognized that end-of-life decisions with a possible or certain life-
shortening effect are frequently taken in relation to minor patients (<18y) (1-4), as they 
are with adults.(5-8) Whereas non-treatment decisions and intensified alleviation of 
pain and symptoms are generally accepted as part of sound medical practice(9-11), 
physician-assisted dying is much more controversial.(12-16) Moreover it is linked with 
additional problems in minor patients, such as issues about whether it is ethically 
justified to let a minor with decision-making capacities participate in decisions to use 
lethal drugs. 
In recent years, laws on euthanasia have been enacted only in Belgium, the Netherlands 
and Luxemburg and physician-assisted suicide has been legally accepted in the 
Netherlands, Luxemburg, Switzerland and the states of Oregon, Washington and 
Montana in the US.(17-19) Only in the Netherlands is the law on euthanasia or 
physician-assisted suicide applicable to minors: they can validly request physician 
assistance in dying from the age of 12 with the consent of their parents, and from the 
age of 16 when their parents are informed. In Belgium, minors are excluded from the 
provisions of the euthanasia act; a debate is currently going on to extend the range of 
the Act to include minors. This debate, which has resulted in several proposed 
amendments (20-24), would be well-served by the availability of empirical data. 
The attitudes of physicians towards physician-assisted death in minors, and how these 
may influence their practice, are important issues in this debate. However, until now, 
research on attitudes towards end-of-life decisions in minors has predominantly 
focused on non-treatment decisions(25), has mostly been conducted among physicians 
of specific specialties or in specific settings, and has rarely linked attitudes to actual 
practices.(26-29). This study aims (1) to investigate the attitudes towards physician-
assisted death in minors of all those physicians involved in the treatment of dying 
minor patients in Flanders, Belgium, no matter their specialty or working environment; 
and (2) to examine how these attitudes are related to the characteristics of physicians 
and patients and to the actual end-of-life practices adopted. 
 
5.2. Methods 
 
In Flanders, Belgium, all deaths are reported to the Flemish Ministry of Health. All 
deaths in Flanders of patients residing in Belgium aged one to 17, occurring from June 
2007 until November 2008 were included in the study, and an anonymous questionnaire 
was mailed by the Flemish Ministry of Health to all physicians who signed the death 
certificates. To enhance response, the Total Design Method was used, with a maximum 
of three reminders per physician.(30) The anonymity procedure was identical to that of 
a study on medical end-of-life practices in all deaths in Flanders described 
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elsewhere.(31) It was possible that a physician reported more than one death during 
the study period, and thus received more than one questionnaire. 
One part of the questionnaire contained 13 statements designed to explore the 
physician’s attitude towards physician-assisted dying. These statements were based on 
previous studies with a similar study design and designed to reflect relevant aspects of 
situations in which physician-assisted death may occur in minors.(4;25) The 13 
statements are listed in full in Table 2. Physicians were asked to indicate their 
agreement with the statements on a five point Likert-type scale (totally disagree, 
disagree, neither agree nor disagree, agree, totally agree). If a physician reported more 
than one death, and as such received more than one questionnaire, he/she was asked to 
fill out the attitude-items only once; these answers were then copied anonymously by 
the researchers onto all questionnaires returned by that physician, so that each death 
could be linked to the reporting physician’s attitudes. 
A second part of the questionnaire contained questions designed to identify end-of-life 
practices, used in previous studies on end-of-life practices in Flanders and the 
Netherlands.(5-7) Questions were kept descriptive, rather than using value-laden terms 
such as ‘euthanasia’. Physicians were asked whether they had withdrawn or withheld 
treatment (non-treatment decision), intensified alleviation of pain and symptoms, 
administered lethal drugs to the patient (physician-assisted death) or sedated the 
patient continuously and deeply until death. They were further asked whether they 
performed this practice with no intention, a co-intention, or an explicit intention of 
shortening the patent’s life.  
Initially, standard descriptive methods were used to provide a descriptive overview of 
the physician’s answers on the 13 statements. To this end, the answer categories of the 
attitude-items were recoded into three categories: ‘disagreeing/disagreeing totally”, 
“neutral” and “agreeing/agreeing totally”. In second instance, a K-means cluster 
analysis was performed on the 13 dichotomized attitude-items (0 = neutral or (totally) 
disagreeing; 1 = (totally) agreeing) to investigated whether physicians could be 
clustered into interpretable attitude-groups. Reporting physicians were the unit of 
analysis. 
To discover whether and if so how these attitudes are related to actual end-of-life 
practices, the deceased patient was the unit of analysis. Chi-square statistics and 
Fisher’s Exact test were used to investigate the relationship between cluster 
membership and actual end-of-life practices and to test whether physician specialty 
and patient characteristics differed between the attitude-clusters. To investigate 
whether the relationship between attitudes and actual end-of-life practices was 
confounded by differences in physician specialty or patient characteristics, a 
multivariate binary logistic regression was used, with end-of-life practices as 
dependent variables and cluster membership, physician specialty and patient 
characteristics (gender, age, cause and place of death) were entered in block as 
independent variables. Adjusted odds ratios and 95% confidence intervals were 
calculated. 
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The protocol was approved by the Ethical Review Board of the University Hospital of 
the Vrije Universiteit Brussel, the Ethics Committee of the University Hospital of Ghent 
University, the Belgian National Disciplinary Board of Physicians and the Belgian 
Federal Privacy Commission. 
 
5.3. Results 
 
From June 2007 until November 2008, 250 children died between the ages of one and 17 
years. These deaths were reported by 206 different physicians. For all 250 deaths, the 
reporting physician received a questionnaire. An additional survey of non-response 
yielded that response was not possible for 16 of these cases (eg because the physician 
had no access to the patient’s file). Of 234 eligible cases, which were reported by 191 
different physicians, 165 were returned (response-rate 70.5%). These 165 cases were 
reported by 137 physicians. Thirteen of these physicians, reporting 16 deaths, 
completed none of the attitude-items. These cases were excluded from analysis. Thus, 
analyses with physicians as unit of analysis contained 124 cases, while analyses with 
deaths contained 149 cases. Physician and patient characteristics are presented in Table 
1. 
 
Table 1: Physician (N=124) and patient (N=149) characteristics 
 N %  N % 
Patients 149  Physicians 124  
Gender   Specialty   
Male 85 57.0 General practitioner 29 23.4 
Female 67 43.0 Emergency medicine 35 28.2 
Age   Anesthesiology and intensive care 25 20.2 
1-5y 58 38.9 Pediatric 24 19.4 
6-11y 30 20.1 Other 11 8.9 
12-17y 61 40.9    
Cause of death      
External 61 40.9    
Cancer 24 16.1    
Central Nervous system 15 10.0    
Congenital 14 9.4    
Other 35 23.8    
Place of death      
Home 49 32.9    
Hospital 62 41.6    
Other 38 25.5    
Number of cases and percentages within physicians and patients 
 
Table 2: Description of physicians’ answers on the thirteen statements (N=124) 
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  (totally) 
disagreeing 
neutral (totally) 
agreeing 
1 The current law on euthanasia should be extended to 
include minors 
16.9 12.9 69.4 
2 If the law on euthanasia was extended to include minors, 
this should be done by establishing clear minimal age 
limits 
50.0 21.8 26.6 
3 The task of a physician sometimes implies that he/she 
must prevent needless suffering in minor patients by 
hastening the end of life 
21.0 17.7 61.3 
4 The decision on possible life-shortening acts in children 
who lack decision-making capacities is the exclusive 
responsibility of the physician 
77.4 10.5 12.1 
5 Treatment aimed at prolonging life is not always in the 
best interests of a severely ill minor patient 
8.1 4.8 85.5 
6 In minor patients, palliative sedation is always to be 
preferred to the administration of a lethal drug 
21.8 29.0 47.6 
7 Adequate pain control and end-of-life care make 
euthanasia superfluous in minors 
43.5 19.4 37.1 
8 Consent of parents/representatives is required before 
taking life-shortening decisions 
15.3 24.2 60.5 
9 The administration of a lethal drug can be acceptable if 
parents/representatives of a minor patient who lacks 
decision-making capacities request it 
22.6 23.4 52.4 
10 Minors are, where decisions about life and death are 
concerned, not yet capable of making a rational 
assessment of their interest 
59.7 16.9 21.8 
11 Experiencing a chronic condition causes younger minor 
patients, as compared to healthy peers, to be more capable 
of assessing their interest 
8.1 19.4 72.6 
12 Wishes of older minor patients should be taken into 
consideration to the same degree as the wishes of adult 
patients 
7.3 10.5 82.3 
13 A request for life termination of minor patients can be 
acknowledged if they are capable of making a rational 
assessment of their interest 
16.9 11.3 71.0 
Percentage of physicians (totally) disagreeing, neither agreeing/disagreeing (neutral) and (totally) 
agreeing with thirteen statements. Percentages do not always add up to 100% because of missing 
values. There were two missing values on statements 2, 5, 6, 9 and 10, and one on statements 1 and 13.  
 
Of all physicians, 69.4% agreed with the statement that the current law on euthanasia 
should be extended to include minors (see Table 2). However, only 26.6% agreed that 
this should be done by establishing clear minimal age-limits. Of all items, the statement 
on the preference of palliative sedation above the administration of a lethal drug 
involved the highest proportion of physicians with a neutral attitude (29.0%) yet 47.6% 
of these agreed that palliative sedation is to be preferred. On the statement that 
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adequate pain control and end-of-life care make euthanasia superfluous in minors, 
roughly as many agreed (37.1%) as disagreed (43.5%). 
 
Table 3: Classification of physicians into a permissive and a reluctant cluster, based on 
the answers on the thirteen statements (N=124) 
  Total 
Permissive 
cluster 
Reluctant 
cluster 
p-value* 
 Number of physicians per cluster (%) 124 84 (67.7) 40 (32.3)  
1 The current law on euthanasia should be extended to 
include minors 
69.4 90.5 25.0 <.001 
2 If the law on euthanasia was extended to include 
minors, this should be done by establishing clear 
minimal age limits 
26.6 23.8 32.5 .306 
3 The task of a physician sometimes implies that he/she 
must prevent needless suffering in minor patients by 
hastening the end of life 
61.3 71.4 40.0 .001 
4 The decision on possible life-shortening acts in 
children who lack decision-making capacities is the 
exclusive responsibility of the physician 
12.1 15.5 5.0 .079 
5 Treatment aimed at prolonging life is not always in 
the best interest of a severely ill minor patient 
85.5 89.3 77.5 .082 
6 In minor patients, palliative sedation is always to be 
preferred to the administration of a lethal drug 
47.6 29.8 85.0 <.001 
7 Adequate pain control and end-of-life care make 
euthanasia superfluous in minors 
37.1 11.9 90.0 <.001 
8 Consent of parents/representatives is required before 
taking life-shortening decisions 
60.5 56.0 70.0 .135 
9 The administration of a lethal drug can be acceptable 
if parents/representatives of a minor patient who 
lacks decision-making capacities request it 
52.4 71.4 12.5 <.001 
10 Minors are, where decisions about life and death are 
concerned, not yet capable of making a rational 
assessment of their interest 
21.8 11.9 42.5 <.001 
11 Experiencing a chronic condition causes younger 
minor patients, as compared to healthy peers, to be 
more capable of assessing their interest 
72.6 77.4 62.5 .082 
12 Wishes of older minor patients should be taken into 
consideration to the same degree as the wishes of 
adult patients 
82.3 92.9 60.0 <.001 
13 A request for life termination of minor patients can 
be acknowledged if they are capable of making a 
rational assessment of their interest 
71.0 95.2 20.0 <.001 
Percentage of physicians agreeing or totally agreeing with the statements, in the total sample and per 
cluster. 
* p-value for Chi square statistic testing differences in agreement between clusters, per statement. 
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Sixty point five percent of physicians thought parental consent should be required 
before taking life-shortening decisions. The administration of a lethal drug to a minor 
who lacks decision-making capacities was acceptable to 52.4% if the parents requested 
it. A minority of 21.8% agreed that minors are not capable of making a rational 
assessment of their interests where decisions about life and death are concerned. 
Where minors are capable of making a rational assessment of their interests, 71.0% of 
physicians agreed that a request for life termination can be acknowledged. 
A cluster analysis on the answers of physicians on the 13 statements yielded two 
interpretable clusters (see Table 3). The first cluster contained 67.7% of physicians, and 
was interpreted as those who tend to regard minor patients as competent decision-
makers at the end of life and regard euthanasia and life termination for minor patients 
as acceptable options under certain circumstances. Physicians in this cluster believe 
the current Belgian law on euthanasia should be extended to include minors and their 
attitude was summarized as “acceptant” towards physician-assisted dying. The second 
cluster contained 32.3% of physicians and was interpreted as those who tend to oppose 
euthanasia and life-termination in minors, even if requested by a patient with decision-
making capacities and/or their parents. They are inclined to prefer palliative sedation 
above the administration of a lethal drug, and are convinced that adequate pain control 
and end-of-life care make euthanasia superfluous. Physicians in the second cluster do 
not want the current Belgian law on euthanasia to be extended, and their attitude was 
summarized as “reluctant” towards physician-assisted dying. 
 
Table 4: Relation between cluster and actual end-of-life practices (N=149) 
 Acceptant 
cluster 
Reluctant 
cluster 
p-value* 
 N=98 N=51  
Sudden and unexpected death 48.0 54.9 .421 
All end-of-life practices 42.9 33.3 .259 
Non-treatment decisions without intention 31.6 25.5 .435 
Non-treatment decisions with intention 16.3 5.9 .070 
Alleviation of pain and symptoms without intention 22.4 21.6 .902 
Alleviation of pain and symptoms with co-intention 17.3 2.0 .006 
Physician assisted death 13.3 0.0 .003 
No end-of-life practice 9.2 11.8 .619 
Continuous deep sedation§ 29.6 11.8 .015 
without intention 18.4 9.8 .170 
with (co-)intention 8.2 0.0 .032 
Percentage of cases in which different types of end-of-life practices occurred, per cluster to which 
the reporting physician belongs. Different end-of-life practices may have co-occurred. 
* p-value for Chi-square statistic testing differences in occurrence of end-of-life practices between 
clusters and per end-of-life practice, or Fisher’s Exact test if expected cell count was smaller than 5. 
§ Data on intention was missing for 3 cases. 
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Physician specialty and patient characteristics of deaths reported by physicians from 
the acceptant cluster did not differ significantly from those reported by physicians 
from the reluctant cluster (data not shown in tables). Significant relations were found 
between a physician’s cluster-membership and actual end-of-life practices (see Table 
4). Physicians from the acceptant cluster were more likely to have intensified the 
alleviation of pain and symptoms with a co-intention of hastening the patient’s death 
(17.3%) and to have practiced physician-assisted death (13.3%) than those from the 
reluctant cluster (2.0% and 0.0% respectively). Sedation with an intention or co-
intention of hastening the patient’s death was more frequent among physicians from 
the acceptant cluster (8.2%) as opposed to the reluctant cluster (0.0%). 
The multivariate binary logistic regression showed that, controlling for specialty and 
patient characteristics (gender, age, cause and place of death), physicians from the 
acceptant cluster had significantly higher chances of implementing non-treatment 
decisions with a life-shortening intention (OR: 4.8; 95% CI: 1.1-21.0), intensified 
alleviation of pain and symptoms (OR: 71.5; 95% CI: 5.0-1023.5) and continuous deep 
sedation (OR: 4.7; 95% CI: 1.4-15.2) than those from the reluctant cluster (data not 
shown in tables). 
 
5.4. Discussion 
 
Most Flemish physicians caring for a dying child accept physician-assisted death as a 
possible intervention at the end of minor patients’ lives. About seven in ten would like 
to see the application of the current Belgian law on euthanasia extended to include 
minors. Based on their attitudes, two thirds of physicians could be considered as quite 
acceptant and about one third as quite reluctant towards physician-assisted death. 
Although they had been confronted with similar patients, physicians with a acceptant 
attitude towards physician-assisted death, no matter what their specialty, were more 
likely to engage in acts with a co-intention of hastening the patient’s death, than were 
their colleagues with a reluctant attitude. 
The present study is to our knowledge only the second worldwide to focus on end-of-
life decisions in minors aged between one and 17 years across patient groups and care 
settings(1) and the first to link attitudes to actual behavior. The study is based on all 
deaths of minors over a considerable time-span (18 months). The method used has been 
successfully applied in previous studies.(31) A shortcoming of the study is the relatively 
small sample of physicians, due to the relative rarity of death in minors over one year 
of age. However, the sample of physicians was representative for all physician 
specialties covering the deaths of children, as they were the signatories of all death 
certificates of minors during an 18-month period. Also, it can not be completely ruled 
out that some participating physicians filled in the death certificate, but were not 
closely involved in the treatments and end-of-life discussions and decision-making. 
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A first major finding of the study is that 68% of studied physicians have an acceptant 
attitude towards physician-assisted dying in minors. A majority acceptance in principle 
of euthanasia in older minors and under certain conditions, including parental consent, 
was also found in a study in the Netherlands.(25) However, the level of acceptance is 
remarkably high when compared with the general acceptance of physician-assisted 
dying in most other countries.(32-35) It seems plausible that in Belgium and the 
Netherlands the context of legal euthanasia under strict due care conditions (even 
though minors are explicitly excluded from the euthanasia law in Belgium) and the 
ensuing experience with the euthanasia laws has coincided with a change in attitudes 
of physicians involved in children’s end-of-life care. In particular the lack of salient 
abuse of the legal framework in both countries may have contributed to Flemish 
physicians having a less reluctant attitude towards the practice. Conversely, it should 
be noted that Belgian and Dutch physicians already had a higher acceptance of 
physician-assisted dying prior to the legalization of euthanasia(36;37), making it 
impossible to state conclusively that changing legislation will result in changing 
attitudes of physicians in countries where euthanasia is still illegal. 
Interestingly, while seven in ten would like to see the application of the current Belgian 
law on euthanasia extended to include minors, half of the Flemish physicians surveyed 
disagree with achieving this by establishing clear age limits. However, the amendments 
under discussion in Belgium do not propose fixing age limits, as does the Dutch law, but 
advance casuistic criteria, referring to “the required discriminatory capacity”(20) and 
“judgmental capacity”.(23) The physicians in the present study appear to support 
similar casuistic criteria. Concordantly, a Dutch study found that about half of all 
pediatricians disagreed with the Dutch law and felt that age limits are arbitrary and 
that each case should be considered individually.(25) It is not surprising that physicians 
support these casuistic criteria, as minor patients’ decision making capacity is a crucial 
and necessary standard in determining whether they can make decisions 
autonomously. By focusing on the minor patients’ decision making capacity rather than 
their age, discrimination on the sole basis of chronological age can be prevented. A 
casuistic approach will also protect children who lack decision-making capacities from 
the undue burden of making high impact choices and decisions autonomously. It is 
important to notice that an extended application of the Belgian law on euthanasia 
should reflect this reality. Any proposed amendments should thus be cautiously 
formulated to prevent age discrimination and to adequately protect children who lack 
decision-making capacities. 
Physicians appear to put a high premium on parental consent. Although 60% believe 
that minors are capable of making a rational assessment of their own interests in life-
and-death-matters, an equal proportion think that consent of parents is required 
before making end-of-life decisions. Respect for parental consent was also found in the 
belief of half the physicians that parental requests for the administration of a lethal 
drug in a minor who lacks decision-making capacities may justify granting that request. 
We hypothesize that a majority of physicians observe a shared responsibility ethic with 
respect to the life-ending of minors; the decisional capacities of minors with decision-
making capacities are recognized, but checked by respect for parental authority and 
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interests. This was in line with a model of shared decision-making, which is generally 
the preferred decision making model in medicine, as it seems best suited to safeguard 
patients’ best interests.(38,39) If euthanasia is ever to be legalized for minors in 
Belgium, or in other countries, the legal framework should not ignore the crucial role 
of parents as partners in end-of-life decision-making. 
Although physicians from both attitude-clusters had been confronted with similar 
patients and although physician specialty did not differ between attitude-clusters, 
actual end-of-life practices were related significantly to the attitude of the physicians. 
In the group of physicians demonstrating acceptance of euthanasia in minor patients 
there were not only more cases of physician-assisted dying, as might be expected, but 
also of intensified alleviation of pain and symptoms and continuous deep sedation with 
a co-intention of shortening life. Euthanasia in minors still being illegal, physicians 
acceptant of euthanasia possibly rely on intended or co-intended life-shortening 
practices such as intensified alleviation of pain and symptoms (eg by strongly 
increasing doses of opiates), or continuous deep sedation, as alternatives to euthanasia. 
These practices involve no risk of prosecution, and are probably more concordant with 
institutional policies. 
 
5.5. Conclusion 
 
A large majority of surveyed physicians appear to accept physician-assisted dying in 
children under certain circumstances and favor a model of shared decision-making. 
Moreover, a large majority of these physicians seem to favor an amendment to the 
euthanasia law to include minor patients, not so much by the setting of an arbitrary 
age-limit as by taking a decision-making capacity approach. These stances, and their 
connection with actual end-of-life practices, may encourage Belgian legislators, and 
policy-makers in other countries, to develop guidelines for medical end-of-life 
practices in minor patients, not limited to euthanasia, that would address specific 
challenges arising in this patient group, including how children and parents should be 
involved in the decision-making process. 
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Abstract: 
 
Objectives 
To estimate the prevalence of end-of-life decisions, and to describe their characteristics 
and the preceding decision-making process, in minors in Belgium. 
 
Design 
Population-based post-mortem anonymous survey among all physicians signing the 
death certificates of all patients aged 1 to 17 years who died between June 2007 and 
November 2008 in Flanders, Belgium. Prevalence and characteristics of end-of-life 
decisions and the preceding decision-making process were measured. 
 
Results 
During the study period, 250 children died. For 165 of these a questionnaire was 
returned. The response-rate was 70.5%. In 36.4% death was preceded by an end-of-life 
decision. Drugs were administered to alleviate pain and symptoms with a possible life-
shortening effect in 18.2% of all deaths, non-treatment decisions in 10.3% and the use of 
lethal drugs without the patient’s explicit request in 7.9%. No cases of euthanasia, i.e. 
the use of drugs with the explicit intention to hasten death at the patient's explicit 
request, were reported. Poor clinical prospects (84.6%) and low quality of life 
expectations (61.5%) were important reasons for the physicians to engage in end-of-life 
decisions. Parents were involved in decision-making in 85.2% of these decisions, 
patients in 15.4%. 
 
Conclusions 
Medical end-of-life decisions are frequent in minors in Flanders, Belgium. Whereas 
parents were involved in most end-of-life decisions, the patients themselves were 
much less so, even where life-ending was intended. At the time of decision-making, 
patients were often comatose or were deemed incompetent or too young to be involved 
by the physician. 
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6.1. Introduction 
 
Medical end-of-life decisions with a possible or certain life-shortening effect have 
become frequently-used options at the end of a patient’s life and the prevalence of 
these have been extensively studied in adults.(1-4) In minors (<18y) they have received 
less attention, and studies have mostly been limited to specific care settings or patient 
groups (5-12). However, end-of-life decisions in minors pose specific clinical and ethical 
challenges for professional caregivers. As parents function as advocates for their child, 
they are the primary partners in communication with professional caregivers.(13) The 
involvement of minor patients in the decision-making process is not always 
straightforward, and depends on their age, level of competence, the nature of the 
decisions concerned and experience with chronic illness.(14;15) The three-way 
interaction between caregivers, parents and patients makes decision-making 
complex.(16) Furthermore, on an ethical level, the interplay between the parents’ 
representative function and the patient’s decision-making capacity raises important 
questions about the rights of minors to self-determination, the limits of parental 
advocacy and the balancing of best interest considerations with the wishes of the minor 
patient.(17) 
Whereas non-treatment decisions and of the administration of drugs to alleviate pain 
and symptoms with a possible life-shortening effect are generally regarded as part of 
common and sound medical practice, physician-assisted death, i.e. the administration, 
prescription or supply of drugs, by a physician, with the explicit intention of ending the 
patient’s life, is much less so.(18-20) If drugs are administrated by a physician to end a 
patient’s life, at the patient’s explicit request, the decision is termed ‘euthanasia’ in the 
three countries where laws on this practice have been enacted in recent years: Belgium, 
the Netherlands and Luxemburg. In other countries, this practice is commonly referred 
to as ‘voluntary euthanasia’. Additionally, physician-assisted suicide, i.e. lethal drugs 
provided by a physician, but administered by the patient, has been legally accepted in 
the Netherlands, Luxemburg, Switzerland and the states of Oregon, Montana and 
Washington in the US.(21-23) Only in the Netherlands is the law on euthanasia or 
physician assisted suicide applicable to minors: they can legitimately request assistance 
in dying from the age of 12 with parental consent and from the age of 16 when parents 
are informed. For neonates, the Groningen protocol was developed to facilitate 
reporting of cases for legal control and to enhance quality of decision-making.(24) 
Debates are taking place in Belgian society and politics to extend the application of the 
law on euthanasia to include minors, and legal propositions on the subject are under 
consideration.(25;26) However, little empirical evidence on these end-of-life decisions 
is available in minors, and in Belgium no population-based data have so far been 
collected. 
This study aims to: (1) estimate prevalence of end-of-life decisions with a possible or 
certain life-shortening effect in minors across care settings in Flanders (Belgium), (2) 
describe clinical and demographic characteristics of patients involved, (3) describe 
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characteristics of end-of-life decisions (estimated life-shortening effect, reasons for 
deciding to perform an end-of-life decision), and (4) describe the decision-making 
process preceding these end-of-life decisions. 
 
6.2. Methods 
 
In Flanders, the largest region of Belgium with approximately six million inhabitants, 
all deaths are to be reported to the Flemish Ministry of Health. From June 2007 until 
November 2008 (18-month period), 250 patients residing in Belgium aged one to 17 
years died in Flanders. The focus was on patients from this age group, because these 
had not been previously studied in Flanders, and only once in the Netherlands.(11) An 
anonymous questionnaire was mailed by the Flemish Ministry of Health to all 
physicians who signed the death certificates in each of these cases. There was generally 
a two to three month delay between death of the patient and receipt of the 
questionnaire. Some physicians signed more than one death certificate, but no 
physician signed more than five during the 18-month study period. To enhance 
response, the Total Design Method was followed, with a maximum of three reminders 
per case.(27) A complex mailing procedure, separating data collection and data 
analyses, with a lawyer as intermediary between physicians and the Flemish Ministry of 
Health, was used to ensure strict anonymity of both physician and patient. As an 
appendix to the questionnaire, physicians were informed about the mailing procedure. 
The anonymity procedure was identical to that of a study on medical end-of-life 
decisions in all deaths in Flanders described elsewhere.(28) 
The questionnaire was similar to those used in previous studies in adults and neonates 
(1-3;6;7;11), but adapted to fit pediatric practice by including questions on the decision-
making capacity of patients and the involvement of parents. All questions were closed 
and contained different answer categories where one or more answers were possible. 
If, according to the physician, a death had not been sudden and unexpected, they were 
asked about end-of-life decisions assessed to have had a possible or certain life-
shortening effect. Instead of using terms with different connotation, like ‘euthanasia’, 
descriptions of the decisions concerned were used: withholding or withdrawing 
treatment (non-treatment decisions); administration of drugs to alleviate pain and 
symptoms (taking a possible hastening of death into account) and the administration, 
prescription or supply of drugs by the physician with the explicit intention of 
hastening the patient’s death (physician-assisted death). The latter was further divided 
according to the person administering the drugs and the presence of an explicit patient 
request: if the drugs were administered by the physician at the patient’s explicit 
request, we categorized the decision as ‘euthanasia’; if the drugs were administered by 
the patient him/herself, the decision was categorized as ‘physician-assisted suicide’; a 
final category contained cases where drugs were administered by someone else than 
the patient, with the explicit intention of hastening the patient’s death, without 
explicit patient request. The exact wordings of the questions are described 
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elsewhere.(28) If more than one decision was made for one patient, the decision with 
the most explicit life-shortening intention was used to classify the decision. If different 
decisions with a similar intention co-occurred, the administration of drugs prevailed 
over the withdrawal or withholding of treatment. 
Further questions were aimed at gathering information on the characteristics of these 
end-of-life decisions (estimated life-shortening effect, main reasons for the decision) 
and the care provided (length and goal of treatment for terminal illness). Others 
focused on the decision-making process preceding the end-of-life decision: discussion 
with patient, parents or other professional caregivers and the reasons that the decision 
was not discussed with the patient. Clinical and demographic information as recorded 
on the death certificate (age, gender, cause and place of death) was provided by the 
Flemish Ministry of Health. The lawyer linked data from the questionnaires case-per-
case to clinical and demographic information of the corresponding deaths, after which 
the data were made anonymous. 
The study, including the anonymity procedure, was approved by the Ethical Review 
Board of the University Hospital of the Vrije Universiteit Brussel and the Ethics 
Committee of Ghent University Hospital, and positive recommendations were received 
from the Belgian National Disciplinary Board of Physicians and the Belgian Federal 
Privacy Commission. 
Standard descriptive statistics (frequencies, 95% confidence intervals corrected for 
finite population size (N=250)) were used to analyze the data. Chi square statistics were 
used to investigate representativeness of the response sample for the population and 
the relation between patient characteristics and end-of-life decisions. SPSS 15.0 was 
used for all analyses. Level of significance was set at p<.05. 
 
6.3. Results 
 
In sixteen of the 250 cases, the physician received the questionnaire but was unable to 
provide information, according to an additional non-response survey, because the 
patient could not be identified or because they had not been involved in the treatment 
of the patient themselves and the treating physician was not known and/or could not 
be reached. For 165 of the 234 remaining cases a questionnaire was returned (response-
rate 70.5%). 
Of the 165 studied deaths, 92 patients were male (55.8%), 71 died at ages 12 to 17 
(43.0%), external causes of death were the most frequent (eg traffic accidents and 
suicide, 44.8%), 25 patients died from cancer (15.2%) and hospital was the most frequent 
place of death (40.0%). The response sample did not differ from the non-response 
sample for gender, age and cause of death. The proportion of hospital deaths was 
significantly higher in the response sample than in the non-response sample (56.5% vs. 
40.0%). When the response sample was compared to the total population, demographic 
and clinical characteristics did not differ (data not shown in tables). 
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Table 1: Frequencies of medical end-of-life decisions (N=165) 
 
Of all 165 deaths studied, 53.3% were indicated by the physician to have been sudden 
and unexpected, thus an end-of-life decision was not possible (Table 1). In 10.3% of all 
deaths, death was expected, but no end-of-life decision was made. In total, 36.4% of all 
deaths were preceded by an end-of-life decision. Administration of drugs to alleviate 
pain and symptoms with a possible life-shortening effect were the most frequent, 
involving 18.2% of all deaths. Non-treatment decisions were made in 10.3% of all 
deaths. Physicians administered, prescribed or supplied drugs with an explicit 
intention to hasten the patient’s death in 7.9% of all deaths (13 cases), and all occurred 
without an explicit patient request. These lethal drugs were muscle relaxants (Curare) 
combined with barbiturates in one case, morphine in eight cases (as sole drug in three 
and in combination with benzodiazepine in five cases) and barbiturates in four cases (as 
sole drug in two and in combination with benzodiazepine in two). The drugs were 
administered by the attending physician in seven of 13 cases, by a nurse in three 
instances, and by both in three cases. Physicians estimated that death had been 
hastened by one week or less in 90.4% of cases. In eight of 13 cases, the main goal of 
treatment in the last week of life was comfort, in five of 13 cases an expert in palliative 
care was consulted by the physician. In six of 13 cases, the physician had been treating 
the patient for the fatal illness for more than a year, in two cases for one week or less. 
Patients died aged younger than six in seven of 13 cases, three patients were 12 or 
older. 
 Observed % 95% C.I. 
Sudden and unexpected death* 88 53.3 48.8-57.8 
Non-sudden death, no end-of-life decision 17 10.3 7.9-13.4 
    
Total end-of-life decisions 60 36.4 32.2-40.8 
withholding or withdrawing of life-sustaining treatment 17 10.3 7.9-13.4 
without intention of shortening the patient’s life 6 3.6 2.3-5.7 
with intention of shortening the patient’s life 11 6.7 4.7-9.3 
alleviation of pain and symptoms with a possible life-shortening effect 30 18.2 15.0-21.9 
without intention of shortening the patient’s life 27 16.4 13.3-20.0 
with co-intention of shortening the patient’s life 3 1.8 0.9-3.5 
use of drugs with the explicit intention of hastening the patient’s death 13 7.9 5.8-10.7 
euthanasia 0 0.0 - 
physician-assisted suicide 0 0.0 - 
life-ending acts without explicit patient request 13 7.9 5.8-10.7 
    
Total 165 100 - 
Number of observed cases, percentage and 95% confidence intervals calculated via complex samples 
procedure (Monte Carlo) and corrected for finite population size (N=250); 
* Including cases where the physician’s first contact was after the child’s death. 
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 Table 2: Type of medical end-of-life decision according to patient characteristics 
(N=165) 
 
End-of-life decisions were relatively more frequent in children younger than 12 (46.8% 
vs. 22.5% in children aged 12-17), children dying from other than external causes and 
children dying in hospital (53.0% hospital vs. 35.8% home and 13.0% other) (Table 2). 
 
 
 
Study 
sample 
Non-
treatment 
decisions 
Alleviation 
of pain and 
symptoms† 
Physician-
assisted 
death 
All end-of 
life 
decisions 
Total 165 17 30 13 60 
Total percentage 100 10.3 18.2 7.9 36.4 
 N (%) % % % % 
Gender      
Male 92 (55.8) 58.8 60.0 53.8 58.3 
Female 73 (44.2) 41.2 40.0 46.2 41.7 
p-value*  .788 .605 .885 .615 
Age      
1-5 62 (37.6) 41.2 46.7 53.8 46.7 
6-11 32 (19.4) 29.4 26.7 23.1 26.7 
12-17 71 (43.0) 29.4 26.7 23.1 26.7 
p-value*  .394 .130 .301 .005 
Cause of death      
Cancer 25 (15.2) 11.8 33.3 30.8 26.7 
External (eg traffic 
accidents and suicide) 74 (44.8) 41.2 10.0 15.4 20.0 
Diseases of the central 
nervous system 16 (9.7) 11.8 16.7 15.4 15.0 
Congenital diseases 14 (8.5) 0.0 13.3 15.4 10.0 
Other 36 (21.8) 35.3 26.7 23.1 18.3 
p-value*  .483 <.001 .179 <.001 
Place of death§      
Home 53 (32.1)  11.8 43.3 30.8 31.7 
Hospital 66 (40.0) 82.4 40.0 69.2 58.3 
Other 46 (27.9) 5.9 16.7 0.0 10.0 
p-value*  .001 .213 .031 <.001 
      
Percentages are column percentages. 
* p-value for Chi square statistic testing differences between patient groups in incidence of end-
of-life decisions. Fisher’s Exact test was used when expected cell counts were less than five. 
† Administration of drugs to alleviate pain and symptoms with a possible life-shortening effect. 
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Table 3: Characteristics of end-of-life decisions (N=60) 
 Non-
treatment 
decisions 
Alleviation 
of pain and 
symptoms† 
Physician-
assisted 
death 
All end-of life 
decisions 
Total number of cases 17 30 13 60 
Estimated shortening of life:         
more than 1 week 13.3 7.7 9.1 9.6 
1-7 days 26.7 7.7 45.5 21.2 
<24 hours 20.0 19.2 45.5 25.0 
no shortening 40.0 65.4 0.0 44.2 
       
Reason for end-of-life decision:*       
no improvement to be expected 87.5 78.3 92.3 84.6 
low expected quality of life 56.3 52.2 84.6 61.5 
not needlessly prolonging life 25.0 39.1 76.9 50.0 
(severe) symptoms of patient 25.0 17.4 69.2 44.2 
expected suffering of the patient 43.8 47.8 61.5 44.2 
wish of parents 18.8 52.2 61.5 32.7 
     
Time treated for fatal illness:     
1-7 days 47.1 13.3 15.4 23.3 
1-4 weeks 5.9 13.3 15.4 11.7 
1-12 months 5.9 16.7 23.1 15.0 
more than 1 year 41.2 56.7 46.2 50.0 
       
Main goal of treatment in last week:         
cure 47.1 13.3 30.8 26.7 
prolonging of life 5.9 3.3 7.7 5.0 
comfort 47.1 83.3 61.5 68.3 
Number of observed cases and percentages. Percentages do not always add up to 100 because of 
rounding;  
Data were missing for 2 to 8 cases for estimated shortening of life and reason for end-of-life 
decision; 
* Multiple answers were possible, percentages may add up to more than 100. 
† Administration of drugs to alleviate pain and symptoms with a possible life-shortening effect. 
 
Estimated life-shortening was less than 24 hours in 69.2% of cases where an end-of-life 
decision was performed and less than 24 hours in 45.5% of physician-assisted death 
cases (Table 3). No improvement prospects and low quality of life expectations were the 
most frequent reasons cited by physicians in all three end-of-life decisions. Not 
needlessly prolonging life, severe symptoms, expected suffering and the wish of the 
parents were other frequently cited reasons in cases of physician-assisted death, but 
were less frequent in non-treatment decisions and administration of drugs to alleviate 
pain and symptoms with a possible life-shortening effect. In 50% of cases where an end-
of-life decision was performed, the patient had been in treatment for the terminal 
illness for more than one year. The main goal of treatment in the last week of life was 
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comfort in 47.1% of cases of non-treatment decisions and 83.3% in cases of 
administration of drugs to alleviate pain and symptoms with a possible life-shortening 
effect. 
Table 4: Decision-making process preceding end-of-life decisions (N=60) 
 Non-
treatment 
decisions 
Alleviation 
of pain and 
symptoms† 
Physician-
assisted 
death 
All end-of-
life 
decisions 
Total number of cases 17 30 13 60 
Decision discussed with parents 100.0 68.0 100.0 85.2 
Discussion with parents was aimed at:*     
reaching a decision together 66.7 82.4 84.6 77.8 
obtaining parental consent 6.7 17.6 23.1 15.6 
informing parents of a decision 13.3 11.8 7.7 11.1 
Decision requested by parents 33.3 30.4 75.0 41.2 
     
Decision discussed with patient 12.5 21.7 7.7 15.4 
Decision requested by patient 0.0 4.3 0.0 1.9 
Reasons for not discussing with patient:*     
patient was comatose 92.3 41.2 66.7 64.3 
patient was too young 38.5 76.5 58.3 59.5 
patient was mentally handicapped 30.8 35.3 50.0 35.7 
     
Patient was found competent 0.0 0.0 7.7 2.1 
     
Decision discussed with other caregivers*      
Physicians 75.0 69.6 92.3 76.9 
Nurses 43.8 43.5 84.6 53.8 
Other 6.3 26.1 7.7 15.4 
Not discussed with other caregivers 12.5 8.7 0.0 7.7 
Number of observed cases and percentages. Percentages do not always add up to 100 because of 
rounding; 
Data were missing for 3 (Reasons for not discussing with patient), 6 (Discussion with parents), 8 
(Discussion with patient and other caregivers), 9 (Request by parents) and 13 cases (Patient 
competence); 
* Multiple answers were possible, percentages may add up to more than 100. 
† Administration of drugs to alleviate pain and symptoms with a possible life-shortening effect. 
 
All non-treatment decisions and cases of physician-assisted death were discussed with 
the parents, as were 68.0% of cases of administration of drugs to alleviate pain and 
symptoms with a possible life-shortening effect (Table 4). Discussion with parents was 
aimed at reaching a joint decision in 77.8% of cases. The decision was requested by the 
parents in 30.4% of non-treatment-decisions, in 33.3% of administration of drugs to 
alleviate pain and symptoms with a possible life-shortening effect and in 75% of cases 
of physician-assisted death. Decisions were discussed with the patient in 7.7% of cases 
of physician-assisted death, 12.5% of non-treatment decisions and 21.7% of cases of 
administration of drugs to alleviate pain and symptoms with a possible life-shortening 
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effect. Where an end-of-life decision was made, patients were found not to have 
decision-making capacity by the physician at the time of decision-making in all cases 
but one. As reasons for not discussing the decision with the patient, physicians most 
frequently cited the patient being comatose (64.3%) or too young (59.5%). Decisions 
were discussed with other professional caregivers in 92.3% of cases. Rates of 
involvement of other physicians (92.3%) and nurses (84.6%) were highest in cases of 
physician-assisted death. 
 
6.4. Discussion 
 
Medical end-of-life decisions preceded 36.4% of all deaths of minors aged one to 17 
years in Flanders, Belgium. If sudden and unexpected deaths were excluded, end-of-life 
decision preceded 78% of deaths. The administration of drugs to alleviate pain and 
symptoms with a possible life-shortening effect was the most frequent end-of-life 
decision. Non-treatment decisions were less frequent. The prevalence of physician-
assisted death was high. No case of euthanasia, i.e. the use of drugs with the explicit 
intention to hasten death at the patient's explicit request, was reported. Poor clinical 
prospects and low quality of life expectations were important reasons for the 
physicians to make an end-of-life decision. Shared decision-making with parents was 
reached in 85.2% of cases, but patients were seldom involved in the process themselves. 
Physicians reported the patient being comatose or too young as the most important 
reasons for not involving them.  
To our knowledge this study was only the second in the world to investigate end-of-life 
decisions in children across different care settings and causes of death.(11) However 
slightly lower than studies in the Netherlands where response rates of 75% (11) to 78% 
(3) were reported and a study in neonates in Flanders were a response-rate of 87% was 
reported(6), a good response-rate of 70.5% was attained, and patients in the response 
group were representative of the total population. The method used has been 
successfully applied in previous studies and allows for making reliable estimates of end-
of-life decisions.(1-3;6;7;11) However, only the physician’s perspective was studied; the 
valuable perspective of parents was not included. The present study was retrospective 
and descriptive, thus less suitable for providing in-depth explanations of its findings. 
Medical end-of-life decisions are frequent in children dying in Flanders, as could be 
expected from previous studies in limited patient groups (eg. neonates) and settings 
(eg. intensive care units), where medical end-of-life decisions were also frequent.(5-10) 
The overall prevalence of end-of-life decisions in the present study was lower than in 
Flemish adults (48%)(4) and in neonates in Flanders and the Netherlands(6;7), but 
consistent with the only comparable population-based study in children aged one to 17 
in the Netherlands in 2001 (36%).(11) However, the finding that Flemish physicians 
frequently intended to hasten death (in 7.9% of all deaths) was remarkable, and 
different from findings in the US, where hastening of death is rather a foreseen but 
unintended side-effect of medical end-of-life decisions.(5) The prevalence was higher 
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than the prevalence of physician-assisted death in Flemish adults (3.8%), and was 
rather at the level found in Flemish neonates (7%).(4;6) The prevalence of physician-
assisted death in children is notably higher in Belgium than in the Netherlands (7.9% 
vs. 2.7%), but in Belgium there was no case where the decision was explicitly requested 
by the patient (euthanasia), as compared to five cases per year in the Netherlands.(11) 
The finding that life-ending without patient request was more frequent in Belgium 
than in the Netherlands is consistent with findings of previous studies among 
adults.(2;3) This may be caused by differences in actual practices of Flemish and Dutch 
physicians, where Flemish physicians in fact acted more often with an explicit life-
shortening intention than their Dutch colleagues, as well as by differences in reported 
intentions, where physicians may have acted in a similar way in both countries, but 
Flemish physicians ascribed a more explicit life-shortening intention to their acts than 
their Dutch colleagues. The present findings further suggest that physician-assisted 
death is not a stand-alone practice in Flanders, but is part of a broader process of care 
and symptom control. In this study, physician-assisted death mostly occurs after a long 
period of illness, often by increasing dosages of morphine in discussion with the 
parents, and - given the limited estimated life-shortening effect - often at the very last 
moments of life. 
All non-treatment decisions and physician-assisted death cases were previously 
discussed with the parents of the minors, and physicians mostly indicated that they 
reached a decision together with the parents, indicating that physicians predominantly 
followed a model of shared decision-making in these decisions. Unfortunately, the 
study does not allow for comparison of physician and parental perspectives on this 
matter, which could have provided a more in depth understanding. The results concur 
with the results from the nationwide study in the Netherlands, where end-of-life 
decisions were always discussed with the parents of the child,(11) and with the findings 
in Flemish neonates, where decisions where discussed with parents in 84% of cases.(29) 
In cases of administration of drugs to alleviate pain and symptoms with a possible life-
shortening effect, discussion with parents occurred less often. It may be that physicians 
find it less necessary to discuss this decision with the parents, considering it a duty and 
part of standard practice to relieve the suffering of their patient irrespective of the 
opinion of others, even if a possible life-shortening side-effect cannot be 
precluded.(30;31) On the other hand, administration of drugs to alleviate pain and 
symptoms with a possible life-shortening effect was relatively more often discussed 
with or requested by the patient. It seems more often to be patient-initiated, possibly 
by the patient indicating to the physician a worsening of his/her symptoms. Non-
treatment decisions and physician-assisted death generally occurred in different 
clinical circumstances from administration of drugs to alleviate pain and symptoms 
with a possible life-shortening effect, with poorer clinical prospects for the patient, 
which make it more difficult to discuss the decisions with them. Given the clear life-
shortening effect of both decisions, it is thus not surprising that parents were consulted 
in all of these cases. 
End-of-life decisions were generally not discussed with minor patients and only one 
patient was considered to have decision-making capacity by the attending physician. 
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This was in line with a Dutch interview study, where pediatricians found minor patients 
incompetent for end-of-life decision-making in 12% of cases, and consequently did not 
discuss the decision with minor patients in 84% of cases.(11) In about two thirds of 
cases, the patient’s comatose condition was cited by the physician as a reason for not 
discussing the end-of-life decision. These patients did no longer have decision-making 
capacity, which obviously precluded any discussion with the patient at that time. In 
nearly 60% of cases, physicians deemed the patients too young to discuss possible end-
of-life decisions. These patients were younger than six in more than 70% of cases. In 
seven of ten cases where a decision was not discussed with a patient aged 12 or older, 
the patient was comatose. These reasons were the same as the reasons for not 
discussing a decision with a minor patient reported by Dutch pediatricians: in 71% were 
patients unconscious or deemed too young.(11) The present data are limited in 
providing a full understanding of which factors determine physicians’ assessment of 
minor patients’ decision-making capacity. Further research is needed to comprehend 
why decisions are not discussed with minor patients, and how their decision-making 
capacity is assessed by physicians. 
 
6.5. Conclusions 
 
Medical end-of-life decisions are frequent in minors in Flanders, Belgium. Although the 
legal representatives of the minors were involved in most end-of-life decisions, patients 
themselves were involved very rarely, even when life-ending was intended. At the time 
of decision-making, patients were often comatose or were deemed incompetent or too 
young to be involved by the physician. 
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Abstract: 
 
Objectives 
This study estimates the incidence of continuous deep sedation in minor patients (aged 
1-17), and describes the characteristics of, and the decision-making process prior to, 
continuous deep sedation. 
 
Methods 
An anonymous population-based post-mortem survey was mailed to all physicians 
signing the death certificates of all patients aged 1 to 17 years who died between June 
2007 and November 2008 in Flanders, Belgium. The questionnaire concerned whether 
or not continuous deep sedation was used at the end-of-life, and measured 
characteristics of sedation and the decision-making process preceding it. 
 
Results 
Response rate was 70.5% (N=165). Of all children, 21.8% had been continuously and 
deeply sedated at the end-of-life. Duration of sedation was one week or less in 72.4% of 
cases and artificial nutrition and hydration were administered until death in 54.3% of 
cases. Benzodiazepines were used as sole drug for sedation in 19.4% of cases, 
benzodiazepines combined with morphine in 50%, and morphine as sole drug in 25%. In 
23.5% of cases physicians had the explicit or co-intention of hastening death. Only 3.0% 
of patients requested sedation, and 6.1% consented. Parents consented in 77.8% of 
cases, and requested sedation in 16.7%. 
 
Discussion 
Minor patients were commonly kept in continuous deep sedation or coma until death 
in Flanders, Belgium. Given the high incidence of the practice, and indications that it is 
often used without involving the patient - and sometimes with a life-shortening 
intention - the development of specific guidelines for sedation in children might 
contribute to due-care practice. 
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7.1. Introduction 
 
Continuous deep sedation is an acceptable last resort option to alleviate refractory 
symptoms in terminally ill patients.(1) Nationwide studies in European countries show 
that the practice precedes between 2.5% and 16.5% of all adult deaths and that it has 
become more widespread in recent years.(2-6) Mono-centric studies exist which 
suggest that sedation is frequently used in pediatric end-of-life practice(7-9), although 
this has not been confirmed at population level. 
Continuous deep sedation at the end-of-life poses clinical and ethical challenges to 
practitioners.(10) To help them deal with these, several guidelines and 
recommendations have been put forward (11-16), including indications for palliative 
sedation, whether or not artificial food and fluids should be administered, and whether 
life-shortening should be intended. Although some people argue that continuous deep 
sedation can have a life-shortening effect, this is still debated. This is one reason why 
its practice should respect strict due-care requirements.(17-20) In minor patients, 
decision-making is further complicated by a limited capacity to make autonomous 
decisions due to still-developing mental competence, by legal restraints on decision-
making by minors, and by the involvement of parents as a third party in the process. 
Given these important clinical and ethical challenges, it is striking that few guidelines 
have yet been put forward for pediatric practice and that empirical data on the practice 
of continuous deep sedation in minors is rare.(21;22) This study aimed to estimate the 
incidence of continuous deep sedation in minor patients (aged 1-17) in Flanders, 
Belgium, and to describe the characteristics of, and the decision-making process 
leading up to, its practice.   
 
7.2. Methods 
 
During an 18-month period from June 2007 until November 2008, an anonymous, self-
administered questionnaire was mailed by the Flemish Ministry of Health to all 
physicians who signed the death certificates of all 250 patients residing in Belgium who 
had died in Flanders at age one to 17 years within that period. To enhance response, the 
Total Design Method was followed, with a maximum of three reminders per case.(23) A 
complex mailing procedure, with a lawyer as intermediary between physicians and the 
Flemish Ministry of Health, was used to ensure anonymity of both physician and 
patient.(24) A one-page non-response survey was mailed to physicians who did not 
respond after three reminders. 
The questionnaire was similar to those used in previous studies in adults and neonates 
(2;4;25;26), albeit slightly adapted to fit pediatric practice by including questions on the 
involvement of parents and minor patients. When death had not been sudden and 
unexpected according to the physician, he or she was asked “Was the patient 
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continuously kept in deep sedation or coma until death, by means of one or more 
drugs?” This implies that, regardless of whether sedation was initiated by the physician 
or a consequence of disease progression, only patients who were kept in coma by 
means of drugs could be considered continuously and deeply sedated until death. 
Further questions were aimed at eliciting the characteristics of continuous deep 
sedation: administration of artificial food/fluids until death, drugs used, duration of 
sedation, consent or request by parents and/or patient, alternatives to sedation and the 
physician’s life-shortening intention when engaging in sedation. The Flemish Ministry 
of Health provided clinical and demographic information as recorded on the death 
certificate (age, gender, cause and place of death) which the lawyer linked case-by-case 
to data from the questionnaires. Afterwards the data were made anonymous. Standard 
descriptive statistics were used to analyze the data. Chi square statistics were used to 
investigate differences between cases where continuous deep sedation was used and 
other non-sudden deaths where no continuous deep sedation was used. SPSS 15.0 was 
used for all analyses. Level of significance was set at p<.05. 
The study was approved by the Ethical Review Board of the University Hospital of the 
Vrije Universiteit Brussel and the Ethics Committee of Ghent University Hospital, and 
positive recommendations were received from the Belgian National Disciplinary Board 
of Physicians and the Belgian Federal Privacy Commission. 
 
7.3. Results 
 
In sixteen of the 250 cases, the physician received the questionnaire but was unable to 
provide information, according to an additional non-response survey, due to lack of 
access to the patient’s medical file or patient identification. For 165 of the 234 
remaining cases a completed questionnaire was returned (response-rate 70.5%). For 88 
of 165 cases, the physician estimated that death had been sudden and unexpected.  
Of all patients, 36 had been continuously and deeply sedated at the end of life. This was 
21.8% of all studied deaths and 46.8% of non-sudden deaths. Patient characteristics are 
presented in Table 1. Benzodiazepines were used as the sole drug for sedation in seven 
patients (19.4%), benzodiazepines combined with morphine in 18 (50.0%), and in nine 
patients (25.0%) morphine was used as the sole drug (see Table 2). One patient had been 
sedated for more than two weeks while most were sedated for one week or less (72.4%). 
Artificial nutrition and hydration were administered until death in more than half of 
cases (54.3%) and were withdrawn during sedation in eight (22.9%). The proportion of 
patients receiving artificial nutrition or hydration during sedation differed according 
to place of death: 44.4% of patients receiving continuous deep sedation at home 
received artificial nutrition and hydration at some point during sedation, compared 
with 91.3% of patients in hospital (data not shown in table). Physicians indicated having 
had the explicit or co-intention of hastening death in eight cases (25.0%). When 
artificial food and fluids were administered until death, 17.6% of physicians reported an 
explicit or co-intention of hastening death, while 37.5% and 33.3% did so when artificial 
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food and fluids were withdrawn during sedation or withheld. In 27 cases (84.4%) 
physicians indicated that there was no alternative to continuous deep sedation for 
treating the patient’s symptoms (see Table 2).  
Table 1: Demographic characteristics, cause of death and treatment duration of patients 
who were continuously and deeply sedated at the end of life (N=36), other non-sudden 
deaths (N=41) 
Non-sudden deaths†  
Continuous deep 
sedation 
No continuous 
deep sedation 
Sudden deaths 
 N (%) N (%) N (%) 
Number of deaths 36 41 88 
% of all deaths 21.8 24.8 53.3 
Gender    
Male 22 (61.1) 22 (53.7) 48 (54.5) 
Female 14 (38.9) 19 (46.3) 40 (45.5) 
p-value* .510   
Age    
1-5 18 (50.0) 17 (41.5) 27 (30.7) 
6-11 8 (22.2) 11 (26.8) 13 (14.8) 
12-17 10 (27.8) 13 (31.7) 48 (54.5) 
p-value* .752   
Cause of death    
External 7 (19.4) 7 (17.1) 60 (68.2) 
Cancer  11 (30.6) 11 (26.8) 3 (3.4) 
Central Nervous System 4 (11.4) 6 (14.6) 6 (6.8) 
Congenital 3 (8.3) 6 (14.6) 5 (5.7) 
Cardiovascular 2 (5.6) 0 (0.0) 6 (5.7) 
Other 9 (25.0) 11 (26.8) 9 (8.0) 
p-value* .655   
Place of death    
Home 10 (27.8) 15 (36.6) 28 (31.8) 
Hospital 23 (63.9) 18 (43.9) 25 (28.4) 
Other 3 (8.3) 8 (19.5) 35 (39.8) 
p-value* .168   
Time in treatment    
1-7 days 9 (25.0) 9 (22.5) -§ 
1 week – 6 months 12 (33.3) 3 (7.5) -§ 
> 6 months 15 (41.7) 28 (70.0) -§ 
p-value* .010   
Number of observed cases (percentage).  Percentages do not always add up to 100 because of 
rounding. 
* p-value for Chi-square statistic testing differences in the distribution of described 
characteristics between cases of CDS and non-sudden deaths without CDS 
§ Information on time in treatment was not available for sudden deaths. 
† Cases were categorized as Sudden when the physician indicated that death had been 
sudden and completely unexpected and when the physician indicated that the first contact 
with the patient was after the child’s death 
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Table 2: Characteristics of continuous deep sedation and decision-making process 
(N=36) 
 N % 
Total 36 100 
Drugs used   
only benzodiazepines 7 19.4 
benzodiazepines and morphine 13 36.1 
benzodiazepines, morphine and other 5 13.9 
only morphine  9 25.0 
morphine and other drug 2 5.6 
Duration of sedation*   
0-48 hours 12 41.4 
2-7 days 9 31.0 
1-2 weeks 7 24.1 
>2 weeks 1 3.4 
Artificial nutrition and hydration*   
administered until death 19 54.3 
withdrawn during sedation 8 22.9 
withheld 8 22.9 
Intention of hastening death*   
no intention 9 28.1 
taking into account possible hastening of death 15 46.9 
co-intention 4 12.5 
explicit intention 4 12.5 
Alternatives to continuous deep sedation*   
none 27 84.4 
only ending the patient’s life 3 9.4 
unspecified other alternatives 2 6.3 
Main goal of care in the last week before death   
cure 14 38.9 
prolongation of life 3 8.3 
comfort 19 52.8 
Patient request for or consent to continuous deep sedation *§   
request 1 3.0 
consent 2 6.1 
no† 30 90.9 
Parental request for or consent to continuous deep sedation §     
request 6 16.7 
consent 28 77.8 
no† 6 16.7 
Number of observed cases and percentages. Percentages do not always add up to 100 because of 
rounding 
* Data were missing for 7 cases (duration of sedation), 4 cases (alternatives), 3 cases (patient 
request/consent), 4 cases (physician’s intention) and 1 case (artificial food or fluids) 
§ Multiple answers were possible, total percentage may add up to more than 100 
† No information was available on whether consent was solicited for by the physician or not. 
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The decision to use continuous and deep sedation was made without patient 
involvement in most cases: one patient requested sedation (3.0%) and two patients 
consented (6.1%).(see Table 2) No patient dying at age 11 or younger consented with or 
requested to be sedated. In 70% of patients dying at age 12 and older, there was no 
request for or consent with sedation (data not shown in table). Parents consented in 
most cases (77.8%) and requested sedation in six cases (16.7%). In six cases (16.7%) there 
was no request or consent from the parents.  
 
7.4. Discussion 
 
Minor patients were commonly kept in continuous deep sedation or coma until death 
(21.8% of all deaths and 46.8% of non-sudden deaths) in Flanders, Belgium. Most 
sedation started one week or less before death and artificial nutrition and hydration 
were administered until death in more than half of cases. Physicians had the explicit or 
co-intention of hastening death in a quarter of cases. Parents consented with sedation 
in most cases, while the patients were seldom involved in decision-making. 
The present study is, to our knowledge, the first to investigate the practice of 
continuous deep sedation in minors across different patient groups and care settings. A 
good response rate was attained. The method used has been successfully applied in 
previous studies and allows the making of reliable estimates of end-of-life 
practices.(2;4;25) However, only the physician’s perspective was studied; the 
perspective of parents was not included. The present study was retrospective and 
descriptive, thus less suitable for providing in-depth explanations of its findings. 
The incidence of continuous deep sedation in our study in minor patients was higher 
than the incidences found in recent population-wide studies in adult patients in 
Belgium (14.5%).(5;6) The high incidence may partly be related to a lack of appropriate 
optimal pain control in children due to the barriers to using sufficiently high doses of 
drugs and to the limited capacity of young children to express their symptom burden 
verbally.(27) Despite recent advances in pediatric pain relief, providing optimal 
symptom relief remains challenging for caregivers. To make sure that total symptom 
control is attained, physicians caring for minor patients may therefore be more easily 
inclined to resort to sedation. In most cases, physicians indicated that sedation was 
used where there were no options left to alleviate symptoms and only when death was 
imminent. Further studies on optimal dosages of pain medication for pediatric use, and 
improved training in palliative care and aggressive symptom control may help 
physicians to resort to sedation less easily. 
At least four different types of sedation may occur at the end of life. The total 
proportion of 22% observed in our study is thus a combination of different practices. A 
first type is “palliative” or “terminal” sedation, which is used as a last resort option to 
treat refractory symptoms in imminently dying patients. This type of sedation has been 
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investigated frequently for the population of adult patients, and guidelines for good 
clinical practice have been formulated.(11-16) A second type of sedation is used to calm 
patients in order to facilitate certain treatments, such as ventilation after surgery. 
However, the patient’s condition may worsen while under sedation, and it may 
consequently become irreversibly impossible to bring the patient back to 
consciousness. This second type of sedation is used when the main goal of treatment is 
curative, and the intention of professional caregivers is still to preserve the patient’s 
life. Our finding that artificial food and fluids were administered until death in just over 
half of cases of sedation may indicate that this type of sedation occurred in our study. A 
third type of sedation is an unintended consequence of a gradual increase in pain 
medication. In our study, a quarter of physicians reported that they had only used 
morphine to sedate the patient. Finally, sedation may also sometimes be used as a 
covert form of life-ending, which was reported as their intention or co-intention by a 
quarter of physicians. The types of sedation described above would all be interpreted as 
continuous deep sedation until death by the physician, but the conditions under which 
sedation was started may have been entirely different. Unfortunately, the study design 
did not allow for clearly distinguishing between different types of sedation. Further 
prospective studies may help to clarify this issue.   
According to Art. 12 § 2 of the Belgian Law on the Rights of the Patient (2002), which 
implicitly applies to continuous deep sedation, minor patients who are thought to be 
capable of judging their own interests may exercise their medical rights autonomously. 
In the great majority of cases studied here, the decision to sedate was taken with 
parental consent, but strikingly, patients themselves were seldom involved in the 
decision-making, if they died at age 12 or older. Of course, discussion would have been 
impossible in cases where sedation was an unintended side-effect of pain and symptom 
control. The findings may indicate that physicians make these decisions, in 
consultation with parents, in the patient’s stead in their best interests, sometimes 
because patients are judged to be too young and sometimes possibly because of their 
diminished consciousness at the time of the decision. However, such circumstances 
cannot always justify the exclusion of minors from the decision-making process. If 
possible, some kind of discussion should perhaps be initiated early enough in the 
disease process. Moreover, in cases where there was neither parental request nor 
consent it is possible that patients and parents missed farewell opportunities. As the 
present data were limited in providing a full explanation of the finding, further studies 
are needed to clarify whether the decision-making process preceding sedation in 
minors is indeed less than optimal, and if so, whether this affects bereavement 
outcomes.  
However, contrary to existing guidelines, physicians intended or co-intended life-
shortening in one quarter of cases of continuous deep sedation in the present study. 
Almost half of physicians reported that they had taken possible hastening of death into 
account when engaging in sedation. These physicians may have observed the principle 
of double effect in these cases: they accept that sedation has two effects (symptom 
relief and shorter longevity), the physicians only intend the good effect, and accept the 
negative effect as a necessary but unintended side-effect. However, our results do not 
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preclude the use of sedation where euthanasia might otherwise have been chosen if it 
were legal in minors. Further studies in other populations are needed to establish 
whether this finding can be generalized to other countries, where the legal framework 
surrounding euthanasia is different from Belgium, and physicians hold less permissive 
attitudes towards the practice.  
 
7.5. Conclusion 
 
The present study indicates that minor patients were commonly kept in continuous 
deep sedation or coma until death in Flanders, Belgium. Given the high incidence of the 
practice, and indications that it is sometimes used with a life-shortening intention 
without involving the patient, the development of specific guidelines for sedation in 
children appears to be appropriate in order to guide physicians and to guarantee the 
practice of due care. These guidelines should be formulated with adequate attention for 
ethical and legal decision-making. Further in-depth research is warranted to improve 
understanding of how decisions are made, why minor patients are seldom involved in 
them, and how sedation relates to acts with an explicit life-shortening intention. 
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Chapter 8: General discussion and conclusion 
 
8.1.  Summary of the main findings 
 
8.1.1. Place of death 
 
In our study of 3.328 death certificates of children who died at age one to 17 in six 
European countries (Belgium, the Netherlands, Italy, Norway, Wales and England) 
described in Chapter 2, 1.037 (31.2%) died of a complex chronic condition. The 
proportion of home deaths differed between countries, and ranged between 19.6% in 
Italy and 28.6% in the Netherlands. Children dying from complex chronic conditions 
had higher chances of dying at home in all studied countries than children dying from 
other causes. The proportion of home deaths for children dying from complex chronic 
conditions varied between 21.7% in Italy and 50% in the Netherlands. Sub analyses 
among children dying from complex chronic conditions demonstrated that home death 
was more likely for chronically ill children dying from cancer and for children dying at 
age 11 or older. Differences in the proportion of home deaths between countries were 
significant, and remained significant after controlling for potentially related clinical 
and socio-demographic factors. As compared to Italy, significantly higher proportions 
of home deaths among children dying from complex chronic conditions were recorded 
in Belgium and the Netherlands. 
 
8.1.2. Attitudes of Flemish adolescents and physicians towards end-of-life 
decisions 
 
The study on attitudes towards end-of-life decision of 1.769 Flemish adolescents 
showed that 61% found a request for euthanasia acceptable, 60% a request for 
intensified alleviation of pain and symptoms and 69% a request for a non-treatment 
decision when a terminally ill 14-year-old patient would request it. This was 
significantly higher than the 18% acceptance for euthanasia and 50% acceptance of 
intensified alleviation of pain and symptoms when requested by a non-terminally ill 
minor patient. Rates of acceptance of requests for end-of-life decisions varied 
significantly among participants. Boys, participants older than 14 years and 
participants from the general type of education were more acceptant towards end-of-
life decisions than were girls, participants aged 14 and younger and participants from 
technical and vocational education. Participants cited different circumstances that 
should hold back a physician from administering a lethal drug. The child not agreeing 
(76%), the child being badly informed about his/her condition (68%) or the opinion of 
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the parents not having been sought (66%) were the most frequently cited reasons. For 
40%, the lack of agreement of the parents with the child’s death wish was a 
circumstance that should hold back a physician from administering a lethal drug. 
Ninety percent of participants thought a minor has the right to be informed about 
terminal prognosis of a disease, while 78% would like to be informed themselves. 
Agreement with the right to be informed about a terminal prognosis and the 
willingness to be informed themselves was highest among female participants and 
students older that 14 years. Agreement with the right to be informed about terminal 
prognosis was lowest for students from vocational education as compared to students 
from general and technical education. 
A second study in adolescents tried to establish the influence of experience with 
chronic illness on end-of-life attitudes. To this end, 83 adolescents who were treated for 
cancer at least two years prior to the study were interviewed with questions similar to 
the first study so that results of both studies could be compared. The response-rate was 
42%. Where a terminally ill cancer patient was concerned, 90.4% of participants found a 
request for a non-treatment decision acceptable and 84.3% a request for intensified 
alleviation of pain and symptoms, which was significantly higher than among the 
adolescents of the first study. The level of acceptance of a request for euthanasia by a 
terminally ill cancer patient was 63.9%, which did not differ significantly between both 
studies. Request for a non-treatment decision and euthanasia were found acceptable by 
respectively 69.9% and 56.6% of adolescent cancer survivors when a terminally ill non-
cancer patient was concerned. Acceptance of requests for end-of-life decisions by non-
terminally ill patients did not differ between the two studies and was, among the 
cancer survivors, 27.7% for requests for a non-treatment decision, 38.6% to 47.0% for a 
request for intensified alleviation of symptoms and 10.8% to 20.5% for a request for 
euthanasia. A majority of 92% thought a physician should not be allowed to administer 
a lethal drug when the child is not well informed about his or her condition, when the 
child wants to die because of the burden he or she causes to the parents, and when the 
parents’ opinion is not asked by the physician. Fewer participants thought that a 
physician should not administer a lethal drug to a child when the parents do not agree 
with their child’s wish to die. Almost all participants agreed that a terminally ill minor 
should have the right to be informed about the terminality of his or her condition; 
while slightly fewer, but still 86%, indicated that they would want to be informed 
themselves if they were ever faced with a similar situation. We will further discuss 
these findings below.  
In our study of physician attitudes towards physician-assisted dying in minors, a 70.5% 
response rate was obtained. The attitude-items of the questionnaire were completed by 
124 physicians. Sixty-nine percent agreed that the Belgian law on euthanasia should be 
extended to include minors, but only 26.6% thought this should be done by establishing 
clear age limits. The role of parents was clearly valued by the participating physicians: 
60.5% thought parental consent is required before taking life-shortening decisions and 
52.4% that the administration of a lethal drug can be acceptable if 
parents/representatives of a non-competent minor patient request for it. Only 21.8% of 
physicians agreed that minors are not yet capable of making a rational assessment of 
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their interests where decisions about life and death are concerned. Seventy-three 
percent acknowledged that experiencing a chronic condition causes younger minor 
patients to be better capable of assessing their interest as compared to healthy peers 
and 82.3% that the wishes of older minor patients should be taken into consideration to 
the same degree as those of adult patients. Opinions were divided where alternatives to 
physician-assisted death were concerned. While 46.7% agreed, 29.0% remained neutral 
as to whether palliative sedation is always to be preferred above the administration of a 
lethal drug in minor patients. About as many physicians agreed as disagreed that 
adequate pain control and end-of-life care make euthanasia superfluous in minors. The 
physicians could be clustered in two groups, based on their attitudes. About two thirds 
of physicians belonged to the “permissive” cluster: they are more likely to regard 
minor patients as competent decision-makers at the end of life, and to see euthanasia 
and life termination for minor patients as acceptable options under certain 
circumstances. Physicians in this cluster believe that the current Belgian law on 
euthanasia should be extended to include minors. The remaining third of physicians 
belonged to the “reluctant” cluster: they oppose euthanasia and life-termination in 
minors, even if requested for by a competent minor patient and/or parents. They tend 
to prefer palliative sedation above the administration of a lethal drug, and believe that 
adequate pain control and end-of-life care make euthanasia superfluous. These 
physicians do not want the current Belgian law on euthanasia to be extended. The 
physicians’ cluster membership was significantly related to their actual end-of-life 
practices. Permissive physicians were more likely to engage in intensified alleviation of 
pain and symptoms with a co-intention of shortening the patient’s life, in physician-
assisted death, and in continuous deep sedation with a (co-)intention of shortening the 
patient’s life. 
 
8.1.3. Incidence and characteristics of end-of-life decisions and sedation in 
minors in Flanders, Belgium 
 
A 70.5% response rate was obtained in our mortality follow-back study. Detailed 
information was collected on 165 deaths in minors aged between one and 17 years. 
Fifty-three percent of patients died sudden and unexpected. An end-of-life decision 
preceded death in 36.4% of cases, of which 10.3% were a non-treatment decision, 18.2% 
intensified alleviation of pain and symptoms and 7.9% physician-assisted death. All 
cases of physician-assisted death occurred without an explicit patient request, but in 
three quarters of cases the decision was requested by the parents. The most frequently 
cited reasons for performing an end-of-life decision were: no improvement to be 
expected (84.6%), low expected quality of life (61.5%) and not needlessly prolonging life 
(50.0%). Half of patients where an end-of-life decision was made had been in treatment 
for their terminal illness for more than a year. End-of-life decisions were generally 
discussed with the parents (85.2%), and discussion was mostly aimed at reaching a 
decision together with them. The decision was discussed with the patient in only 15.4% 
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of cases, mainly because the patient was comatose, too young or mentally disabled. In 
our study, only one patient was found to be competent by the physician. 
In 21.8% of cases, the patient was continuously and deeply sedated until death. 
Benzodiazepines were used to sedate the patient in a majority of cases, yet in 25% of 
cases only morphine was used. Patients were sedated for 48 hours or less in 41.8% of 
cases and longer than two weeks in only 3.4% of cases. In a majority of cases, artificial 
nutrition was administered until death. In a quarter of cases, the physician indicated 
having had the intention or a co-intention of shortening the patient’s life. Patients did 
not request or consent with sedation in 90.9% of cases. Parents however were involved 
in decision-making in most, but not all, cases of sedation. 
 
8.2.  Strengths and limitations of the study designs 
 
To help readers to appreciate the general discussion of the findings below, we 
summarize and elaborate on the methodological strengths and shortcomings of the 
study designs used.  
 
8.2.1. Death certificate study on place of death 
 
The use of death certificates for studying place of death on a population level has been 
demonstrated to be a feasible study design.(1) Advantages of the design include the 
accuracy of the data, the inclusion of deaths across all care settings and places of death, 
the inclusion of patients across all causes of death and the exclusion of non-response 
on a patient level. Our study was, to our knowledge, the first to study place of death of 
children on a population-level in Europe, and the first to provide international 
comparisons. The detailed information on death certificates allowed us to distinguish 
the group of children who died from complex chronic illness, a relevant group where 
planning of place of death is more likely than for children dying from external causes. 
The study, however, had some limitations. First, not all deaths were included in all 
countries. For Italy and Belgium, not all regions were included in the study, which may 
obscure some of the variance in place of death and associated factors in these 
countries. Second, while a comparison was made between six countries, a lot of 
European countries remain to be studied. Third, for some variables, estimates had to be 
made in some countries because detailed information was missing. This was the case 
for cause of death in Italy, age in Norway and socio-economic status in all countries. 
The estimates for cause of death in Italy may have been imperfect, which may have led 
to false positives or false negatives when selecting children who died from complex 
chronic conditions. The lack of detailed information on age in Norway led to Norway 
being excluded from the multivariate binary logistic regression. More detailed 
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information on age would have allowed for a more complete model. Fourth, while 
studying death certificates is a feasible study design, inaccuracies and errors cannot be 
entirely excluded.(2) Finally, some information, which is relevant for studying place of 
death, is not available on death certificates, and was thus missing. There was, for 
instance, no information on patient or parent preference for place of death, a factor 
which has been demonstrated to be relevant for pediatric end-of-life care. However, 
collecting population-wide data via death certificates precludes collecting more 
detailed information, which was not the primary aim of the study. 
 
8.2.2. Questionnaire study among secondary school students 
 
The questionnaire study among secondary school students was, to our knowledge, the 
first to study systematically the attitudes of minors towards end-of-life decisions in 
minors. The study design, using concise case descriptions and touch screen units, 
attempted to appeal to the participating adolescents’ sphere of interest. The sampling 
procedure allowed for students and schools from different religious backgrounds to 
participate in the study. Because students were sampled by the school principals, there 
was also no non-response at student level. This precluded any selection bias at 
participant level. Moreover, because computerized touch screen units were used to 
administer the survey, there were no missing values on any of the questions. By 
informing the participants about the scope of the study only in general terms 
beforehand, there was no risk of class consensus being formed. 
On the other hand, the fact that classes of participating pupils were proposed by the 
school principals also carried some risk of selection bias. However, we estimated that it 
was not likely that this had a significant and systematic effect on the data, as the 
selection bias could have gone either way: principals may have proposed their most 
accepting students as well as their least accepting students. A second limitation of the 
study was that the short case description and limited answer categories may not have 
given enough information and response options to the participants to express their 
opinions with as much nuance as they would have liked. An additional limitation was 
that we had to use a student’s membership of a school network as an approximation of 
the individual life stance. This may have been an imprecise estimation, as students and 
parents no longer primarily opt for a certain school on the basis of its life stance, but 
rather on the basis of social, academic or practical arguments. It would have been 
interesting to have more precise information on the students’ individual life stances, a 
factor which has already been shown to be related to attitudes towards end-of-life 
matters.(3)  
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8.2.3. Interview study among cancer survivors 
 
As the design of the study among cancer survivors was similar to the study in 
secondary school students, most strengths and limitations are also similar. An 
additional strength of the study among cancer survivors was that it used interviews to 
survey the adolescents, which allowed the researchers to support the participants if 
any of the questions would prove to be burdensome for the participants. A second 
additional strength was the focus on a group of minors who had been treated for cancer 
in the past, a group which had not yet been studied. This met the need for more patient 
reported outcomes, one of the principal needs of research in pediatric oncology.(4) 
A specific limitation of the study in cancer survivors was its relatively low response 
rate of 42%. The non-response was partly caused by parents refusing consent for their 
child to participate in the study. Non-response was also partly at participant level, 
where parents consented but the adolescents did not. We can thus not preclude that 
there may have been some selection bias. Non-response may have been systematic to 
some extent. Parents and adolescents who had less positive experiences with the care 
received may have been less inclined to consent to participation in research. 
Adolescents who did not participate in the study often indicated that the study subject 
was still too confrontational for them. However, we deem it implausible that this non-
response, even if it were systematic, significantly biased the results on adolescent’s 
attitudes towards end-of-life decisions. We see few reasons to suspect that only the 
adolescents with the most distinct positive or negative attitudes have participated in 
the study.      
 
8.2.4. Mortality follow-back study on end-of-life practices 
 
A retrospective post-mortem physician survey is a study design that has been shown to 
be feasible for studying end-of-life practices on a population level, and has been 
successfully used several times in the past for making epidemiological estimates of end-
of-life practices.(5-9) Our study was based on these previous studies, which allowed for 
putting the findings in perspective with findings in the Netherlands and in adults. The 
design is well suited to investigate deaths across care settings and causes of death, and 
the opportunity to link the survey data to case-wise death certificate data adds detail to 
the findings. Our study was, next to a study in the Netherlands, only the second to focus 
on deaths of minors dying between the age of one and 17, and the first to do so in a 
country where euthanasia was legal.(10) Moreover, our study was the first worldwide to 
study the practice of continuous deep sedation at the end-of-life systematically, at the 
end-of-life in minors. Furthermore, our study did not use a sample of death certificates. 
Instead, all deaths of minor patients in an 18-month period from June 2007 until 
November 2008 were included. The response-rate of 70.5% was satisfying, although 
somewhat lower than in previous studies.(10;11) The response-group was 
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representative for the total group of 250 deaths in the study period. An additional 
strength of the study was the inclusion of attitude-items in the questionnaire. This not 
only made it possible to study physicians’ attitudes towards physician-assisted dying in 
minors, a rarely studied topic, but also to relate their attitudes to their actual reported 
end-of-life practices. Our study is, to our knowledge, the first to do so in minor patients 
other than neonates.  
The study also had some shortcomings. Inherent to the study design was the 
retrospective nature of the survey. This may have induced some recall bias in the 
physicians’ responses. This problem was present in similar previous studies.(5;7;8;12;13) 
We do however expect this recall bias to have played a smaller role in the present 
study. As physicians were surveyed on the death of minor patients, we would expect 
them to recall these cases more clearly, because of the rarity of child deaths, and the 
powerful impact the event has on families and caregivers. A second shortcoming was 
the fact that only the physician’s perspective was studied. The valuable perspective of 
the parents and other professional caregivers thus remained unstudied. Including these 
perspectives in the study would of course have added to the richness of the data and 
interpretation, but was ultimately beyond the scope of the study and impossible 
because deceased patients were anonymous – not only for the researchers, but also for 
the Flemish Ministry of Health who collected the data. A third shortcoming was the 
limited potential of our survey to fully capture the complex decision-making process 
prior to end-of-life decisions in minors. It would have been useful to gather more 
detailed information on minor patients’ competence to be involved in decision-making, 
the way this was assessed, what were the main reasons for deeming the patient 
incompetent, etcetera. Unfortunately, including these questions would have 
considerably lengthened the survey, and would possibly have reduced the response 
rate. A compromise between length and detail of the questionnaire had to be made. Of 
course, as noted above, a complete picture of decision-making is hard to achieve by 
studying only the physician’s perspective. A final limitation of the study was that the 
group of physicians who completed the attitude items was relatively small (N=124). 
However, while the group was small, they nevertheless represented a very relevant 
sample of physicians. They were in fact all the physicians who certified the death of a 
minor patient during an 18-month period in Flanders, Belgium. Because they represent 
the physicians caring for dying children in Flanders, their attitudes are the most 
relevant of all physicians. 
 
8.3.  General discussion and implications 
 
8.3.1. Place of death of children 
 
Our death certificate study on place of death in children in six European countries 
demonstrated a low rate of home deaths in all countries studied, varying between 20% 
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and 29%. As only few population-based studies on place of death in children are 
available, it is not easy to frame these results in an international context. Comparison 
with similar population-based studies in the US suggests that our findings are largely 
concordant with findings in the US, where also a large majority of children died in 
hospital.(14;15) The high proportion of hospital deaths is of course linked to the pattern 
of causes of death. A lot of children die from external causes, where there are no 
opportunities to plan end-of-life care, and attempts to keep children alive are logically 
maximized in emergency or intensive care units. 
In order to come to meaningful interpretations, a focus on children dying from 
complex chronic diseases was necessary, and we found that chronically ill children died 
more often at home than did children dying from other causes. This was, again, 
concordant with Feudtner’s population-based studies in the US.(14;15) This result was 
to be expected, as end-of-life care is easier to plan when a child suffers from chronic 
disease and has longstanding relationships with professional caregivers. When death is 
an imminent outcome, and frequent contacts with professional caregivers occur, it 
appears plausible that parents more frequently get a chance to articulate their 
preference concerning place of end-of-life care and death to health professionals. 
Although our study did not provide information on parental preferences, previous 
studies lead us to expect that a majority of parents will have preferred to care for their 
child at home.(16-23) The fact that most children, even when dying from a chronic 
condition, did not die at home in the studied countries, suggests that a considerable gap 
exists between preferences and outcomes regarding place of end-of-life care and death. 
In this context, it is important to notice the significant differences between countries, 
even after controlling for patient characteristics and socio-demographic variables. 
Children dying from chronic disease in Italy had significantly lower chances of dying at 
home than their Belgian and Dutch counterparts. In Chapter 2, we have elaborated on 
some possible cultural and structural explanations for this finding. To understand why 
Italian chronically ill children had low chances of dying at home, we hypothesized 
some cultural factors to be in play. In Italy, we expected parents and professional 
caregivers to hold strong attitudes towards preserving the lives of children, which may 
ultimately even lead to therapeutic obstinacy. Knowledge of such cultural factors is in 
principle needed to fully understand the results, as home death may not be a desirable 
outcome for a lot of Italian parents. Further research should try to take these factors 
into account.  
A marked finding was that home death was more likely for children dying from cancer 
in four out of six countries studied, even when compared with children dying from 
other chronic diseases. This was not a novel finding, as previous studies in the US and 
the UK already suggested higher chances of home death in children dying from 
cancer.(14;24) However, the finding was important, in that understanding the 
mechanisms which facilitate home death in children dying from cancer may lead to 
factors being uncovered which can improve rates of home death in children dying from 
other diseases. A factor that will evidently play a role in the higher rate of home death 
among cancer patients is the more predictable course of the illness, which makes it 
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easier for parents and professional caregivers to plan end-of-life care.(25-28) This 
factor however provides little indication of how to improve the rate of home deaths in 
other patient groups, as we cannot just change the predictability of illness trajectories. 
A second factor which undoubtedly improves the rate of home death among cancer 
patients in Belgium, is the availability of palliative home care teams in three of four 
academic hospitals in Flanders. These teams operate from pediatric oncology settings, 
and still reach predominantly cancer patients – although aiming to care for all 
terminally ill children. Within the “Koester”-project in Ghent, for instance, 84% of 
patients between 1996 and 2005 had malignant pathologies.(29) It is logical that 
palliative care teams for terminally ill children originate in oncology settings, as 
professional caregivers operating in these settings are relatively experienced in the 
care of dying children. The care models of “Koester” in Ghent and “KITES” in Leuven 
are aimed at providing palliative home care for their patients. This is done by providing 
a liaison between caregivers in the home situation (including the general practitioner, 
the parents and home nurses) and the hospital.(29) This link between hospital and 
home allows for good continuity of care. It is reassuring for families that the specialists 
in hospital keep track of the progression of their child’s condition, and that they can 
admit their child to hospital more easily if home care can no longer be managed. The 
experienced caregivers of the specialized pediatric palliative home care teams do not 
only organize and coordinate home care, they also train and instruct the less 
experienced caregivers in the home situation. By doing this, the scarce expertise in 
children’s end-of-life care is shared efficiently with other professional caregivers such 
as home nurses or general practitioners, who generally have little or no experience 
with pediatric end-of-life care. As we outlined in the introduction to this dissertation, 
the limited level of experience and expertise of professional caregivers is one of the 
principal challenges and barriers in pediatric end-of-life care.(30-35) Additionally, the 
fact that these home care teams are hospital-based and provide outreach to the home 
setting allows them to cover a relatively large geographical area, and adds to their cost 
efficiency. 
Unfortunately, the home care teams have depended on fund raising and charity for a 
long time. Only recently, a first structural financing was made available for pediatric 
palliative home care.(36) Given the expertise and efficiency of the existing home care 
teams, we recommend extending structural financing for these services in the future. 
With extra resources, the teams can elaborate their services and focus more on 
children dying from diseases other than cancer, a group where our study clearly 
indicates that the most progress is still to be made. By doing so, other dying children 
may in the future also benefit from the end-of-life care expertise available in pediatric 
oncology settings. Of course, further studies are needed to monitor the quality of care 
delivered by these pediatric palliative home care teams. Parents should feel confident 
that reliable support is readily available and that continuity of care is 
guaranteed.(17;37;38) Results in other countries already suggest that palliative home 
care, although not yet accessible to all children, can indeed be successfully 
organized.(19;39-45)  
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8.3.2. Attitudes towards end-of-life decisions in children 
 
Our studies on attitudes of adolescents towards end-of-life decisions show a similar 
pattern of acceptance of requests for different kinds of end-of-life decisions as in 
adults.(3;46-48) They generally accept requests for a non-treatment decision more 
easily that requests for intensified alleviation of pain and symptoms, and the latter 
more easily that a request for euthanasia. All requests were generally more accepted 
when formulated by a terminally ill minor patient than when formulated by a non-
terminally ill minor patient. When we assume that adults, in general, think rationally 
about end-of-life decisions, and adolescents show a similar pattern of attitudes, the 
findings suggest a certain degree of “outcome rationality” in adolescents. The data do 
not allow for establishing whether the adolescents in fact formed their opinion in a 
rational and competent way, but the outcome of their thinking suggests that they did. 
This was to be expected, based on the literature on adolescents’ competence for 
medical decision making, which indicates that adolescents from the age of 14 years on 
are generally competent decision-makers, and no less than adults.(49) Additionally, 
adolescents indicated that they do not want to be left alone with end-of-life decisions. 
This was in line with previous studies.(50-52) Parental input was generally highly 
valued by the participants, in that they found the administration of a lethal drug to a 
minor patient unacceptable if the parents’ opinions were not asked. However, the final 
decisional authority should, according to the participants, lie with the adolescents.  
There was a considerable degree of variance in attitudes according to the participants’ 
characteristics. Experience with chronic illness appeared to have some influence, but 
the general pattern of results was generally similar between both studies. The main 
implication of this finding for professional caregivers is that adolescents generally 
think that requests for end-of-life decisions by minors are acceptable under certain 
circumstances, and that they generally want to be informed about a terminal prognosis, 
but that the variance in the results urges professionals to assess preferences and needs 
case by case when faced with adolescents at the end of their life. Our studies provided 
some guidance as to which adolescents are most likely to be open to end-of-life 
decisions: males, adolescents older than 14, with a general education and with 
experience with chronic illness. It is important to notice that our studies did not 
provide information on adolescents currently living with cancer. Their attitudes may 
be different from those with chronic illness experience or those who have been clear of 
cancer treatment for at least two years, but further study is needed to clarify this issue. 
The findings are hard to put into an international context. Not only because 
comparable studies are scarce, but also because in Belgium, unlike in other countries, 
end-of-life decisions in minors can be openly discussed - even the more controversial 
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physician-assisted death. It is thus possible that acceptance towards requests for end-
of-life decisions is lower in other countries, where a less open culture of debate exists. 
Studies among other groups already indicate that people in Belgium hold generally 
more positive attitudes towards physician-assisted dying than do people in a lot of 
other countries.(53) Further research would be needed to investigate whether 
adolescents in other countries hold similar attitudes to the Flemish adolescents. A 
repeat study of the survey in Flemish secondary schools would also be interesting, as it 
would provide a first measure of adolescents’ attitudes after the Belgian law on 
euthanasia came into effect. Although minors are excluded from the law, it is possible 
that the debates around it have changed adolescents’ opinions. 
The results of our study on attitudes of physicians towards end-of-life decisions in 
minors showed a clear majority of Flemish physicians favorable to physician-assisted 
death in minors. This is an important finding, especially in the context of societal and 
political debate concerning the adaptation of the current law to extend its application 
to minors.(54-59) Nearly 70% of surveyed Flemish physicians involved in the care of 
dying children agreed with the thesis that the Belgian law on euthanasia should be 
extended. This result was even more distinct than previous findings among Flemish 
physicians involved in the care of dying infants and neonates, where 58% favored a law 
which would make termination of life possible in some cases.(60) This study was 
however conducted before the euthanasia law was enacted in Belgium, a process which 
may have influenced physicians’ attitudes.   
Physicians surveyed in our study generally did not favor an adaptation of the Belgian 
law on euthanasia by establishing clear age limits. This accords with most of the 
submitted bills to supplement the law on euthanasia, where generally no age limits are 
proposed.(55-59) Only one proposal put forward age limits, not to determine which 
minors would be eligible for euthanasia, but rather to determine when parental 
consent is needed.(54) In this proposal, the age limits determining the degree of 
parental involvement were modeled on the Dutch law on euthanasia, where parental 
consent is needed if the child has not yet reached the age of 16, and parents need only 
to be informed of their child’s wish if the child is 16 or older.(61) The Dutch euthanasia 
law additionally formulates an age limit for minors to validly request euthanasia: 
minors need to have reached the age of 12 in order to do so. This is of course an 
attractive way of formulating a law, and it has the advantage of providing objectively 
assessable criteria for the evaluation commissions. However, an age limit always 
remains arbitrary and raises the question why, for instance, a request for euthanasia by 
a competent 11-year old cannot be granted, whereas a request by an equally competent 
12-year old would be granted if all other evaluation criteria are met. Formulating a 
clear age limit thus does not take away all age discrimination, which is still one of the 
main reasons for including minors in a law on euthanasia. Clearly, the surveyed Flemish 
physicians are opposed to age limits if the Belgian law on euthanasia is ever to be 
extended. This was in line with Dutch pediatricians, of whom a majority do not agree 
with the existing age-limits in the Dutch law on euthanasia.(62) Our findings suggest to 
policy makers that there is support for an extension of the Belgian law among Flemish 
physicians involved in the care of dying children, albeit not by formulating age limits 
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but by focusing on competence. The current and past bills to supplement the law all 
included the competence of the patient as a prerequisite to formulating a valid 
request.(54-59) It is important for policy makers to understand the attitudes of 
physicians involved in the care of dying children, as these physicians will be a principal 
party in the decision-making process if euthanasia is ever to be legalized for minors in 
Belgium. Parents and children would be the other two principal parties in the process. 
While we have presented data above on how adolescents view the issue of euthanasia in 
children, many questions remain unanswered, such as how younger children and 
parents view these issues. From our attitude studies, we have already learnt that 
physicians and adolescents clearly value and appreciate parents as partners in decision-
making. 
An additional striking finding from our survey among Flemish physicians was that 
attitudes were significantly linked to actual end-of-life practices. This link was already 
reported in other studies, but our study was the first to demonstrate it in minors.(3;63) 
Notably, a positive attitude towards physician-assisted death was also positively related 
to continuous deep sedation. This already suggests that physician-assisted death and 
sedation are not two perfectly separated practices. Below we will go into this these 
more deeply. It was important to see that physicians’ decision-making in end-of-life 
situations is not only determined by the clinical characteristics of the patient’s 
condition, but also by their own attitudes and opinions on end-of-life decisions. This 
may have implications for clinical practice. If physicians do not communicate their own 
attitudes towards these issues to parents and patients, there is a possibility that major 
conflicts arise between all parties involved as to whether or which end-of-life decisions 
are to be taken at a certain point. While we have no indications from our data that 
major conflicts arose, we suggest that physicians articulate their attitudes towards end-
of-life decisions to parents and patients early enough. By doing so, parents and patients 
get a chance to learn what they can and cannot expect from their physician if end-of-
life decisions are ever considered. If parents or patients foresee that major conflicts 
may arise, they can prevent this by openly discussing the differences in opinions 
beforehand or even by seeking a second opinion, instead of being faced with a fait 
accompli. In any case, if attitudes are linked to actual practices, they cannot be 
disregarded by policy makers in the current debates on euthanasia in children.  
 
8.3.3. End-of-life decisions and decision-making 
 
As could be expected based on the existing body of literature, albeit often in limited 
settings and patient groups(64-78), our population-wide study demonstrated that end-
of-life decisions are also frequently taken in minors. Our study was only the second 
population-wide account of end-of-life decisions in children dying after infancy. The 
findings were remarkably similar to the only previous study in the Netherlands, where 
36% of all deaths in minors dying at age one to 17 in 2001 were also preceded by an end-
of-life decision.(10) When only non-sudden deaths are taken into consideration, the 
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proportion of end-of-life decisions was even higher in Flanders than in the Netherlands 
(78% vs. 66%). This difference could indicate a higher frequency of end-of-life decisions 
in Flanders than in the Netherlands, but it is more plausible that a time effect is 
influential: the frequency of end-of-life decisions in the total population rose 
significantly in Flanders between 2001 and 2007.(8) Flemish physicians strongly take 
expected quality of life into consideration as an argument for engaging in end-of-life 
decisions in children. The young age of children can be an important factor when 
weighing quality and quantity of life. While chronically ill patients in very old age are 
already approaching death, chronically ill children may still face a long life of agony 
and unbearable suffering if no intervention is made. Therefore, it is easy to understand 
why the expected quality of life plays an important role in a physician’s considerations.  
While the general pattern of end-of-life decisions in children in Flanders resembled the 
pattern found in the Netherlands (intensified alleviation of pain and symptoms was the 
most frequent, physician-assisted death the least frequent), there were some marked 
differences in the proportion of physician-assisted death.(10) In Flanders, nearly eight 
percent of all deaths were preceded by a decision which was explicitly intended to 
shorten the patient’s life, whereas a proportion of 2.7% was recorded in the 
Netherlands, and 3.8% among adults in Flanders.(10;79) Meanwhile, there were no cases 
of euthanasia recorded among children in Flanders, as compared to 0.7% (or an annual 
five cases) in the Netherlands. It is not surprising that euthanasia was more frequent in 
the Netherlands, where a the practice is legal for minors from the age of 12 on.(80) It 
was nonetheless striking that euthanasia did not occur in children in Flanders during 
an 18-month period. The fact that the practice is still illegal in Flanders does not 
preclude that it is used in practice. This was a novel and important finding, and should 
inform policy-makers who are debating the extension of the Belgian law on euthanasia. 
If an amendment to the law would be principally aimed at regulating existing practices 
among physicians, in order to protect them legally, our data suggest that an amended 
law would not substantially add to the actual legal protection of physicians, since they 
are apparently rarely or never faced with requests for euthanasia by minors. Evidently, 
a law should not necessarily be aimed at regulating existing practices. The amended 
law on euthanasia could also aim to eliminate age discrimination which is present in 
the existing law. To this end, it is irrelevant whether euthanasia occurs frequently or 
not, more important is that minors are no longer denied a privilege purely on the basis 
of an age criterion, without taking their competence into account. 
More pertinent to everyday pediatric end-of-life practice in Flanders than euthanasia 
seems to be the practice of life-ending without patient request. Physicians appear to 
take these decisions with more caution: they discuss the decision more often with other 
professional caregivers, and take more reasons into consideration when engaging in 
this practice than they do in other practices. This indicates that this kind of decision is 
also very hard for physicians to take. That does not take away the fact that, by engaging 
in the practice of life-ending without patient request, physicians expose themselves to 
legal prosecution. It is hard to see how an amended law on euthanasia could ever 
reassure physicians in this kind of practice. Characteristic to the practice is the absence 
of a valid request, which represents exactly one of the underlying principles of the law 
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on euthanasia: the right to self-determination. Apparently, requests for life-
termination do no occur among Flemish children. We can only hypothesize as to why 
these requests do not occur. Possibly, Flemish children are very resilient and prefer to 
fight for their lives until the very end.(81;82) Alternatively, the lack of a legal 
framework for children to validly request euthanasia may impede them from 
requesting it. It is possible that if the application of the Belgian law on euthanasia is 
extended, Flemish children will also request euthanasia, because they then have the 
opportunity to legally do so. Notably, physician-assisted death was requested by the 
parents in three quarters of cases, possibly because it is too hard for them to see their 
child suffering unbearably. In any case, the data suggest that pain control and palliative 
care are not always sufficient alternatives in end-of-life care for physicians and parents 
in Flanders. 
One may wonder whether the intentional life-ending of a patient who did not explicitly 
request it can ever be ethically justified. In answering this question, the four principles 
of ethics will have to be taken into consideration: respect for autonomy, beneficence, 
non-maleficence and  justice.(83) The active life-ending of a hopelessly and unbearably 
suffering patient can be regarded as an act of non-maleficence, with a compassionate 
intention of ending the patient’s suffering. By doing this, a physician would intend to 
safeguard a patient from a life full of unbearable pain and suffering, which fits the 
“primum non nocere” precept of the Hippocratic Oath. Additionally, prolonging the life 
of a patient, when only a life full of agony is to be expected can be regarded as an 
infliction of the principle of beneficence. However, physicians will always need to be 
careful not to violate the patient’s autonomy. Different ethical principles can conflict 
with each other, and physicians can face dilemmas in how to prioritize one of the 
principles in a particular situation. In assessing the ethical justifiability of an act of life-
ending, a distinction will have to be made between competent and incompetent 
patients. In incompetent patients, the principle of autonomy will understandably have 
a lower priority than the principles of beneficence and non-maleficence. Incompetent 
patients cannot make their own autonomous decisions, which makes it morally 
justifiable for physicians to act paternalistically on their behalf, albeit with respect for 
the patient’s best interests and parental rights. In incompetent patients, it can thus be 
ethical to terminate life without the patient’s explicit request, insofar as the principles 
of beneficence and non-maleficence are respected.(84) The situation is different where 
competent patients are concerned. In competent patients, the principle of autonomy 
will have a much higher priority, and it is hard to see how life-ending can ever be 
justified when it violates the patient’s autonomy, even when the principles of 
beneficence and non-maleficence are respected. 
Decision-making was shared with parents in most cases of all end-of-life decision. This 
is in accordance with most guidelines on pediatric end-of-life care, which recommend 
that parents should be involved in decision-making, and the Belgian law on patient 
rights which states that parents act as representatives of their minor children.(85-90) It 
also accords with the findings from our attitude studies described above, in which 
adolescents and physicians put a high premium on parental involvement in decision-
making. Discussion with parents however varied according to the type of end-of-life 
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decision concerned: in all cases of non-treatment decisions and physician-assisted 
death the decision was discussed with the parents, but in only 68% of cases of 
intensified alleviation of pain and symptoms. In Chapter 6 we hypothesized that this 
lower rate of discussion with parents when pain and symptom alleviation was 
intensified can be related to the fact that life-shortening is less certain in these cases. In 
non-treatment decisions and physician-assisted death, life-shortening is a necessary 
effect of the decision, and it is a reassuring part of quality decision-making that all 
these high impact decisions were indeed discussed with the parents.  
Minor patients, on the other hand, were seldom involved in decision-making 
themselves. This is in contradiction with existing guidelines and legal frameworks, 
which prescribe that minors should be involved in decision-making as much as 
possible, and in function of their maturity and competence. We found no evidence in 
our data that decision-making at the end-of-life in children fits a model of shared 
decision-making, which is however the recommended model.(38;91;91-97) Only a few 
studies are available on minor patients’ involvement in end-of-life decisions, but the 
15% involvement found in our study was parallel to the 16% found in a Dutch interview 
study among pediatricians.(10) In order to understand whether minor patient’s 
involvement was in fact less than optimal, it is necessary to know whether patients 
were competent or not at the time that decisions had to be made. Our findings suggest 
that minor patients were almost never deemed competent by the physician, compared 
with almost 13% in the Dutch interview study.(10) As in the Netherlands, the estimated 
lack of competence appeared to be related in our study to young age and a comatose 
condition in the patient. The first factor, very young age, is evidently a factor which 
complicates patient involvement. When patients are for instance too young to speak, it 
is hard to see how they can be involved in any meaningful way in decision-making. The 
ability to communicate is acknowledged to be a prerequisite for competence.(83) 
However, when children have acquired the skills to speak and to express themselves, a 
phase of development exists where meaningful discussion would be possible in 
principle, but would require extensive efforts by physicians to adapt their information 
to the developmental level of the child.(95;98-100) Using age as a criterion for not 
involving children in decision-making therefore seems to be an inadequate argument - 
at least when dealing with children who are already verbally skilled. Training health 
professionals to communicate better with children, to adapt the information to the 
developmental level of their minor patient, may not only improve the skills of health 
providers in fostering competence in their patients, but may also ultimately improve 
minor patient’s involvement in end-of-life decision making. This is a recommendation 
for existing training for pediatricians and nurses, as we know from studies in other 
countries that pediatricians and nurses currently still feel inadequately trained to face 
these end-of-life situations.(31;32;35;40;101-105)  
The second reported factor for not involving children in decision-making, the patients’ 
comatose condition, of course precludes any meaningful involvement. However, it 
remains possible that children were competent enough to be involved in decision-
making at some point before they became comatose. Unfortunately, our data were too 
limited to fully understand why children were not involved in decision-making, and 
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why they were found to be not competent. The findings suggest less than optimal 
involvement by minor patients, but further studies are required to investigate whether 
this was really the case. Prospective studies could help to better understand the 
physician’s consideration. An aspect of decision-making that remained unstudied in 
our survey was the complex interaction between physicians, parents and children. In 
this triad, parents may make an appeal on physicians to conceal information from the 
child/patient. In order to sketch a complete and detailed image of decision-making, 
these complex interactions should be included in future studies.    
 
8.3.4. Continuous deep sedation 
 
The proportion of continuous deep sedation at the end-of-life of children was, at 22% of 
all deaths, remarkably high. Although previous limited studies already suggested that 
sedation may be frequently used at the end of children’s lives, the proportion found 
across all settings and patient groups in Flanders was striking.(106-110) The proportion 
even surpassed that found in Flemish adults in 2007, which had already significantly 
increased since 2001.(8;111) This upward trend was also demonstrated in the 
Netherlands.(7) Our findings represented the first detailed account of continuous deep 
sedation at the end-of-life of children, where information about characteristics and the 
decision-making process was available. 
In Chapter 7 we have already tried to seek explanations for the high incidence of 
sedation in minors. In order to make clear interpretations about what role sedation 
plays at the end of children’s lives, it is necessary to make a distinction between 
different types of continuous deep sedation. At least four different types of sedation 
may occur at the end of life. The total proportion of 22% observed in our study is thus a 
combination of different practices, and the data suggest that all the different types 
have occurred in our study. A first type is “palliative” or “terminal” sedation, which is 
used as a last resort option to treat refractory symptoms in imminently dying patients. 
This type of sedation has been investigated frequently for the population of adult 
patients, and guidelines for good clinical practice have been formulated.(112-122) A 
second type of sedation is used to calm patients in order to facilitate certain 
treatments, such as ventilation after surgery. This second type of sedation is used when 
the main goal of treatment is curative, and the intention of professional caregivers is 
still to preserve the patient’s life. Our finding that artificial food and fluids were 
administered until death in just over half of cases of sedation may reflect this type of 
sedation. When cure is still the main goal of treatment, it is of course necessary to 
administer food and fluids to the patient. However, the patient’s condition may worsen 
while under sedation, and it may consequently become irreversibly impossible to bring 
the patient back to consciousness. A third type of sedation is an unintended 
consequence of a gradual increase in pain medication. Fourth, sedation may also 
sometimes be used as a covert form of intentional life-ending. In retrospect, the types 
of sedation described above would all be interpreted as continuous deep sedation until 
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death, but the conditions under which sedation was started may have been entirely 
different. Unfortunately, our study design did not allow for clearly distinguishing 
between different types of sedation. This, of course, complicates the interpretation of 
the findings. 
Besides being mostly used as a last resort option for symptom control, patients in our 
study were mostly sedated for one week or less. This was in line with previously 
formulated guidelines.(121;123-125) Yet, in more than a quarter of cases, patients were 
sedated for a week or longer. It is to be recommended that the duration of sedation be 
kept as short as possible, as the situation can be very distressing for the parents (see 
below). The drugs used were not always in line with recommendations. While 
benzodiazepines are recommended, minor patients appeared to be sedated by means of 
only morphine or morphine in combination with drugs other than benzodiazepines in 
about 30% of cases. The use of non-recommended drugs holds a risk of less than 
optimal sedation. However, as noted above, the cases where sedation was initiated by 
means of morphine may reflect situations where the doses of morphine were gradually 
increased in the context of intensified symptom control, and lowered conscience was 
an inevitable and unintended side-effect. This finding suggests that specific guidelines 
for sedation in children are necessary, or that existing guidelines in adults should 
become better known among pediatricians. 
While all guidelines on terminal or palliative sedation recommend that life-shortening 
should not be intended when engaging in sedation at the end of life(115;120;126;127), 
physicians indicated having at least co-intended to shorten the patient’s life in a 
quarter of cases in our study. This was slightly higher than the 17% life-shortening 
intention observed in Flemish adults who were continuously and deeply sedated until 
death in 2007.(128) Moreover, sedation was frequently terminated by physician-
assisted death, which was mostly requested by the parents, possibly because it is hard 
for parents to witness their child deeply sedated with no prospect of regaining 
conscience. Decisions to sedate patients at the end-of-life indeed have a profound 
impact on the families, as the patient is made unconscious and further communication 
between child and parents is rendered impossible. Under these circumstances, it is vital 
that decisions are made with great care and caution, and that practice and 
communication by physicians is optimized. Specific guidelines can help to further 
improve the practice in the future. The current findings on life-shortening intentions 
appear to contradict existing guidelines, and rather support the hypothesis that 
sedation is sometimes also used as a form of “slow euthanasia” in children.(129;130) 
This is an important and interesting finding, and warrants further study of the practice 
of continuous deep sedation at the end-of-life of children. 
Decision-making was comparable in continuous deep sedation and end-of-life 
decisions. In over 90% of cases, continuous deep sedation was neither consented to nor 
requested by the minor patients themselves. As noted above, our data are too limited 
too conclude unequivocally that decision-making was less than optimal, but the data 
suggest that it was. In other end-of-life decisions, the patient’s comatose condition was 
one of the main reasons why decisions were not discussed with the patient. This reason 
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seems not to suffice when physicians consider sedating a patient, as it can be 
reasonably expected that the patient was still conscious prior to the administration of 
sedatives. As with other end-of-life decisions, more research is needed to clarify the 
reasons for not involving minor patients in decision making where sedation is 
concerned. 
As in other end-of-life decisions, parents were involved in most cases; however they 
requested the sedation themselves in only 17% of cases. This suggests that the decision 
to sedate the patient is mostly physician-initiated. This is a reasonable expectation, as 
physicians indicated in nearly 85% of cases that there were no alternatives other than 
sedation to treat the patient’s symptoms. When patients suffer from refractory 
symptoms, physicians propose sedation as a last resort option for symptom control. 
This is in line with existing guidelines.(121;124;125;131) As the incidence of sedation is 
higher in children than in adults, one can wonder whether refractory symptoms are 
more frequent in children. We hypothesize that this is not necessarily the case, but that 
other factors come into play. A possible explanation is that physicians are more easily 
urged to resort to sedation, as probabilities for suboptimal symptom control are higher 
in children than in adults, as (especially young) children lack skills to verbalize their 
symptom burden and drugs are often less thoroughly tested for use in pediatric 
populations.(108;132-139) Physicians will then, understandably, prefer to treat 
symptoms maximally by means of sedation, rather than risking suboptimal pain 
control.   
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Chapter 9: Nederlandstalige samenvatting “Zorg en beslissingen 
aan het levenseinde van minderjarigen: studies naar attitudes 
en praktijk” 
 
9.1.  Situering en onderzoeksvragen 
 
Het overlijden van een kind is in moderne ontwikkelde samenlevingen een zeldzame 
gebeurtenis geworden. Ouders worden gemiddeld genomen zelden geconfronteerd met 
deze ingrijpende gebeurtenissen, maar blijven door het gedaalde geboortecijfer wel 
vaker kinderloos achter. De impact van het overlijden van een kind voor ouders, maar 
ook voor alle andere betrokkenen en nabestaanden, kan dan ook nauwelijks overschat 
worden. Doordat het overlijden van een kind zo zeldzaam is geworden, krijgen 
zorgverleners relatief weinig kansen om specifieke expertise op te bouwen in het 
begeleiden van terminaal zieke kinderen en hun families. 
Zorgverleners die werken met terminaal zieke kinderen worden daarenboven 
geconfronteerd met heel wat specifieke uitdagingen. Zo is het door de ontwikkelende 
competentie van minderjarigen moeilijk om correct in te schatten in welke mate zij 
betrokken kunnen of moeten worden bij beslissingen aan het levenseinde, en moet dit 
afgewogen worden tegen de beslissingsbevoegdheid van de ouders die optreden als 
vertegenwoordiger van hun kind. 
Deze uitdagingen komen zeer uitgesproken tot uiting wanneer beslissingen overwogen 
worden om het leveneinde te bespoedigen, waaronder: niet-behandelbeslissingen, 
opgedreven pijn- en symptoombestrijding en levensbeëindiging. Levensbeëindiging 
kan verder onderverdeeld worden in hulp bij zelfdoding, euthanasie (wanneer de 
patiënt er expliciet om verzoekt) en levensbeëindiging zonder verzoek. In België is 
euthanasie, hoewel wettelijk geregeld voor volwassenen, niet mogelijk voor 
minderjarigen. Dat neemt niet weg dat er hevig gedebatteerd wordt, zowel in de 
politiek als in de maatschappij, over het al dan niet uitbreiden van de huidige Belgische 
euthanasiewet. Opvallend genoeg zijn deze beslissingen, en de attitudes van de 
belangrijkste betrokken partijen, tot op heden nauwelijks onderzocht in Vlaanderen, 
waardoor de debatten niet ondersteund konden worden door empirische gegevens. 
Een bijkomende uitdaging voor zorgverleners is de planning van de plaats van 
levenseindezorg voor kinderen. Ouders verkiezen doorgaans om hun kind thuis te 
kunnen verzorgen aan het levenseinde, alsook om het thuis te laten overlijden. Dit is 
gerelateerd aan positievere rouwuitkomsten bij ouders en nabestaande broertjes en 
zusjes. Voor Vlaanderen en Europa zijn er echter geen onderzoeksgegevens 
beschikbaar over de plaats van overlijden van kinderen.  
In deze doctoraatsthesis hebben we daarom geprobeerd om een antwoord te vinden op 
volgende onderzoeksvragen: 
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-Waar sterven kinderen, en met welke factoren hangt dit samen? 
-Hoe staan minderjarigen tegenover levenseindebeslissingen? 
-Speelt ervaring met chronische ziekte een rol in de attitudes van jongeren ten 
opzichte van levenseindebeslissingen? 
-Hoe staan artsen tegenover levensbeëindiging bij minderjarigen en een aanpassing 
van de Belgische wet betreffende euthanasie naar minderjarigen toe? 
-Hoe vaak worden levenseindebeslissingen, waaronder continue diepe sedatie, 
genomen bij minderjarigen in Vlaanderen, België? 
-Wat zijn de kenmerken van deze beslissingen, en hoe worden ze genomen? 
 
9.2.  Methode 
 
Om bovenstaande onderzoeksvragen te beantwoorden, werd gebruik gemaakt van 
verschillende onderzoeksmethodes. 
De eerste onderzoeksvraag werd benaderd door gebruik te maken van een database die 
informatie bevat van overlijdenscertificaten van alle kinderen die tussen 1 en 17 jaar 
overleden in negen Europese landen. Binnen deze database werden de landen 
geselecteerd waarvoor de data toelieten om eenduidig thuis van andere plaatsen van 
overlijden te onderscheiden. Er werden zes landen behouden in de dataset: België 
(Vlaanderen en Brussel), Nederland, Italië (de regio’s Toscane en Emilia Romagna en de 
stad Milaan), Noorwegen, Wales en Engeland. Standaard beschrijvende statistieken 
werden gebruikt om de proportie thuissterfte te beschrijven. Chi-kwadraat statistieken 
en multivariate binomiale logistische regressies werden gebruikt om na te gaan welke 
factoren de kans op thuisoverlijden beïnvloeden voor kinderen die overlijden aan een 
complexe chronische aandoening. 
Om de twee onderzoeksvraag te beantwoorden, werd gebruik gemaakt van de gegevens 
van een studie uit 2000-2001 bij 1.769 Vlaamse jongeren uit het tweede en vierde 
leerjaar van het secundair onderwijs uit 20 scholen. Hypothetische 
gevalsbeschrijvingen werden voorgelegd aan deze jongeren. Alle gevallen beschreven 
een situatie waar een 14-jarige leed aan een terminale of aan een niet-terminale ziekte. 
Aan de deelnemers werd gevraagd of de patiënt de arts mocht verzoeken om 
verschillende levenseindebeslissingen. Daarnaast werden de deelnemers bevraagd naar 
hun mening over het recht van minderjarigen om geïnformeerd te worden over een 
terminale prognose, en of zij zelf zouden willen geïnformeerd worden wanneer ze zich 
in een gelijkaardige situatie zouden bevinden. Beschrijvende statistieken werden 
gebruikt om de attitudes van de deelnemers te beschrijven, en Chi-kwadraat 
statistieken om te testen of attitudes en patiëntkenmerken gerelateerd zijn. 
Een gelijkaardige methode werd gehanteerd om de derde onderzoeksvraag te 
beantwoorden. Er werden gegevens gebruikt van een interviewstudie uit 2004 bij 83 
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jongeren die minstens twee jaar voor aanvang van de studie behandeld werden voor 
kanker. Tijdens de interviews werden gelijkaardige gevalsbeschrijvingen voorgelegd 
aan de deelnemers, waarbij gelijkaardige vragen gesteld werden. Naast het beschrijven 
van de attitudes van deze jongeren, werden Chi-kwadraat toetsen gebruikt om na te 
gaan of de attitudes van deze jongeren verschilden van de jongeren uit de eerste studie. 
De overige onderzoeksvragen werden beantwoord aan de hand van een bevraging van 
alle artsen die gedurende een periode van 18 maanden overheen 2007 en 2008 het 
overlijden van een minderjarige hadden vastgesteld die in Vlaanderen overleed op een 
leeftijd van 1 tot en met 17 jaar. Naar de artsen die een dergelijk overlijden vaststelden 
werd een anonieme vragenlijst gestuurd, die handelde over levenseindebeslissingen, 
waaronder continue diepe sedatie, en het beslissingsproces voorafgaand aan de 
beslissing. Daarnaast werden de artsen aan de hand van 13 stellingen bevraagd over 
hun attitudes ten opzichte van euthanasie en levensbeëindiging bij minderjarigen. Om 
de anonimiteit van de artsen strikt te garanderen, werd een complexe 
verzendingsprocedure opgezet, met een advocaat als tussenpersoon tussen het 
Vlaamse Ministerie van Gezondheid die de vragenlijsten verstuurde en de 
onderzoekers, die de vragenlijsten pas ontvingen nadat ze volledig anoniem gemaakt 
waren door de advocaat. Om de respons te verhogen, werd de Total Design Method 
gebruikt, met een maximum van drie herinneringsbrieven voor artsen die niet 
antwoordden. Standaard beschrijvende statistieken werden gebruikt om de incidentie, 
kenmerken en het beslissingsproces bij levenseindebeslissingen te beschrijven. De 
attitudes van de artsen werden beschreven en daarnaast geclusterd in een K-means 
cluster analyse. Het behoren tot een bepaalde attitude-cluster werd gebruikt om na te 
gaan of attitudes en feitelijke handelwijzen gerelateerd waren aan elkaar. 
 
9.3.  Resultaten 
 
9.3.1. Plaats van overlijden 
 
In onze studie van 3.328 overlijdenscertificaten van kinderen die overleden tussen een 
en 17 jaar in zes Europese landen (België, Nederland, Italië, Noorwegen, Wales en 
Engeland) overleden er 1.037 (31.2%) ten gevolge van een complexe chronische 
aandoening (Hoofdstuk 2). De proportie thuissterfte verschilde tussen landen, en 
varieerde tussen 19.6% in Italië en 28.6% in Nederland. Kinderen die overleden ten 
gevolge van een complexe chronische aandoening hadden in alle bestudeerde landen 
een grotere kans om thuis te sterven dan kinderen die ten gevolge van andere oorzaken 
overleden. Ook hier verschilde de proportie thuissterfte tussen landen, en varieerde 
tussen 21.7% in Italië en 50.0% in Nederland. Subanalyses voor de groep van kinderen 
die ten gevolge van een complexe chronische aandoening overleden toonden aan dat 
thuissterfte waarschijnlijker was voor kinderen die aan kanker overleden en voor 
kinderen die stierven toen ze 11 jaar of ouder waren. De verschillen in proporties 
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thuissterfte tussen landen waren significant, en bleven significant nadat gecontroleerd 
werd voor mogelijk gerelateerde klinische en socio-demografische factoren. In 
vergelijking met Italië, stierven kinderen die aan een complexe chronische aandoening 
overleden in België en Nederland significant vaker thuis.  
 
9.3.2. Attitudes van Vlaamse jongeren en artsen ten opzichte van beslissingen 
aan het levenseinde 
 
De studie over attitudes ten opzichte van beslissingen aan het levenseinde van 1.769 
Vlaamse jongeren (Hoofdstuk 3) toonde aan dat 61% van hen een verzoek voor 
euthanasie aanvaardbaar zou vinden, 60% een verzoek voor opgedreven pijn- en 
symptoombestrijding en 69% een verzoek voor een niet-behandelbeslissing, wanneer 
een terminaal zieke 14-jarige patiënt erom zou verzoeken. Dit was significant hoger dan 
de 18% aanvaarding voor euthanasie en 50% aanvaarding van opgedreven pijn- en 
symptoombestrijding wanneer een niet-terminaal zieke minderjarige erom zou 
verzoeken. De mate van aanvaarding van verzoeken om levenseindebeslissing 
varieerde significant tussen de deelnemers: jongens, deelnemers ouder dan 14 jaar en 
deelnemers uit het algemeen secundair onderwijs, waren meer aanvaardend dan 
meisjes, deelnemers van 14 jaar of jonger en deelnemers uit technisch en beroeps 
secundair onderwijs. De deelnemers haalden verschillende omstandigheden aan die een 
arts ervan zouden moeten weerhouden om een dodelijk midden toe te dienen. De 
vaakst aangehaalde redenen waren dat het kind het niet wil (76%), dat het kind slecht 
geïnformeerd is over zijn/haar toestand (68%) en dat de mening van de ouders niet 
gevraagd werd (66%). Voor 40% van de deelnemers was het ontbreken van instemming 
van de ouders met de doodswens van hun kind een omstandigheid die een arts ervan 
zou moeten weerhouden een dodelijk middel toe te dienen. Negentig percent van de 
deelnemers vond dat een minderjarige het recht heeft om geïnformeerd te worden 
over de terminale prognose van een ziekte, terwijl 78% zelf wou willen ingelicht 
worden. Ook hier varieerden de attitudes naargelang de deelnemerskenmerken. 
Vrouwelijke deelnemers en deelnemers ouder dan 14 jaar vonden vaker dat 
minderjarigen het recht hebben om geïnformeerd te worden, en zij wilden ook vaker 
zelf geïnformeerd worden over een terminale prognose. Jongeren uit het algemeen en 
uit het technisch secundair onderwijs waren meer geneigd om te vinden dat jongeren 
het recht hebben om geïnformeerd te worden dan jongeren uit het beroeps secundair 
onderwijs.  
In een tweede studie bij jongeren (Hoofdstuk 4) probeerden we na te gaan of ervaring 
met chronische ziekte een verschil maakt voor levenseinde-attitudes. Hiertoe werden 
83 jongeren die minstens twee jaar voor de studie in behandeling waren geweest voor 
kanker geïnterviewd met vragen die vergelijkbaar waren aan de eerste studie. De 
responsgraad was 42%. Wanneer de casus handelde over een terminaal zieke patiënt 
vond 90.4% van de deelnemers een verzoek voor een niet-behandelbeslissing 
aanvaardbaar, en 84.3% een verzoek voor opgedreven pijn- en symptoombestrijding, 
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wat significant hoger was dan bij de jongeren uit de eerste studie. Bijna 64% van de 
geïnterviewde jongeren vond een verzoek om euthanasie van een terminaal zieke 
minderjarige aanvaardbaar, wat niet significant verschilde van de eerste studie. De 
aanvaarding van verzoeken om levenseindebeslissingen door niet-terminaal zieke 
jongeren verschilde niet significant tussen de twee studies, en was bij de geïnterviewde 
jongeren 27.7% voor een verzoek om een niet-behandelbeslissing, 38.6% tot 47.0% voor 
verzoeken om opgedreven pijn- en symptoombestrijding en 10.8% tot 20.5% voor een 
verzoek om euthanasie. Een ruime meerderheid van 92% van de geïnterviewden vond 
dat een arts geen dodelijk middel mag toedienen aan een kind dat niet goed 
geïnformeerd is over zijn/haar aandoening, wanneer het kind wil sterven omwille van 
de last die hij/zij vormt voor de ouders en wanneer de mening van de ouders niet 
gevraagd werd. Minder deelnemers vonden dat de ouders ook akkoord moeten gaan 
met de doodswens van hun kind. Bijna alle deelnemers waren het ermee eens dat een 
minderjarige het recht zou moeten hebben om geïnformeerd te worden over een 
terminale prognose. Zesentachtig percent gaf aan dat ze zelf zouden geïnformeerd 
willen worden wanneer ze met een gelijkaardige situatie geconfronteerd zouden 
worden. 
In onze studie van attitudes van artsen ten opzichten van levensbeëindiging bij 
minderjarigen (Hoofdstuk 5) werd een responsgraad van 70.5% bereikt. De attitude-
items van de vragenlijst werden ingevuld door 124 artsen. Negenenzestig percent van 
de artsen was het ermee eens dat de Belgische wet betreffende euthanasie zou moeten 
uitgebreid worden zodat ze ook betrekking heeft op minderjarigen, hoewel slechts 
26.6% vond dat dat zou moeten gebeuren door duidelijke leeftijdsgrenzen vast te 
leggen. De deelnemende artsen schatten de rol van de ouders duidelijk naar waarde: 
60.5% vond dat instemming van de ouders noodzakelijk is wanneer er beslissingen rond 
levensbeëindiging genomen worden en 52.4% vond dat het toedienen van een dodelijk 
middel aanvaardbaar kan zijn wanneer de ouders van een niet-competente 
minderjarige erom verzoeken. Slechts 21.8% van de artsen vond dat minderjarigen nog 
niet in staat zijn tot het een redelijke beoordeling van hun belangen wanneer het gaat 
om beslissingen rond leven en dood. Drieënzeventig percent van de artsen erkende dat 
het ondergaan van een chronische aandoening jongere minderjarigen beter in staat 
kunnen zijn om hun belangen redelijk te beoordelen dan hun gezonde leeftijdsgenoten. 
Tweeëntachtig percent vond dat met de wensen van oudere minderjarigen evenveel 
rekening moet gehouden worden als met die van volwassenen. De meningen waren 
verdeeld wanneer het over alternatieven voor levensbeëindiging ging: terwijl 47% het 
ermee eens was, bleef 29% van de artsen neutraal op de stelling dat palliatieve sedatie 
altijd verkozen moet worden boven de toediening van een lethaal middel bij kinderen. 
Ongeveer evenveel artsen waren het eens als oneens met de stelling dat goede 
pijncontrole en levenseindezorg euthanasie overbodig maken bij minderjarigen. Op 
basis van hun profiel van antwoorden, konden de artsen onderverdeeld worden in twee 
attitude-clusters. Twee derde van de artsen behoorde tot de “permissieve” cluster: zij 
waren meer geneigd om minderjarigen te beschouwen als competente beslissers aan 
hun leveneinde en beschouwen euthanasie en levensbeëindiging als aanvaardbare 
opties aan het leveneinde, onder bepaalde voorwaarden. Artsen uit deze cluster vonden 
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dat de Belgische euthanasiewet moet uitgebreid worden. Het overblijvende derde van 
artsen behoorde tot de “terughoudende” cluster: zij zijn eerder tegen euthanasie en 
levensbeëindiging bij minderjarigen, zelfs wanneer een competente minderjarige en/of 
de ouders erom zouden verzoeken. Zij zijn eerder geneigd om palliatieve sedatie te 
verkiezen boven de toediening van een lethaal middel, en zijn ervan overtuigd dat 
adequate pijncontrole en levenseindezorg euthanasie overbodig maken. Artsen uit deze 
cluster willen niet dat de Belgische euthanasiewet wordt uitgebreid. Het behoren tot de 
eerste of tweede cluster bleek significant gerelateerd aan de feitelijke praktijken van de 
bevraagde artsen. Artsen die tot de permissieve cluster behoorden namen vaker 
beslissingen om pijn- en symptoombestrijding op te drijven met een co-intentie om het 
leven van de patiënt te verkorten, alsook levensbeëindiging en continue diepe sedatie 
met een (co-)intentie om het leven van de patiënt te verkorten.  
 
9.3.3. Incidentie en kenmerken van beslissingen aan het levenseinde en sedatie 
bij minderjarigen in Vlaanderen, België 
 
In onze sterfgevallenstudie (Hoofdstuk 6) werd een responsgraad van 70.5% bereikt. Er 
werd gedetailleerde informatie verzameld voor 165 sterfgevallen van minderjarigen die 
overleden tussen de leeftijd van 1 en 17 jaar. Drieënvijftig percent van de patiënten 
overleed plots en geheel onverwacht. Het overlijden werd voorafgegaan door een 
levenseindebeslissing in 36.4% van alle sterfgevallen, waarvan 10.3% een niet-
behandelbeslissing was, 18.2% opgedreven pijn- en symptoombestrijding en 7.9% 
levensbeëindiging. Alle gevallen van levensbeëindiging gebeurden zonder dat de 
minderjarige patiënt er zelf om verzocht, maar in drie vierde van deze gevallen was er 
een verzoek van de ouders. De vaakst aangehaalde redenen om een 
levenseindebeslissing te nemen waren: er kon geen verbetering meer verwacht worden 
(84.6%), lage verwachte levenskwaliteit (61.5%) en het niet onnodig verlengen van het 
leven (50.0%). De helft van de patiënten waar een levenseindebeslissing werd genomen 
waren meer dan een jaar behandeld voor de ziekte die tot hun overlijden had geleid. 
Levenseindebeslissingen werden in het algemeen besproken met de ouders (85.2%), 
waarbij de bespreking er doorgaans op gericht was om samen tot een beslissing te 
komen. In slechts 15.4% van de gevallen werd de beslissing besproken met de 
minderjarige patiënt, voornamelijk omdat deze comateus, te jong of mentaal 
gehandicapt was. In onze studie werd er slechts één patiënt competent gevonden door 
de arts. 
In 21.8% van de gevallen werd de patiënt continu en diep gesedeerd tot aan het 
overlijden (Hoofdstuk 7). In een meerderheid van deze gevallen werden 
benzodiazepines gebruikt om de patiënt te sederen, hoewel in een kwart van de 
gevallen enkel morfine gebruikt werd. Patiënten werden doorgaans maar gedurende 
48u of minder gesedeerd, en slechts in 3.4% van de gevallen langer dan twee weken. In 
een meerderheid van de gevallen werden vocht en voeding kunstmatig toegediend tot 
aan het overlijden. In bijna een kwart van de gevallen gaf de arts aan de intentie of co-
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intentie te hebben gehad om het leven van de patiënt te verkorten. In 90.9% van de 
gevallen was er geen verzoek voor of instemming met sedatie vanwege de patiënt. De 
ouders werden echter wel betrokken in het beslissingsproces in de meeste, maar niet 
alle, gevallen. 
 
9.4.  Bespreking van de resultaten en implicaties 
 
In Hoofdstuk 8 worden de belangrijkste resultaten besproken en wordt ingegaan op de 
implicaties van de bevindingen voor de praktijk en verder onderzoek. Hieronder 
worden de belangrijkste elementen van deze bespreking kort samengevat.  
 
9.4.1. Plaats van overlijden van kinderen 
 
Uit onze studie bleek dat slechts een minderheid van 20 à 30% van alle kinderen thuis 
overlijdt in de zes onderzochte Europese landen. Kinderen die overleden ten gevolge 
van een complexe chronische ziekte stierven weliswaar vaker thuis, maar ook hier is er 
nog veel ruimte voor het verhogen van de proportie thuissterfte bij kinderen. De 
verschillen in thuissterfte tussen landen waren significant. Culturele en zorg-
organisatorische factoren kunnen aan de basis liggen van deze verschillen. 
Uit de resultaten komt verder naar voor dat kankerpatiënten doorgaans hogere kansen 
hebben om thuis te sterven dan kinderen die aan een andere chronische ziekte sterven. 
Deze bevinding is waarschijnlijk deels gerelateerd aan het beter voorspelbare 
ziekteverloop van kanker (waardoor planning van levenseindezorg beter mogelijk is), 
maar deels ook aan de expertise met levenseindezorg bij zorgverleners in kinder-
oncologische settings. Wanneer men de proportie thuissterfte bij kinderen in de 
toekomst verder wil verbeteren, zullen zorgverleners uit kinder-oncologische settings 
een belangrijke rol te spelen hebben. De bestaande pediatrische palliatieve 
thuiszorginitiatieven in Vlaanderen zijn reeds opgebouwd vanuit deze settings. Het 
verder structureel ondersteunen van deze initiatieven zal nodig zijn om palliatieve 
thuiszorg en thuisoverlijden mogelijk te maken, ook voor kinderen die aan andere 
aandoeningen dan kanker overlijden. Verder onderzoek is nodig om de evolutie van de 
proportie thuisoverlijden bij kinderen in Europa op te volgen, alsook om na te gaan in 
welke mate kwaliteitsvolle levenseindezorg kan gerealiseerd worden in de 
thuisomgeving van stervende kinderen.  
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9.4.2. Attitudes ten opzichte van beslissingen aan het levenseinde bij kinderen 
 
Uit onze studies van attitudes bij jongeren bleek dat jongeren over het algemeen 
genuanceerd denken over levenseindebeslissingen. Zij maken onderscheid naargelang 
het een terminale situatie betreft en naargelang het type levenseindebeslissing, op een 
gelijkaardige manier als volwassenen dat doen, wat lijkt te wijzen op een 
“uitkomstrationaliteit” in de manier hoe jongeren nadenken over 
levenseindebeslissingen. Ervaring met chronische ziekte had weliswaar enig effect op 
de attitudes, maar het algemene resultatenpatroon van de jongeren uit beide studies 
was vergelijkbaar. De deelnemende jongeren zouden over het algemeen geïnformeerd 
willen worden over een terminale prognose. Zij zien echter ook een belangrijke rol 
voor de ouders in het beslissingsproces bij levenseindebeslissingen. Hoewel de rol van 
de ouders erg gewaardeerd wordt door de jongeren, willen zij de uiteindelijke 
beslissingsbevoegdheid zelf dragen. Deze bevindingen schetsen een beeld van jongeren 
die gesteld zijn op hun autonomie wanneer het over levenseindebeslissingen gaat, maar 
passend in een beslissingsmodel van “shared decision-making”.  
De studie over attitudes van artsen toonde aan dat een meerderheid van Vlaamse 
artsen die betrokken waren bij levenseindezorg van minderjarigen, voorstander is van 
een uitbreiding van de huidige Belgische euthanasiewet zodat ze ook betrekking heeft 
op minderjarigen. Bovendien vonden de deelnemende artsen dat een wetsuitbreiding 
best niet kan gebeuren door strikte leeftijdsgrenzen vast te leggen, eerder waren zij 
voorstander van een aanpak gericht op competentie van de patiënt. Dit was een 
belangrijke bevinding, die de actuele debatten rond een eventuele wetsuitbreiding 
empirisch kan onderbouwen. Uit de antwoorden van de artsen bleek eveneens dat zij, 
net zoals jongeren dat doen, de rol van ouders bij het nemen van 
levenseindebeslissingen naar waarde schatten. 
Opvallend was verder dat de attitudes van artsen gerelateerd waren aan hun 
beslissingen in de praktijk. Dit gegeven kan belangrijke implicaties hebben voor de 
betrokken ouders en patiënten, aangezien beslissingen niet enkel gestuurd worden 
door de klinische situatie en de evolutie van de aandoening van de patiënt, maar ook 
door de houding van de arts. Ten einde conflicten tussen de betrokken partijen te 
vermijden aan het levenseinde, kan het aangewezen zijn voor artsen om met patiënt en 
ouders te communiceren over deze attitudes. Op die manier krijgen ouders en patiënt 
de kans om een realistisch verwachtingspatroon op te bouwen over welke beslissingen 
al dan niet overwogen kunnen worden.  
 
9.4.3. Beslissingen aan het levenseinde en beslissingsproces 
 
Medische beslissingen met een mogelijk levensverkortend effect worden frequent 
genomen bij kinderen tussen 1 en 17 jaar in Vlaanderen. De incidentie van 36% kwam 
overeen met de incidentie die eerder in Nederland gevonden werd, maar 
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levensbeëindiging was frequenter in Vlaanderen (7.9%) dan in Nederland (2.7%). 
Opvallend was dat euthanasie, i.e. levenbeëindiging op expliciet verzoek van de patiënt, 
niet voorkwam in Vlaanderen. In drie vierde van deze gevallen was er wel een verzoek 
van de ouders. Deze bevinding is belangrijk in de context van de debatten rond 
uitbreiding van de Belgische euthanasiewet. Het is moeilijk om te zien hoe een 
aangepaste euthanasiewet de artsen meer juridische zekerheid zou kunnen geven, 
wanneer zij levensbeëindigend handelen zonder een verzoek van de patiënt. Het 
verzoek van de patiënt is immers één van de fundamentele voorwaarden van de 
euthanasiewet, en laat toe om de autonomie van de patiënt te verhogen aan het 
levenseinde. Het reguleren van de bestaande praktijk zal dan ook niet de voornaamste 
beweegreden kunnen zijn van voorstellen tot wetsuitbreiding. Het opheffen van een 
bestaande leeftijdsdiscriminatie kan dan wel zijn.  
Ouders werden meestal betrokken in het beslissingsproces voorafgaand aan 
levenseindebeslissingen. De minderjarigen zelf werden daarentegen eerder zelden 
betrokken. Dit lijkt in te gaan tegen bestaande richtlijnen van diverse verenigingen, 
alsook van de Belgische wet betreffende de patiëntenrechten, die aanbevelen dat 
minderjarigen in functie van hun leeftijd en maturiteit dienen betrokken te worden bij 
beslissingen aan het levenseinde. Uit onze studie bleek dat slechts één minderjarige 
patiënt competent werd bevonden door de arts, en dat de jonge leeftijd en een 
comateuze toestand van de patiënt vaak aangehaalde redenen waren om beslissingen 
niet te bespreken met de minderjarige patiënt. Deze redenen kunnen soms valide 
redenen zijn om minderjarigen niet te betrekken, toch blijft de mogelijkheid bestaan 
dat enige bespreking mogelijk was indien ze aangepast werd aan het 
ontwikkelingsniveau van de patiënt (bij jonge kinderen), of in een vroeg stadium van 
het ziekteproces werd aangevat (bij comateuze patiënten). Onze studie was echter te 
beperkt om ondubbelzinnig na te gaan of de betrokkenheid van minderjarigen in 
realiteit onvoldoende was. Het verder uitklaren van de betrokkenheid van 
minderjarigen, en de rol die competentie en competentiebeoordeling hierin speelt, is 
dan ook een van de meest noodzakelijke aanbevelingen voor vervolgonderzoek die op 
basis van onze bevindingen naar voor geschoven kunnen worden. Verder onderzoek 
kan ook nagaan of artsen die werken met terminaal zieke kinderen zich voldoende 
opgeleid en ervaren voelen om te communiceren met kinderen, op een aangepast 
ontwikkelingsniveau, en of verdere verbeteringen aan de opleiding van pediaters de 
huidige praktijk zou kunnen verbeteren. 
 
9.4.4. Continue diepe sedatie 
 
Continue diepe sedatie, een praktijk die recent meer en meer aandacht krijgt, bleek 
eveneens vaak voor te komen bij kinderen in Vlaanderen. Dit is, voor zover wij weten, 
de allereerste studie die deze praktijk systematisch onderzocht heeft bij minderjarigen. 
Verschillende types van sedatie leken voor te komen in onze studie. Een eerste type is 
“terminale” of “palliatieve” sedatie, die gebruikt wordt als een laatste redmiddel voor 
169
Chapter 9 - Nederlandstalige samenvatting__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
onbehandelbare symptomen. Een tweede type van sedatie wordt gebruikt wanneer de 
behandeling van de patiënt nog gericht is op genezing. Sedatie kan dan soms gebruikt 
worden om bepaalde ondersteunende ingrepen, zoals beademing, mogelijk te maken. 
Een derde vorm van sedatie is een onbedoeld gevolg van een geleidelijke toename van 
de pijn- en symptoombestrijding. Ten vierde kan sedatie soms ook worden gebruikt als 
een verdoken vorm van opzettelijke levensbeëindiging. Terugkoppelend naar 
bestaande richtlijnen voor volwassenen, zagen we dat sedatie meestal in 
overeenstemming met deze richtlijnen gebeurde: artsen gaven aan dat er geen andere 
alternatieven waren om de symptomen te bestrijden en patiënten werden zelden 
langer dan twee weken gesedeerd. Anderzijds werden niet in alle gevallen de 
aanbevolen middelen gebruikt en gaven artsen in een vierde van de gevallen aan dat ze 
een intentie hadden om het levenseinde te bespoedigen. De gegevens laten dus niet toe 
om uit te sluiten dat sedatie bij kinderen soms aangewend wordt als een verdoken vorm 
van levensbeëindiging. De betrokkenheid van ouders en minderjarigen bij het 
beslissingsproces volgde hetzelfde patroon als bij de andere levenseindebeslissingen: 
ouders werden meestal betrokken, maar de minderjarige patiënten veel minder. Het 
patroon van resultaten leidt ons ertoe te suggereren dat specifieke richtlijnen over 
sedatie bij kinderen nuttig kunnen zijn om de praktijk in de toekomst te verbeteren. 
Meer onderzoek is echter nodig om na te gaan op welke punten eventuele richtlijnen 
zouden moeten verschillen van de bestaande richtlijnen, alsook om uit te klaren hoe 
vaak sedatie in de praktijk wordt aangewend als een palliatieve optie, dan wel als een 
ondersteuning om bepaalde curatieve en supportieve ingrepen te faciliteren. 
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Appendices 
 
Appendix 1 - Questionnaire “Attitudes of secondary school students” (Chapter 3) 
 
Vragenlijst attitude-onderzoek Vlaamse minderjarige scholieren 
2000-2001 
 
 
Q1 Doe je even mee? Druk met je vinger op start.  
 Q2 ja 
 neen 
 
Femke is een veertienjarig meisje met botkanker. Ze heeft veel pijn. Ook de 
behandelingen die ze ondergaat zijn erg pijnlijk. Iedereen, ook zijzelf, weet 
dat ze in het beste geval nog maar een paar jaar te leven heeft. Femke kan 
de pijn niet meer verdragen en wil graag doodgaan. Vind jij dat ze aan de 
dokter een spuitje met een dodelijk middel mag vragen, waardoor haar leven 
beëindigd wordt? 
ik weet het niet 
 Q3 ja 
 neen 
 
Vind jij dat ze mag vragen om de behandelingen stop te zetten? Haar leven 
wordt daardoor wel verkort. 
ik weet het niet 
 Q4 ja 
 neen 
 
Vind jij dat ze mag vragen om de pijnmedicatie te verhogen? Daardoor 
wordt haar leven misschien verkort. 
ik weet het niet 
 Q5 ja 
 neen 
 
Pieter is veertien jaar en heeft kanker. Door zijn ziekte is hij afhankelijk 
geworden van andere mensen. Hij moet zich aan iedereen letterlijk en 
figuurlijk blootgeven. Pieter kan bijvoorbeeld niet meer alleen naar het toilet 
gaan. Dat is dan een heel gedoe met vuilniszakken onder bed leggen, 
handschoenen omdoen, … Pieter beseft dat hij niet lang meer zal leven en 
hij verdraagt niet langer dat hem al zijn eer wordt ontnomen. Hij wil graag 
sterven.  Vind jij dat hij aan de dokter mag vragen om zijn levenseinde te 
versnellen? 
ik weet het niet 
 Q6 ja 
 neen 
 
Thomas is veertien jaar en heeft een spierziekte, waardoor hij langzaam aan 
het aftakelen is. Thomas vreest dat hij als een plant zal eindigen. Hij kan 
gerust nog meer dan tien jaar leven, maar toch wil hij niet meer verder 
leven.  Vind jij dat hij aan de dokter mag vragen om zijn levenseinde te 
versnellen? 
ik weet het niet 
 Q7 ja 
 neen 
 
Nathalie, veertien jaar, is ernstig verbrand over heel haar lichaam en 
gezicht. Ze heeft veel pijn en door de vele brandwonden kan ze zich niet 
meer goed bewegen. Nathalie wil zo niet verder leven, hoewel ze een 
normale levensverwachting heeft.  Vind jij dat ze aan de dokter een spuitje 
met een dodelijk middel mag vragen, waardoor haar leven beëindigd wordt? 
ik weet het niet 
 Q8 ja 
 neen 
 
Vind jij dat ze mag vragen op de pijnmedicatie te verhogen? Daardoor wordt 
haar leven misschien verkort. 
ik weet het niet 
 
171
Appendices__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
Q9 ja 
 neen 
 
Kevin, veertien jaar, heeft een ernstig accident gehad met de fiets. Hij is 
daardoor beide benen verloren. Bovendien moet hij ook nog zware en 
pijnlijke operaties ondergaan om in leven te blijven. Kevin wil niet blijven 
leven zonder benen.  Vind jij dat hij aan de dokter een spuitje met een 
dodelijk middel mag vragen, waardoor zijn leven beëindigd wordt? 
ik weet het niet 
 Q10 ja 
 neen 
 
Mag hij weigeren de operaties te ondergaan? 
ik weet het niet 
 Q11 ja 
 neen 
 
Katrien is veertien jaar en heeft een ziekte waardoor ze niet lang meer zal 
leven. Iedereen in haar omgeving weet dat ze binnenkort zal sterven. 
Katrien heeft reeds herhaaldelijk gevraagd of ze zal dood gaan, maar 
niemand wil het haar vertellen. Vind jij dat Katrien mag weten dat ze zal 
doodgaan? 
ik weet het niet 
 Q12 ja 
 neen 
 
Zou  jij het willen weten? 
ik weet het niet 
 Q13 0 tot 8 jaar 
 9 tot 12 jaar 
 13 tot 15 jaar 
 16 tot 17 jaar 
 ouder dan 17 jaar 
 eender welke leeftijd 
 nooit 
 
Vanaf welke leeftijd mag de dokter het kind een spuitje met een dodelijk 
middel geven, in de veronderstelling dat het kind het zelf wil. 
ik weet het niet 
 Q14 het kind is stervende, maar wil geen spuitje met een dodelijk middel 
 het kind is niet goed ingelicht over zijn toestand 
 het kind wil niet blijven leven als het door zijn ziekte zijn ouders tot 
last is 
 de ouders zijn het niet eens met de doodswens van het kind 
 de dokter heeft de mening van de ouders niet gevraagd 
 
Wanneer mag volgens 
jou de dokter GEEN 
spuitje met een dodelijk 
middel geven? 
het kind wil alleen maar dood omdat het door zijn ziekte verdrietig is 
 Q15 een jongen 
 
Je bent… 
een meisje 
 Q16 jonger dan 12 jaar 
 12 jaar 
 13 jaar 
 14 jaar 
 15 jaar 
 16 jaar 
 17 jaar 
 
Je bent… 
ouder dan 17 jaar 
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Appendix 2 - Questionnaire “Attitudes of cancer survivors” (Chapter 4) 
 
Mijn geboortedatum is .................................... 
Ik ben 
 
1 Een jongen 
2 Een meisje 
Ik ga naar school 1 In het Algemeen 
Secundair Onderwijs 
2 In het Buitengewoon 
Secundair Onderwijs 
Toen de diagnose van kanker gesteld werd, was ik ................. jaar oud 
De precieze diagnose die gesteld werd, was ……………………… 
Femke is een veertienjarig meisje met botkanker. Ze heeft 
veel pijn. Ook de behandelingen die ze ondergaat zijn erg 
pijnlijk. Iedereen, ook zijzelf, weet dat ze in het beste geval 
nog maar een paar jaar te leven heeft. Femke kan de pijn niet 
meer verdragen en wil graag doodgaan. Vind jij dat ze aan de 
dokter een spuitje met een dodelijk middel mag vragen, 
waardoor haar leven beëindigd wordt? 
1 Ja 
2 Neen 
3 Ik weet het niet 
Vind jij dat ze mag vragen om de behandelingen stop te 
zetten? Haar leven wordt daardoor wel verkort. 
1 Ja 
2 Neen 
3 Ik weet het niet 
Vind jij dat ze mag vragen om de pijnmedicatie te verhogen? 
Daardoor wordt haar leven misschien verkort. 
1 Ja 
2 Neen 
3 Ik weet het niet 
Pieter is veertien jaar en heeft kanker. Door zijn ziekte is hij 
afhankelijk geworden van andere mensen. Hij moet zich aan 
iedereen letterlijk en figuurlijk blootgeven. Pieter kan 
bijvoorbeeld niet meer alleen naar het toilet gaan. Dat is dan 
een heel gedoe met vuilniszakken onder bed leggen, 
handschoenen omdoen, … Pieter beseft dat hij niet lang meer 
zal leven en hij verdraagt niet langer dat hem al zijn eer wordt 
ontnomen. Hij wil graag sterven. 
Vind jij dat hij aan de dokter mag vragen om zijn levenseinde 
te versnellen? 
1 Ja 
2 Neen 
3 Ik weet het niet 
 
Thomas is veertien jaar en heeft een spierziekte, waardoor hij 
langzaam aan het aftakelen is. Thomas vreest dat hij als een 
plant zal eindigen. Hij kan gerust nog meer dan tien jaar leven, 
maar toch wil hij niet meer verder leven. 
Q: Vind jij dat hij aan de dokter mag vragen om zijn 
levenseinde te versnellen? 
1 Ja 
2 Neen 
3 Ik weet het niet 
 
Nathalie, veertien jaar, is ernstig verbrand over heel haar 
lichaam en gezicht. Ze heeft veel pijn en door de vele 
brandwonden kan ze zich niet meer goed bewegen. Nathalie 
wil zo niet verder leven, hoewel ze een normale 
levensverwachting heeft. 
Q: Vind jij dat ze aan de dokter een spuitje met een dodelijk 
middel mag vragen, waardoor haar leven beëindigd wordt? 
1 Ja 
2 Neen 
3 Ik weet het niet 
 
173
Appendices__________________________________________________________________________________________________
__________________________________________________________________________________________________
  
 
Vind jij dat ze mag vragen op de pijnmedicatie te verhogen? 
Daardoor wordt haar leven misschien verkort. 
1 Ja 
2 Neen 
3 Ik weet het niet 
Kevin, veertien jaar, heeft een ernstig accident gehad met de 
fiets. Hij is daardoor beide benen verloren. Bovendien moet hij 
ook nog zware en pijnlijke operaties ondergaan om in leven te 
blijven. Kevin wil niet blijven leven zonder benen. 
Q: Vind jij dat hij aan de dokter een spuitje met een dodelijk 
middel mag vragen, waardoor zijn leven beëindigd wordt? 
1 Ja 
2 Neen 
3 Ik weet het niet 
 
Mag hij weigeren de operaties te ondergaan? 
 
1 Ja 
2 Neen 
3 Ik weet het niet 
Katrien is veertien jaar en heeft een ziekte waardoor ze niet 
lang meer zal leven. Iedereen in haar omgeving weet dat ze 
binnenkort zal sterven. Katrien heeft reeds herhaaldelijk 
gevraagd of ze zal dood gaan, maar niemand wil het haar 
vertellen. 
Vind jij dat Katrien mag weten dat ze zal doodgaan? 
1 Ja 
2 Neen 
3 Ik weet het niet 
 
Zou  jij het willen weten? 
 
1 Ja 
2 Neen 
3 Ik weet het niet 
Vanaf welke leeftijd mag de dokter het kind een spuitje met 
een dodelijk middel geven, in de veronderstelling dat het kind 
het zelf wil. 
1 Vanaf ..... jaar 
2 Eender welke leeftijd 
3 nooit 
4 Ik weet het niet 
Evelien is stervende, maar wil geen spuitje met een dodelijk 
middel. Vind jij dat de dokter een spuitje met een dodelijk 
middel mag geven? 
1 Ja 
2 Neen 
3 Ik weet het niet 
Mieke is niet goed ingelicht over haar toestand. Vind jij dat de 
dokter een spuitje met een dodelijk middel mag geven? 
 
1 Ja 
2 Neen 
3 Ik weet het niet 
Johan wil niet blijven leven als hij door zijn ziekte zijn ouders 
tot last is. Vind jij dat de dokter een spuitje met een dodelijk 
middel mag geven? 
1 Ja 
2 Neen 
3 Ik weet het niet 
De ouders zijn het niet eens met de doodswens van het kind. 
Vind jij dat de dokter een spuitje met een dodelijk middel mag 
geven? 
1 Ja 
2 Neen 
3 Ik weet het niet 
De dokter heeft de mening van de ouders niet gevraagd. Vind 
jij dat hij een spuitje met een dodelijk middel mag geven? 
1 Ja 
2 Neen 
3 Ik weet het niet 
Sander wil dood omdat hij door zijn ziekte verdrietig is. Vind jij 
dat de dokter een spuitje met een dodelijk middel mag geven? 
1 Ja 
2 Neen 
3 Ik weet het niet 
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          Appendix 3: Questionnaire “End-of-life decisions in children” (Chapter 5-7) 
 
 
 
 Algemeen 
1 U was met betrekking tot dit sterfgeval werkzaam als…  specialist (of specialist in opleiding) 
   welk specialisme?   
   huisarts (of huisarts in opleiding) 
   andere   
    2 Van wanneer dateerde uw eerste contact met de patiënt?  vóór of tijdens het overlijden 
   na het overlijden  door naar vraag 33 
    
3 Ging het om een plotseling en geheel onverwacht overlijden?  ja  door naar vraag 30 
   neen 
    
4  samenwonende ouders/vertegenwoordigers 
 
Probeer de gezinssituatie van de patiënt te omschrijven. 
  alleenstaande ouder/vertegenwoordiger 
   andere   
    
 Medische handelwijzen 
5 Heeft u of een andere arts één of meer van de volgende handelwijzen uitgevoerd of doen uitvoeren, rekening houdend met de 
mogelijkheid dat deze handelwijze het levenseinde van de patiënt zou bespoedigen? – zowel a, b als c beantwoorden – 
 
 a.  Het niet instellen van een behandeling*?  ja 
   neen 
      Zo ja, welke behandeling(en) betrof dit?    
          
    
 b.  Het staken van een behandeling*?  ja 
   neen 
      Zo ja, welke behandeling(en) betrof dit?    
          
      ja 
 
c.  Het intensiveren van pijn- en/of symptoombestrijding    
     d.m.v. één of meer middelen?  neen  door naar vraag 7 
          Zo ja, welk(e) middel(en) werd(en) gebruikt?    morfine of ander opiaat 
      - meerdere antwoorden mogelijk -   benzodiazepine 
   ander middel   
 * onder ‘behandeling’ wordt ook de kunstmatige toediening    
   van vocht en/of voeding verstaan.  
  
    
6  ja 
 
Was het bespoedigen van het levenseinde mede het doel  
van het intensiveren van pijn- en/of symptoombestrijding?  neen 
   
7 Was het overlijden het gevolg van één of meer van de volgende handelwijzen, waartoe door u of een andere arts is besloten 
met het uitdrukkelijke doel het levenseinde van de patiënt te bespoedigen? – zowel a als b beantwoorden – 
 
 a.  Het niet instellen van een behandeling*?  ja 
   neen 
      Zo ja, welke behandeling(en) betrof dit?    
          
     b.  Het staken van een behandeling*?  ja 
   neen 
      Zo ja, welke behandeling(en) betrof dit?    
          
 * onder ‘behandeling’ wordt ook de kunstmatige toediening   
   van vocht en/of voeding verstaan. 
  
    
8  ja 
 
Was het overlijden het gevolg van het gebruik van een  
middel dat door u of een andere arts werd voorgeschreven, 
verstrekt of toegediend met het uitdrukkelijke doel het 
levenseinde van de patiënt te bespoedigen (of de patiënt in 
staat te stellen zelf het leven te beëindigen)? 
 neen 
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     Naam Toedieningswijze Dosis 
 
spierverslapper (curare 
of gelijkaardig middel) 
      
        
 Zo ja, welk(e) middel(en) betrof dit?  
– meerdere antwoorden mogelijk – 
 barbituraat       
             benzodiazepine       
             morfine of ander opiaat       
             ander middel       
      de patiënt zelf 
  u of een andere arts 
 
Zo ja, door wie is (zijn) dit (deze) middel(en) 
toegediend? 
– meerdere antwoorden mogelijk – 
 verpleegkundige 
   iemand anders   
    
  ja 
 
Indien het (de) middel(en) niet door een arts 
werd(en) toegediend, was u of een andere arts 
aanwezig bij de toediening? 
 neen 
 
 
Indien ‘ja’ is geantwoord op één van de onderdelen van de vragen 5 tot en met 8  door naar vraag 9 
 
Indien op geen enkel onderdeel van de vragen 5 tot en met 8 ‘ja’ is geantwoord  door naar vraag 23 
 
 
 De laatstgenoemde handelwijze 
Let op: de vragen 9 tot en met 22 hebben betrekking op de laatstgenoemde handelwijze, dit wil zeggen op het laatst 
gegeven ‘ja’-antwoord bij de vragen 5 tot en met 8 
9  meer dan een half jaar 
 
Met hoeveel tijd is het leven van de patiënt naar uw 
schatting verkort door de laatstgenoemde handelwijze?  één tot zes maanden 
   één tot vier weken 
   één tot zeven dagen 
   minder dan 24 uur 
   heeft waarschijnlijk geen verkorting van de levensduur 
gegeven 
    
10  ja 
  patiënt had geen ouder(s)/vertegenwoordiger(s)  door 
naar vraag 13 
 
Heeft u of een andere arts de (mogelijke) bespoediging van  
het levenseinde besproken met ouder(s)/vertegenwoor-
diger(s) voordat werd besloten tot de laatstgenoemde 
handelwijze? 
 neen  door naar vraag 12 
      samen tot een beslissing te komen 
 
Welk doel had de bespreking? 
- meerdere antwoorden mogelijk -  verkrijgen van toestemming 
   op de hoogte brengen van de reeds genomen beslissing 
   anders   
    
11  ja  door naar vraag 13 
 
Is de beslissing over de laatstgenoemde handelwijze  
genomen na een uitdrukkelijk verzoek van 
ouder(s)/vertegenwoordiger(s)? 
 neen  door naar vraag 13 
    
12  patiënt had geen ouder(s)/vertegenwoordiger(s)  door 
naar vraag 13   
  emotioneel te belastend voor ouder(s)/vertegenwoordiger(s) 
  te weinig tijd 
  ouder(s)/vertegenwoordiger(s) was/waren niet bereikbaar 
 
Om welke reden(en) is de (mogelijke) bespoediging van het 
levenseinde door de laatstgenoemde handelwijze niet met 
de ouder(s)/vertegenwoordiger(s) besproken?  
-meerdere antwoorden mogelijk- 
 patiënt wilde niet dat dit met ouder(s)/vertegenwoordiger(s) 
besproken werd 
   de beslissing over (mogelijke) bespoediging van het 
levenseinde komt toe aan de patiënt, en niet aan de 
ouders(s)/vertegenwoordiger(s) 
   andere reden   
    
13  ja 
 
Heeft u of een andere arts de (mogelijke) bespoediging van  
het levenseinde door die laatstgenoemde handelwijze 
besproken met de patiënt? 
 neen  door naar vraag 17 
    
14  ja 
 
Achtte u de patiënt tijdens deze bespreking in staat zijn of  
haar situatie te overzien en daarover op adequate wijze een 
besluit te nemen? 
 neen  
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 15  ja, na een mondeling verzoek 
  ja, na een schriftelijk verzoek 
 
Is de beslissing over de laatstgenoemde handelwijze  
genomen na een uitdrukkelijk verzoek van de  
patiënt? 
 ja, na een mondeling én een schriftelijk verzoek 
   neen  door naar vraag 20 
    
16  ja  door naar vraag 20 
 
Achtte u de patiënt tijdens dit verzoek in staat zijn of haar  
situatie te overzien en daarover op adequate wijze een 
besluit te nemen? 
 neen  door naar vraag 20 
    
17  ja 
 
Achtte u de patiënt in staat zijn of haar situatie te overzien 
en daarover op adequate wijze een besluit te nemen?  neen 
    
18  de patiënt was te jong 
 
 
 de patiënt was niet in staat om de handelwijze adequaat  
te beoordelen 
 
Om welke reden is de (mogelijke) bespoediging van het  
levenseinde door de laatstgenoemde handelwijze niet met 
de patiënt besproken? 
– meerdere antwoorden mogelijk – 
 de patiënt was subcomateus of buiten bewustzijn 
   de patiënt was verstandelijk gehandicapt 
   de patiënt had een psychiatrische stoornis 
   de laatstgenoemde handelwijze was duidelijk het beste voor 
de patiënt 
   de bespreking zou de patiënt meer schaden dan goed doen 
   andere reden   
    
19  ja, uitdrukkelijk 
  ja, maar niet uitdrukkelijk 
 
Had de patiënt, voor zover u bekend, ooit een wens tot  
bespoediging van het levenseinde kenbaar gemaakt? 
 neen 
    
20  ja, met collega-arts(en) 
  ja, met verpleegkundige(n) 
  ja, met anderen   
 
Heeft u of een andere arts de (mogelijke) bespoediging van  
het levenseinde met andere professionele zorgverleners 
besproken voordat werd besloten tot de laatstgenoemde  
handelwijze? 
– meerdere antwoorden mogelijk –  neen 
    
21  de patiënt had (ernstige) pijn 
  de patiënt had andere (ernstige) symptomen 
 
Wat was (waren) de belangrijkste reden(en) om te besluiten  
tot de laatstgenoemde handelwijze? 
– meerdere antwoorden mogelijk – 
 verzoek of wens van ouder(s)/vertegenwoordiger(s) 
   verzoek of wens van de patiënt 
   verwacht (verder) lijden van de patiënt 
   er was geen uitzicht op verbetering 
   het leven niet onnodig verlengen 
   geringe verwachte levenskwaliteit 
   situatie werd ondraaglijk voor de naasten 
   verlies van waardigheid 
   andere reden, desgewenst toelichten bij vraag 32 
    
  verzoek van ouder(s)/vertegenwoordiger(s) 
  verzoek van de patiënt 
 
Indien zowel het verzoek van de ouders als het verzoek van  
de patiënt werd aangeduid: welk had het meeste invloed op  
de uiteindelijke besluitvorming? 
 beide verzoeken even veel 
    
22  niet-behandelbeslissing 
  symptoombestrijding 
 
Welke term past volgens u het best bij de laatstgenoemde  
handelwijze? 
– slechts één antwoord mogelijk – 
 palliatieve of terminale sedatie 
   levensbeëindiging uit compassie 
   euthanasie 
   hulp bij zelfdoding 
   andere   
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 Zorg en behandeling 
23  één tot zeven dagen 
 
Hoe lang is de patiënt in behandeling geweest voor de  
aandoening die tot zijn of haar overlijden heeft geleid?  één tot vier weken 
   één tot drie maanden  
   drie tot zes maanden  
   zes maanden tot een jaar 
   meer dan een jaar 
    24  genezing  
 
Waar was de behandeling tijdens de laatste week vóór het  
overlijden in hoofdzaak op gericht?  levensverlenging 
   comfort 
    25  ja, met LevensEinde Informatie Forum-arts(en) (LEIF) 
  ja, met palliatieve zorg-arts(en) 
 
Is er een bespreking geweest met zorgverleners     
gespecialiseerd in levenseindezorg? 
– meerdere antwoorden mogelijk – 
 ja, andere   
   neen 
26 In welke mate waren naar uw schatting de volgende symptomen of verschijnselen bij de patiënt aanwezig tijdens de laatste 24 
uur vóór het overlijden - ondanks eventuele behandeling? 
 0 1 2 3 4 5 6 7 8 9 10  
geen pijn            ergst mogelijke pijn 
niet vermoeid            ergst mogelijke vermoeidheid 
niet misselijk            ergst mogelijke misselijkheid 
niet depressief            ergst mogelijke depressie 
niet angstig            ergst mogelijke angst 
niet suf            ergst mogelijke sufheid 
best mogelijke eetlust            slechtst mogelijke eetlust 
best mogelijk gevoel van welbevinden            slechtst mogelijk gevoel van welbevinden 
niet kortademig            ergst mogelijke kortademigheid 
bij bewustzijn            comateus 
niet verward            ergst mogelijke verwardheid 
 
27  ja 
 
Werd de patiënt tot aan het overlijden continu in diepe  
sedatie of coma gehouden d.m.v. één of meer middelen?  neen  door naar vraag 28 
     Welk(e) middel(en) werd(en) daartoe gebruikt?   midazolam 
 – meerdere antwoorden mogelijk –  ander benzodiazepine 
   morfine of ander opiaat 
   ander middel   
       uren 
  
Hoe lang vóór het overlijden werd gestart met het continu  
diep sederen van de patiënt?  dagen 
    weken 
      ja, continu tot aan het overlijden 
 
Kreeg de patiënt daarbij kunstmatig vocht en/of voeding  
toegediend?  ja, maar niet tot aan het overlijden 
   neen 
      ja, met instemming van de patiënt 
  ja, op verzoek van de patiënt 
 
Is de beslissing over het continu diep sederen genomen met 
instemming en/of op verzoek van de patiënt? 
- meerdere antwoorden mogelijk -   
 neen 
    
  ja, met instemming van de naasten  
  ja, op verzoek van de naasten 
 
Is de beslissing over het continu diep sederen genomen met 
instemming en/of op verzoek van de naasten?   
- meerdere antwoorden mogelijk – 
 neen 
    
  neen 
  ja, symptoombestrijding zonder continue diepe sedatie 
 
Waren er naast continue diepe sedatie alternatieven om de 
symptomen te behandelen? 
- meerdere antwoorden mogelijk - 
 ja, maar alleen levensbeëindiging 
   ja, andere   
      wetende dat dit het levenseinde niet zou bespoedigen 
  rekening houdend met de mogelijke bespoediging van het 
levenseinde 
 
Deze wijze van diep sederen, al dan niet in combinatie met 
het kunstmatig toedienen van vocht en/of voeding, werd 
uitgevoerd... 
 mede met het doel het levenseinde te bespoedigen 
   met het uitdrukkelijke doel het levenseinde te bespoedigen 
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 28  ja 
  neen  door naar vraag 29                                     Dosering 
 
Heeft de patiënt morfine en/of een ander opiaat  
toegediend gekregen tijdens de laatste 24 uur vóór het  
overlijden?   Middel (laatste 24u) 
  Pleisters  fentanyl (o.a. Durogesic
®
) µg/uur 
    buprenorfine (o.a. Transtec
®
) µg/uur 
  
Naam van het (de) middel(en) en dosering in de laatste  
24 uur vóór het overlijden?  
– meerdere antwoorden mogelijk – 
Pomp  morfine  mg 
     tramadol mg 
     fentanyl mg 
   Injecties  morfine mg 
     piritramide (o.a. Dipidolor
®
) mg 
   Drank  morfine mg 
   Tabletten  morfine retard (o.a. MS Contin
®
) mg 
     morfine (o.a. MS Direct
®
) mg 
     tramadol mg 
     gabapentine (o.a. Neurontin
®
) mg 
   Druppels  tramadol (o.a. Tramal
®
) mg 
     Anders  middel mg 
    toedieningswijze     
      ja 
 
Is een hogere dosis gegeven dan nodig was om pijn en/of 
andere symptomen te bestrijden?  neen 
       uren 
  
Hoe lang vóór het overlijden werd gestart met het  
toedienen van de morfine en/of een ander opiaat?  dagen 
    weken 
      geen verhoging  geleidelijke 
verhoging 
 sterke verhoging 
laatste dag 
  
 
 
   
       
 
 
 
 
 
 
Welke figuur geeft het beste het beloop van de dosering  
van de morfine en/of een ander opiaat weer in de laatste  
3 dagen vóór het overlijden van de patiënt? 
          3         2         1        0         3         2         1        0           3         2         1        0 
    29  ja  
 
Heeft de patiënt benzodiazepine(s) toegediend gekregen  
tijdens de laatste 24 uur vóór het overlijden?  neen   door naar vraag 30                                   Dosering 
  Naam Toedieningswijze (laatste 24u) 
        
        
 
Naam van het (de) middel(en), toedieningswijze en  
dosering in de laatste 24 uur vóór het overlijden? 
       
      ja, namelijk  (een van) de ouder(s) 
  de patiënt 
30 Hebben de patiënt en/of de ouders een uitdrukkelijk verzoek 
om levensbeëindiging gedaan dat niet werd ingewilligd? 
 
  beiden 
   neen  door naar vraag 31 
     Om welke reden(en) werd dit verzoek niet ingewilligd?  de patiënt overleed voordat het tot inwilliging kon komen 
 – meerdere antwoorden mogelijk –  de patiënt was niet terminaal ziek 
   het lijden was niet ondraaglijk 
   de medische toestand was niet uitzichtloos 
   het was geen weloverwogen verzoek 
   het was geen vrijwillig verzoek 
   ontbreken van instemming van de patiënt 
   ontbreken van instemming van ouders/vertegenwoordigers 
   de patiënt trok het verzoek weer in 
   vanwege instellingsbeleid 
   vanwege principiële bezwaren tegen levensbeëindiging in 
het algemeen 
   vanwege principiële bezwaren tegen levensbeëindiging bij 
minderjarigen 
   uit vrees voor juridische consequenties 
   andere reden, desgewenst toelichten bij vraag 32 
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 31 Hoe tevreden bent u, achteraf bekeken, met het verloop van het levenseinde van de patiënt? 
  0 1 2 3 4 5 6 7 8 9 10  
 niet tevreden            heel tevreden 
 Hoe schat u de tevredenheid van de naasten hieromtrent in? 
  0 1 2 3 4 5 6 7 8 9 10  
 niet tevreden            heel tevreden 
32  ja, fysieke nazorg 
  ja, emotionele/psychologische nazorg 
  ja, sociale/materiële nazorg 
  nee, maar zij hadden aangegeven hier geen behoefte aan 
te hebben 
 
Kregen de ouder(s)/vertegenwoordiger(s) een of andere 
vorm van nazorg aangeboden na het overlijden van hun 
kind? 
- meerdere antwoorden mogelijk -  
 nee 
     Beweringen/stellingen 
33  OPGELET : Indien U deze vraag 33 reeds eerder heeft ingevuld in het kader van dit onderzoek   ga door naar vraag 34     
De volgende vragen gaan niet meer specifiek over dit overlijden, maar over uw mening of opvattingen in het 
algemeen over minderjarige patiënten die zich in een situatie van ondraaglijk en uitzichtloos lijden bevinden.   
Gelieve bij elke stelling/bewering het antwoord aan te duiden dat het best bij u past. 
  volledig 
oneens 
-- 
eerder 
oneens 
- 
noch eens, 
noch oneens 
-/+ 
eerder 
eens 
+ 
volledig 
eens 
++ 
1 De huidige euthanasiewet moet aangepast worden zodat ze ook betrekking heeft op 
minderjarigen. 
          
2 Als de euthanasiewet wordt uitgebreid tot minderjarigen, moet dat gebeuren door 
duidelijke minimum leeftijdsgrenzen vast te leggen.  
          
3 Minderjarigen zijn, als het gaat om beslissingen rond leven en dood, nog niet in staat 
tot een redelijke beoordeling van hun belangen. 
          
4 Het  verzoek tot levensbeëindiging van minderjarige patiënten mag ingewilligd worden, 
als zij in staat zijn tot een redelijke beoordeling van hun belangen. 
          
5 Het ondergaan van een chronische aandoening maakt dat, in vergelijking met hun 
gezonde leeftijdsgenoten, jongere minderjarige patiënten vaak beter in staat zijn hun 
belangen redelijk te beoordelen. 
          
6 De toediening van een letaal middel kan aanvaardbaar zijn als ouder(s)/vertegen-
woordiger(s) van een niet wilsbekwame minderjarige patiënt er om verzoeken. 
          
7 Met de wensen van oudere minderjarige patiënten moet principieel even veel rekening 
gehouden worden als met de wensen van meerderjarige patiënten. 
          
8 Voor het nemen van levensverkortende beslissingen bij minderjarigen is steeds de 
toestemming van de ouder(s)/vertegenwoordiger(s) vereist. 
          
9 De beslissing over mogelijk levensverkortende handelingen bij wilsonbekwame 
kinderen is uitsluitend de verantwoordelijkheid van de arts. 
          
10 De taak van de arts houdt soms in dat hij/zij overbodig lijden bij minderjarige patiënten 
moet verhinderen door het levenseinde te bespoedigen. 
          
11 Op levensverlening gerichte behandeling is niet altijd in het belang van een ernstig 
zieke minderjarige patiënt. 
          
12 Palliatieve sedatie is bij minderjarige patiënten steeds te verkiezen boven de 
toediening van een letaal middel. 
          
13 Adequate pijnbestrijding en zorg rond het levenseinde maken euthanasie overbodig bij 
minderjarigen. 
          
 Toelichting 
34 Als bepaalde van uw antwoorden volgens u nog verdere verduidelijking behoeven, kunt u dit hier neerschrijven. 
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